Werner Seeger

Q: What Schools Are Affiliated With Werner Seeger

Werner Seeger is affiliated with the following schools: University of Vienna, University of Giessen, University of Cambridge, Monash University, Goethe University Frankfurt, Medical University of Vienna, Humboldt University of Berlin, University of Lübeck, University of Sheffield, University of Marburg, University of Cologne, University of Konstanz

Werner Seeger's AcademicInfluence.com Rankings

Werner Seeger

Philosophy

#3267

World Rank

#5315

Historical Rank

Logic

#1045

World Rank

#1668

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Werner Seeger's Degrees

Doctorate Medicine University of Marburg

Why Is Werner Seeger Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Werner Seeger's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Inhaled iloprost for severe pulmonary hypertension. (2002) (1369)
Reversal of experimental pulmonary hypertension by PDGF inhibition. (2005) (1053)
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial (2002) (765)
Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. (2000) (627)
Real-time quantitative RT–PCR after laser-assisted cell picking (1998) (613)
Pulmonary hypertension due to left heart diseases. (2013) (556)
Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension (2002) (516)
Clinical classification of pulmonary hypertension. (2001) (508)
WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. (2009) (489)
Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. (2010) (488)
Imatinib for the treatment of pulmonary arterial hypertension. (2005) (469)
Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis. (2008) (442)
Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis (2008) (432)
[Updated treatment algorithm of pulmonary arterial hypertension]. (2014) (421)
Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. (1996) (405)
Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. (2004) (400)
Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension (1996) (397)
Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. (1985) (389)
Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. (1999) (386)
Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension. (2003) (368)
Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand (2008) (356)
Mutations of the TGF‐β type II receptor BMPR2 in pulmonary arterial hypertension (2006) (344)
Pulmonary hypertension in chronic lung disease and hypoxia (2019) (339)
Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. (2000) (338)
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. (2004) (332)
Hypoxia-Dependent Regulation of Nonphagocytic NADPH Oxidase Subunit NOX4 in the Pulmonary Vasculature (2007) (330)
Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. (1996) (323)
Pulmonary hypertension in chronic lung diseases. (2013) (321)
A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. (2000) (312)
Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange (2006) (306)
Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy (2000) (305)
Sildenafil Increased Exercise Capacity during Hypoxia at Low Altitudes and at Mount Everest Base Camp (2004) (300)
Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. (2003) (289)
Inducible NOS Inhibition Reverses Tobacco-Smoke-Induced Emphysema and Pulmonary Hypertension in Mice (2011) (289)
Aerosolised prostacyclin in adult respiratory distress syndrome (1993) (283)
Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension. (2012) (279)
Inhaled Iloprost To Treat Severe Pulmonary Hypertension: An Uncontrolled Trial (2000) (275)
Mesenchymal Stem Cells in Fibrotic Disease. (2017) (274)
Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats. (2004) (272)
Updated treatment algorithm of pulmonary arterial hypertension. (2013) (272)
Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. (2004) (269)
Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. (1993) (267)
Reproduction of transfusion-related acute lung injury in an ex vivo lung model. (1990) (259)
End points and clinical trial design in pulmonary arterial hypertension. (2004) (246)
Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. (2003) (245)
Whole-genome sequencing of patients with rare diseases in a national health system (2020) (239)
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension (2018) (238)
[Pulmonary hypertension in chronic lung diseases]. (2014) (233)
Alveolar Epithelial Cells Direct Monocyte Transepithelial Migration upon Influenza Virus Infection: Impact of Chemokines and Adhesion Molecules1 (2006) (229)
Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension (2008) (228)
Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. (1996) (228)
Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia. (2007) (227)
Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. (2005) (220)
Activation of Soluble Guanylate Cyclase Reverses Experimental Pulmonary Hypertension and Vascular Remodeling (2006) (219)
Impact of TASK-1 in Human Pulmonary Artery Smooth Muscle Cells (2006) (219)
Surfactant alteration and replacement in acute respiratory distress syndrome (2001) (218)
Stress Doppler Echocardiography in Relatives of Patients With Idiopathic and Familial Pulmonary Arterial Hypertension: Results of a Multicenter European Analysis of Pulmonary Artery Pressure Response to Exercise and Hypoxia (2009) (217)
The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice. (2002) (217)
Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. (2002) (216)
Surfactant abnormalities in patients with respiratory failure after multiple trauma. (1989) (215)
Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension (2014) (215)
Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. (2009) (210)
Monocytes Are Potent Facilitators of Alveolar Neutrophil Emigration During Lung Inflammation: Role of the CCL2-CCR2 Axis1 (2003) (209)
Short-Time Infusion of Fish Oil-Based Lipid Emulsions, Approved for Parenteral Nutrition, Reduces Monocyte Proinflammatory Cytokine Generation and Adhesive Interaction with Endothelium in Humans 1 (2003) (208)
Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms (2008) (201)
Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung. (2006) (197)
Inhibition of monocyte, lymphocyte, and neutrophil adhesion to endothelial cells by human milk oligosaccharides (2004) (195)
Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species. (2004) (192)
Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy (2017) (192)
ω-3 vs. ω-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation (2003) (188)
Macrophage-expressed IFN-β Contributes to Apoptotic Alveolar Epithelial Cell Injury in Severe Influenza Virus Pneumonia (2013) (187)
Sildenafil treatment for portopulmonary hypertension (2006) (187)
Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension (2005) (186)
Adrenomedullin Reduces Endothelial Hyperpermeability (2002) (184)
The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups. (2017) (183)
MicroRNA-124 Controls the Proliferative, Migratory, and Inflammatory Phenotype of Pulmonary Vascular Fibroblasts (2014) (182)
Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. (2006) (181)
Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation. (2006) (179)
Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. (1996) (175)
The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (2018) (175)
Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension (2007) (175)
Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome. (2000) (174)
Simvastatin Inhibits Inflammatory Properties of Staphylococcus aureus &agr;-Toxin (2002) (170)
Activation of TRPC6 channels is essential for lung ischaemia–reperfusion induced oedema in mice (2012) (168)
Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial (2015) (167)
Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits. (2003) (167)
Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension. (2012) (165)
Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer. (2015) (162)
AMP-activated protein kinase regulates CO2-induced alveolar epithelial dysfunction in rats and human cells by promoting Na,K-ATPase endocytosis. (2008) (159)
Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14. (2001) (158)
Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension. (2019) (153)
Cardio-Pulmonary-Renal Interactions: A Multidisciplinary Approach. (2015) (153)
Pulmonary surfactant: functions, abnormalities and therapeutic options (2001) (148)
Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies. (2006) (147)
Dysregulated Bone Morphogenetic Protein Signaling in Monocrotaline-Induced Pulmonary Arterial Hypertension (2007) (146)
Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features. (2003) (146)
Role of resident alveolar macrophages in leukocyte traffic into the alveolar air space of intact mice. (2002) (144)
Phosphodiesterase 1 Upregulation in Pulmonary Arterial Hypertension: Target for Reverse-Remodeling Therapy (2007) (141)
Monocyte Migration Through the Alveolar Epithelial Barrier: Adhesion Molecule Mechanisms and Impact of Chemokines1 (2000) (140)
Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis (2019) (138)
Transgelin is a direct target of TGF‐β/Smad3‐dependent epithelial cell migration in lung fibrosis (2008) (137)
Fgf10-positive cells represent a progenitor cell population during lung development and postnatally (2014) (136)
The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies. (2000) (136)
Bacterial exotoxins and endothelial permeability for water and albumin in vitro. (1988) (134)
Abnormalities of gastric mucosal oxygenation in septic shock: partial responsiveness to dopexamine. (1998) (134)
Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia. (2001) (132)
Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery. (2012) (131)
Endotoxin-Induced Myocardial Tumor Necrosis Factor-&agr; Synthesis Depresses Contractility of Isolated Rat Hearts: Evidence for a Role of Sphingosine and Cyclooxygenase-2–Derived Thromboxane Production (2000) (128)
Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis. (2017) (128)
Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis. (2017) (127)
Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis. (1999) (126)
Role of epidermal growth factor inhibition in experimental pulmonary hypertension. (2010) (126)
Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. (2002) (126)
ω-3 Fatty acid–based lipid infusion in patients with chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, multicenter trial (1998) (125)
NOX4 regulates ROS levels under normoxic and hypoxic conditions, triggers proliferation, and inhibits apoptosis in pulmonary artery adventitial fibroblasts. (2008) (124)
Prostacyclin and its analogues in the treatment of pulmonary hypertension. (2004) (124)
Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes. (1986) (121)
Effects of aerosolized prostacyclin in severe pneumonia. Impact of fibrosis. (1995) (119)
Matrix metalloproteinases and their inhibitors in pulmonary hypertension (2012) (118)
HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells. (2010) (118)
Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension. (2001) (117)
Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF (2013) (116)
Role of Src Tyrosine Kinases in Experimental Pulmonary Hypertension (2012) (116)
Reserve of Right Ventricular-Arterial Coupling in the Setting of Chronic Overload (2019) (114)
Macrophage tumor necrosis factor-alpha induces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair. (2009) (111)
Hypoxic pulmonary artery fibroblasts trigger proliferation of vascular smooth muscle cells‐role of hypoxia‐inducible transcription factors (2002) (110)
Nitric oxide generation and hypoxic vasoconstriction in buffer-perfused rabbit lungs. (1995) (108)
Relevance of the TAPSE/PASP ratio in pulmonary arterial hypertension. (2018) (108)
Antiremodeling Effects of Iloprost and the Dual-Selective Phosphodiesterase 3/4 Inhibitor Tolafentrine in Chronic Experimental Pulmonary Hypertension (2004) (107)
Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension. (2006) (107)
Biophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitro. (2011) (106)
TGF-β directs trafficking of the epithelial sodium channel ENaC which has implications for ion and fluid transport in acute lung injury (2013) (106)
Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension (2005) (106)
Staphylococcal alpha-toxin-induced PGI2 production in endothelial cells: role of calcium. (1985) (105)
Transforming Growth Factor-β-Dependent Growth Inhibition in Primary Vascular Smooth Muscle Cells Is p38-Dependent (2005) (104)
Alveolar JE/MCP-1 and endotoxin synergize to provoke lung cytokine upregulation, sequential neutrophil and monocyte influx, and vascular leakage in mice. (2001) (104)
Identification of novel Nox4 splice variants with impact on ROS levels in A549 cells. (2005) (104)
Obstructive Sleep Apnea, Oxidative Stress and Cardiovascular Disease: Lessons from Animal Studies (2013) (104)
Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model. (2009) (102)
Genetic association of the serotonin transporter in pulmonary arterial hypertension. (2006) (101)
Evaluation of angiogenesis using micro-computed tomography in a xenograft mouse model of lung cancer. (2009) (100)
Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs. (2017) (99)
Neoalveolarisation contributes to compensatory lung growth following pneumonectomy in mice (2008) (97)
Characterisation of post-pneumonectomy lung growth in adult mice (2004) (97)
Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension. (2011) (96)
Differential sensitivity to fibrinogen inhibition of SP-C- vs. SP-B-based surfactants. (1992) (96)
Hypoxia‐driven proliferation of human pulmonary artery fibroblasts: cross‐talk between HIF‐1α and an autocrine angiotensin system (2005) (96)
Hypoxic vasoconstriction in intact lungs: a role for NADPH oxidase-derived H(2)O(2)? (2000) (96)
Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4. (2009) (96)
Alveolar epithelial cells orchestrate DC function in murine viral pneumonia. (2012) (96)
Fish oil in critical illness (2008) (96)
Impact of mitochondria and NADPH oxidases on acute and sustained hypoxic pulmonary vasoconstriction. (2006) (95)
A Search for subgroups of patients with ARDS who may benefit from surfactant replacement therapy: a pooled analysis of five studies with recombinant surfactant protein-C surfactant (Venticute). (2008) (95)
Lysyl Oxidases Play a Causal Role in Vascular Remodeling in Clinical and Experimental Pulmonary Arterial Hypertension (2014) (94)
The noncanonical WNT pathway is operative in idiopathic pulmonary arterial hypertension. (2009) (94)
Circulating Vascular Progenitor Cells Do Not Contribute to Compensatory Lung Growth (2003) (93)
Changes in extracranial arteries in obstructive sleep apnoea (2005) (92)
Whole genome sequencing of a sporadic primary immunodeficiency cohort (2018) (92)
Senescence-associated secretory phenotype and its possible role in chronic obstructive pulmonary disease. (2014) (91)
Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma (2015) (91)
Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. (1998) (91)
Surfactant protein A down-regulates proinflammatory cytokine production evoked by Candida albicans in human alveolar macrophages and monocytes. (1999) (91)
Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats (2010) (91)
Pneumolysin-Induced Lung Injury Is Independent of Leukocyte Trafficking into the Alveolar Space1 (2004) (91)
The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats (2012) (90)
Inhaled prostanoids in the therapy of pulmonary hypertension. (2008) (90)
Role of Hypoxia-Inducible Factor-1α in Hypoxia-Induced Apoptosis of Primary Alveolar Epithelial Type II Cells (2005) (90)
Fish oil in the critically ill: from experimental to clinical data (2006) (89)
TGF‐β signaling is dynamically regulated during the alveolarization of rodent and human lungs (2008) (89)
Inflammation, immunological reaction and role of infection in pulmonary hypertension. (2011) (88)
PKR regulates TLR2/TLR4-dependent signaling in murine alveolar macrophages. (2008) (88)
Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity. (1993) (88)
Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis (2015) (88)
SNAI transcription factors mediate epithelial–mesenchymal transition in lung fibrosis (2009) (88)
Influenza Virus Infects Epithelial Stem/Progenitor Cells of the Distal Lung: Impact on Fgfr2b-Driven Epithelial Repair (2016) (88)
Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection. (2016) (87)
CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels. (2005) (87)
Human endothelial cell activation and mediator release in response to the bacterial exotoxins Escherichia coli hemolysin and staphylococcal alpha-toxin. (1997) (87)
Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension. (1997) (86)
cDNA array hybridization after laser-assisted microdissection from nonneoplastic tissue. (2002) (86)
Adult respiratory distress syndrome: model systems using isolated perfused rabbit lungs. (1994) (86)
Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair. (2009) (85)
Staphylococcal alpha-toxin-induced vascular leakage in isolated perfused rabbit lungs. (1990) (85)
Effects of Escherichia coli hemolysin on endothelial cell function (1990) (85)
Comparative proteomic analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and lung transplant donor lungs. (2011) (85)
Barriers to new drug development in respiratory disease (2015) (84)
Pivotal Role of Matrix Metalloproteinase 13 in Extracellular Matrix Turnover in Idiopathic Pulmonary Fibrosis (2013) (84)
Classical transient receptor potential channel 1 in hypoxia-induced pulmonary hypertension. (2013) (83)
Fhl-1, a New Key Protein in Pulmonary Hypertension (2008) (82)
Surfactant-Free, Biodegradable Nanoparticles for Aerosol Therapy Based on the Branched Polyesters, DEAPA-PVAL-g-PLGA (2003) (82)
Enhanced Tissue Factor Pathway Activity and Fibrin Turnover in the Alveolar Compartment of Patients with Interstitial Lung Disease (2000) (82)
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis (2019) (81)
Effects of NADPH oxidase inhibitors on hypoxic vasoconstriction in buffer-perfused rabbit lungs. (1995) (81)
Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis (2015) (81)
Epithelial stress and apoptosis underlie Hermansky-Pudlak syndrome-associated interstitial pneumonia. (2010) (81)
Novel and emerging therapies for pulmonary hypertension. (2014) (81)
RNA interference for HIF-1alpha inhibits its downstream signalling and affects cellular proliferation. (2003) (81)
Stimulation of soluble guanylate cyclase prevents cigarette smoke-induced pulmonary hypertension and emphysema. (2014) (81)
Nocturnal periodic breathing in primary pulmonary hypertension (2002) (80)
Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension. (2002) (80)
Differential Effects of Drugs Targeting Cancer Stem Cell (CSC) and Non-CSC Populations on Lung Primary Tumors and Metastasis (2013) (80)
Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. (1990) (80)
Long-term therapy with inhaled iloprost in patients with pulmonary hypertension. (2010) (80)
Inhaled iloprost reverses vascular remodeling in chronic experimental pulmonary hypertension. (2005) (80)
The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis. (2007) (79)
Mitochondrial Complex IV Subunit 4 Isoform 2 Is Essential for Acute Pulmonary Oxygen Sensing (2017) (79)
Hypoxic vasoconstriction in buffer-perfused rabbit lungs. (1995) (78)
Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation. (1996) (78)
Impact of arachidonic versus eicosapentaenoic acid on exotonin-induced lung vascular leakage: relation to 4-series versus 5-series leukotriene generation. (1997) (78)
Oleic acid inhibits alveolar fluid reabsorption: a role in acute respiratory distress syndrome? (2005) (78)
Safety and tolerability of bosentan in idiopathic pulmonary fibrosis: an open label study (2007) (78)
Cell-Specific Nitric Oxide Synthase-Isoenzyme Expression and Regulation in Response to Endotoxin in Intact Rat Lungs (2002) (77)
Functional role and species-specific contribution of arginases in pulmonary fibrosis. (2008) (77)
Increased lung vascular permeability after arachidonic acid and hydrostatic challenge. (1986) (77)
Exudate macrophages attenuate lung injury by the release of IL-1 receptor antagonist in gram-negative pneumonia. (2011) (77)
Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia (2017) (76)
Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension. (1999) (76)
Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension. (2008) (76)
Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics (2002) (76)
A double-blind, randomized, placebo-controlled trial of n-3 versus n-6 fatty acid-based lipid infusion in atopic dermatitis. (2002) (76)
Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation (1996) (76)
Escherichia coli hemolysin is a potent inductor of phosphoinositide hydrolysis and related metabolic responses in human neutrophils. (1991) (75)
The listerial exotoxins listeriolysin and phosphatidylinositol-specific phospholipase C synergize to elicit endothelial cell phosphoinositide metabolism. (1996) (75)
Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium. (1984) (75)
Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats (2011) (75)
Iloprost-Containing Liposomes for Aerosol Application in Pulmonary Arterial Hypertension: Formulation Aspects and Stability (2007) (75)
Effects of cell‐penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs (2008) (75)
Lysyl oxidase activity is dysregulated during impaired alveolarization of mouse and human lungs. (2009) (74)
Alveolar surfactant and adult respiratory distress syndrome (1993) (74)
Role of endothelial MCP-1 in monocyte adhesion to inflamed human endothelium under physiological flow. (2002) (74)
Increased pulmonary vascular resistance and permeability due to arachidonate metabolism in isolated rabbit lungs. (1982) (73)
Oxygen sensors in hypoxic pulmonary vasoconstriction. (2006) (73)
Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension (2016) (73)
Wegener's Granulomatosis: Anti–proteinase 3 Antibodies Are Potent Inductors of Human Endothelial Cell Signaling and Leakage Response (1998) (73)
Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration (2007) (73)
NO and reactive oxygen species are involved in biphasic hypoxic vasoconstriction of isolated rabbit lungs. (2001) (72)
Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties (2002) (71)
Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts: role of thromboxane generation. (2000) (71)
Mechanism of leukotriene generation in polymorphonuclear leukocytes by staphylococcal alpha-toxin (1987) (71)
Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin (2015) (71)
WNT 1-inducible signaling protein – 1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis (2009) (71)
5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure (2015) (71)
Inhaled iloprost is a potent acute pulmonary vasodilator in HIV‐related severe pulmonary hypertension (2004) (71)
Executive functions and cognitive subprocesses in patients with obstructive sleep apnoea (2008) (71)
Sleep apnea in precapillary pulmonary hypertension. (2013) (71)
Cellular pathophysiology and therapy of pulmonary hypertension. (2001) (70)
miR-142-3p balances proliferation and differentiation of mesenchymal cells during lung development (2014) (70)
Cellular and molecular mechanisms of hypoxia-inducible factor driven vascular remodeling (2007) (70)
Adenosine diphosphate-ribosylation of G-actin by botulinum C2 toxin increases endothelial permeability in vitro. (1991) (70)
Basic features of hypoxic pulmonary vasoconstriction in mice (2004) (69)
Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention (2010) (69)
Hypoxia induces Kv channel current inhibition by increased NADPH oxidase-derived reactive oxygen species. (2012) (69)
Importance of Phosphoinositide 3-Kinase γ in the Host Defense against Pneumococcal Infection (2007) (68)
Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension. (2008) (68)
Role of Listeria monocytogenes Exotoxins Listeriolysin and Phosphatidylinositol-Specific Phospholipase C in Activation of Human Neutrophils (1999) (68)
Listeriolysin is a potent inducer of the phosphatidylinositol response and lipid mediator generation in human endothelial cells (1996) (67)
Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations (2011) (67)
ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension (2017) (67)
Alveolar antioxidant status in patients with acute respiratory distress syndrome (2004) (67)
Human Endothelial Cell Activation and Mediator Release in Response to Listeria monocytogenesVirulence Factors (2001) (66)
Pseudomonas aeruginosa cytotoxin stimulates prostacyclin production in cultured pulmonary artery endothelial cells: Membrane attack and calcium influx (1985) (66)
Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids (2007) (66)
Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension. (2010) (66)
Thrombin impairs alveolar fluid clearance by promoting endocytosis of Na+,K+-ATPase. (2005) (66)
Preoperative Renal Functional Reserve Predicts Risk of Acute Kidney Injury After Cardiac Operation. (2018) (65)
Inhaled granulocyte/macrophage colony-stimulating factor as treatment of pneumonia-associated acute respiratory distress syndrome. (2014) (65)
Molecular pathways of monocyte emigration into the alveolar air space of intact mice. (2002) (65)
Thromboxane-mediated hypertension and vascular leakage evoked by low doses of Escherichia coli hemolysin in rabbit lungs. (1989) (65)
Microenvironmental Th9- and Th17- lymphocytes induce metastatic spreading in lung cancer. (2020) (65)
Characterization of the platelet-derived growth factor receptor-α-positive cell lineage during murine late lung development. (2015) (65)
Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity. (2001) (65)
The Role of Dimethylarginine Dimethylaminohydrolase in Idiopathic Pulmonary Fibrosis (2011) (64)
Pirfenidone exerts anti-fibrotic effects through Inhibition of GLI transcription factors (2017) (64)
Alteration of alveolar surfactant function after exposure to oxidative stress and to oxygenated and native arachidonic acid in vitro. (1985) (64)
Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non–Small Cell Lung Carcinoma (2020) (64)
Mediator generation and signaling events in alveolar epithelial cells attacked by S. aureus alpha-toxin. (2002) (64)
p38 MAPK Inhibition Improves Heart Function in Pressure‐Loaded Right Ventricular Hypertrophy (2017) (64)
Novel 'nano in nano' composites for sustained drug delivery: biodegradable nanoparticles encapsulated into nanofiber non-wovens. (2010) (64)
Serum matrix metalloproteinases in adult CF patients: Relation to pulmonary exacerbation. (2009) (64)
FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis (2017) (64)
An ELISA technique for quantification of surfactant apoprotein (SP)-C in bronchoalveolar lavage fluid. (1995) (63)
Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease model. (2013) (63)
Function of NADPH oxidase 1 in pulmonary arterial smooth muscle cells after monocrotaline-induced pulmonary vascular remodeling. (2013) (63)
Evidence for a role of protein kinase C in hypoxic pulmonary vasoconstriction. (1999) (63)
Hydrogen peroxide-induced increase in lung endothelial and epithelial permeability--effect of adenylate cyclase stimulation and phosphodiesterase inhibition. (1995) (63)
Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors. (2013) (62)
Alveolar fluid clearance in acute lung injury: what have we learned from animal models and clinical studies? (2007) (61)
Complement complex C5b-8 induces PGI2 formation in cultured endothelial cells. (1987) (61)
Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension: response to iloprost inhalation. (2001) (61)
Receptor for Activated C-Kinase 1, a Novel Interaction Partner of Type II Bone Morphogenetic Protein Receptor, Regulates Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension (2007) (61)
Cardiac Magnetic Resonance Imaging-Based Right Ventricular Strain Analysis for Assessment of Coupling and Diastolic Function in Pulmonary Hypertension. (2019) (61)
Lung cancer–associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell–immune cell cross-talk (2017) (61)
In situ localization of TNFα/β, TACE AND TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue (2003) (61)
APOPTOSIS CONTRIBUTES TO SEPTIC CARDIOMYOPATHY AND IS IMPROVED BY SIMVASTATIN THERAPY (2008) (60)
Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias (2006) (60)
Identification of right heart-enriched genes in a murine model of chronic outflow tract obstruction. (2010) (60)
Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchange. (2000) (60)
Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates. Experimental and clinical studies. (1999) (60)
Collagen and elastin cross-linking is altered during aberrant late lung development associated with hyperoxia. (2015) (60)
The inflammatory versus constitutive trafficking of mononuclear phagocytes into the alveolar space of mice is associated with drastic changes in their gene expression profiles (2006) (59)
Effects of mitochondrial inhibitors and uncouplers on hypoxic vasoconstriction in rabbit lungs. (2003) (59)
Immunostaining for cell picking and real-time mRNA quantitation. (2000) (59)
Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer (2020) (59)
High mobility group protein-mediated transcription requires DNA damage marker γ-H2AX (2015) (59)
Amplified canonical transforming growth factor-β signalling via heat shock protein 90 in pulmonary fibrosis (2017) (59)
Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles. (2014) (59)
Amplification of the pulmonary vasodilatory response to inhaled iloprost by subthreshold phosphodiesterase types 3 and 4 inhibition in severe pulmonary hypertension (2002) (59)
Immunostaining and Laser-Assisted Cell Picking for mRNA Analysis (2000) (58)
Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization. (2012) (58)
Stereological monitoring of mouse lung alveolarization from the early postnatal period to adulthood. (2017) (58)
Oligopeptidase B from Trypanosoma evansi (2005) (58)
Lipoteichoic acid (LTA) from Staphylococcus aureus stimulates human neutrophil cytokine release by a CD14-dependent, Toll-like-receptor-independent mechanism: Autocrine role of tumor necrosis factor-&agr; in mediating LTA-induced interleukin-8 generation (2006) (58)
PAR-2 Inhibition Reverses Experimental Pulmonary Hypertension (2012) (58)
Surfactant protein A (SP‐A) is decreased in acute parenchymal lung injury associated with polytrauma * (1992) (58)
Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients (2011) (58)
The transforming growth factor-β/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension (2007) (57)
Physiologic basis for the treatment of pulmonary hypertension. (2001) (57)
Carbon monoxide rapidly impairs alveolar fluid clearance by inhibiting epithelial sodium channels. (2009) (57)
Severe organising pneumonia following COVID-19 (2020) (57)
Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial. (1998) (57)
The hemolysin of escherichia coli (1988) (56)
Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk (2020) (56)
Pulmonary targeting with biodegradable salbutamol-loaded nanoparticles. (2010) (56)
Diacylglycerol regulates acute hypoxic pulmonary vasoconstriction via TRPC6 (2011) (56)
Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis. (2015) (56)
The effect of 1 ppm nitrogen dioxide on bronchoalveolar lavage cells and inflammatory mediators in normal and asthmatic subjects. (1995) (55)
Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension. (2020) (55)
Arachidonic acid lipoxygenase pathways and increased vascular permeability in isolated rabbit lungs. (1987) (55)
Modified polyethylenimines as non-viral gene delivery systems for aerosol gene therapy: investigations of the complex structure and stability during air-jet and ultrasonic nebulization. (2004) (55)
Effects of hypercapnia with and without acidosis on hypoxic pulmonary vasoconstriction. (2009) (55)
Hmga2 is required for canonical WNT signaling during lung development (2014) (54)
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension (2019) (54)
Ultrasonic nebulization for efficient delivery of surfactant in a model of acute lung injury. Impact on gas exchange. (1997) (54)
Sildenafil Improves Dynamic Vascular Function in the Brain: Studies in Patients with Pulmonary Hypertension (2006) (54)
Impact of HIF‐1α and HIF‐2α on proliferation and migration of human pulmonary artery fibroblasts in hypoxia (2006) (54)
Effect of PEGylation on the stability of liposomes during nebulisation and in lung surfactant. (2006) (53)
Synthesis of arachidonic acid-derived lipoxygenase and cytochrome P450 products in the intact human lung vasculature. (2000) (53)
Fgf10 deficiency is causative for lethality in a mouse model of bronchopulmonary dysplasia (2017) (53)
Influence of microvascular adherence on neutrophil leukotriene generation. Evidence for cooperative eicosanoid synthesis. (1990) (52)
On-line measurement of nitric oxide generation in buffer-perfused rabbit lungs. (1995) (52)
Wegener’s granulomatosis: antiproteinase 3 antibodies induce monocyte cytokine and prostanoid release—role of autocrine cell activation (2002) (52)
Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy (2019) (52)
Parenteral nutrition with n-3 lipids in sepsis (2002) (51)
Acute lung injury is reduced in fat-1 mice endogenously synthesizing n-3 fatty acids. (2009) (51)
Hypoxic pulmonary vasoconstriction: a multifactorial response? (2001) (51)
Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers. (2012) (51)
Potentiation of leukotriene production following sequestration of neutrophils in isolated lungs: indirect evidence for intercellular leukotriene A4 transfer. (1988) (51)
miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach. (2016) (51)
Phagocytosis of viable Candida albicans by alveolar macrophages: lack of opsonin function of surfactant protein A. (1997) (51)
TIAR and TIA-1 mRNA-binding proteins co-aggregate under conditions of rapid oxygen decline and extreme hypoxia and suppress the HIF-1α pathway. (2010) (51)
Safety and tolerability of inhaled heparin in idiopathic pulmonary fibrosis. (2010) (51)
Interactions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesis (2014) (51)
Hypoxia- and non-hypoxia-related pulmonary hypertension - established and new therapies. (2006) (50)
Inhibition of urokinase activity reduces primary tumor growth and metastasis formation in a murine lung carcinoma model. (2010) (50)
Altered fatty acid composition of lung surfactant phospholipids in interstitial lung disease. (2002) (50)
Influence of intravenous n‐3 lipid supplementation on fatty acid profiles and lipid mediator generation in a patient with severe ulcerative colitis (1993) (50)
Changing the Mindset in Life Sciences Toward Translation: A Consensus (2014) (50)
Subhemolytic doses of Escherichia coli hemolysin evoke large quantities of lipoxygenase products in human neutrophils. (1991) (49)
Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension (2012) (49)
Hypoxia-inducible factor signaling in pulmonary hypertension. (2020) (49)
Glucocorticoids Recruit Tgfbr3 and Smad1 to Shift Transforming Growth Factor-β Signaling from the Tgfbr1/Smad2/3 Axis to the Acvrl1/Smad1 Axis in Lung Fibroblasts* (2013) (49)
Development of a biodegradable nanoparticle platform for sildenafil: formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters. (2012) (49)
Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation (2012) (48)
Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis (2018) (48)
Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury (2008) (48)
Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension (2010) (48)
Nanocomposites of lung surfactant and biodegradable cationic nanoparticles improve transfection efficiency to lung cells. (2009) (48)
High yield enzymatic conversion of intravascular leukotriene A4 in blood-free perfused lungs. (1988) (48)
Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia (2009) (48)
Evaluation and Prognostic Relevance of Right Ventricular-Arterial Coupling in Pulmonary Hypertension. (2019) (47)
Rat porphobilinogen deaminase gene: a pseudogene-free internal standard for laser-assisted cell picking. (1999) (47)
Expression of pro-inflammatory cytokines by flow-sorted alveolar macrophages in severe pneumonia. (1998) (47)
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension (2019) (47)
Increased neutrophil mediator release in patients with pulmonary hypertension – suppression by inhaled iloprost (2003) (47)
Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-β (2011) (47)
Release of leukotrienes into the perfusate of calcium-ionophore stimulated rabbit lungs. Influence of 5-lipoxygenase inhibitors. (1986) (47)
Importance of phosphoinositide 3-kinase gamma in the host defense against pneumococcal infection. (2007) (46)
In vitro mimicry of essential fatty acid deficiency in human endothelial cells by TNFα impact of ω-3 versus ω-6 fatty acids (2002) (46)
Role of actin depolymerization in the surfactant secretory response of alveolar epithelial type II cells. (1999) (46)
PROTECTION AGAINST GAS EXCHANGE ABNORMALITIES BY PRE-AEROSOLIZED PGE 1, ILOPROST AND NITROPRUSSIDE IN LUNG ISCHEMIA-REPERFUSION1 (2001) (46)
BDNF/TrkB signaling augments smooth muscle cell proliferation in pulmonary hypertension. (2012) (46)
Systemic hydrogen sulfide administration partially restores normal alveolarization in an experimental animal model of bronchopulmonary dysplasia. (2014) (46)
Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension. (2001) (45)
Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension (2018) (45)
Arterial hypertension in a murine model of sleep apnea: role of NADPH oxidase 2 (2014) (45)
Rat pulmonary cyclooxygenase-2 expression in response to endotoxin challenge: differential regulation in the various types of cells in the lung. (2000) (45)
More on Single-Beat Estimation of Right Ventriculoarterial Coupling in Pulmonary Arterial Hypertension. (2018) (45)
Alveolar oxidative stress is associated with elevated levels of nonenzymatic low-molecular-weight antioxidants in patients with different forms of chronic fibrosing interstitial lung diseases. (2009) (45)
Identification and Functional Characterization of Hypoxia-Induced Endoplasmic Reticulum Stress Regulating lncRNA (HypERlnc) in Pericytes (2017) (45)
Pathophysiology of acute lung injury. (2001) (44)
Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension (2010) (44)
Omega-3 lipid infusion in a heart allotransplant model. Shift in fatty acid and lipid mediator profiles and prolongation of transplant survival. (1996) (44)
The H2S-generating enzymes cystathionine β-synthase and cystathionine γ-lyase play a role in vascular development during normal lung alveolarization. (2015) (43)
ELISA technique for quantification of surfactant protein B (SP-B) in bronchoalveolar lavage fluid. (1995) (43)
Vasoregulatory prostanoid generation proceeds via cyclooxygenase-2 in noninflamed rat lungs. (1998) (43)
Nitric oxide inhibits highly selective sodium channels and the Na+/K+-ATPase in H441 cells. (2011) (43)
Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension (2018) (42)
Phenotypical and ultrastructural features of Oct4-positive cells in the adult mouse lung (2014) (42)
Efficiency of aerosolized nitric oxide donor drugs to achieve sustained pulmonary vasodilation. (1997) (42)
Procoagulant activity in bronchoalveolar lavage of severely traumatized patients--relation to the development of acute respiratory distress. (1991) (42)
Prostacyclin enhances stretch-induced surfactant secretion in alveolar epithelial type II cells. (1999) (42)
Short-term "preconditioning" with inhaled nitric oxide protects rabbit lungs against ischemia-reperfusion injury. (2001) (41)
Comparison of the effects of carbon ion and photon irradiation on the angiogenic response in human lung adenocarcinoma cells. (2011) (41)
Evolutionary Conserved Role of c-Jun-N-Terminal Kinase in CO2-Induced Epithelial Dysfunction (2012) (41)
Nitro blue tetrazolium inhibits but does not mimic hypoxic vasoconstriction in isolated rabbit lungs. (1998) (41)
Altered surfactant homeostasis and alveolar epithelial cell stress in amiodarone-induced lung fibrosis. (2014) (41)
Phosphodiesterase 10A Upregulation Contributes to Pulmonary Vascular Remodeling (2010) (41)
Congestive nephropathy: a neglected entity? Proposal for diagnostic criteria and future perspectives (2020) (41)
The lectin-like domain of tumor necrosis factor-&agr; improves alveolar fluid balance in injured isolated rabbit lungs* (2008) (41)
Antihistone Properties of C1 Esterase Inhibitor Protect against Lung Injury (2017) (41)
Ex vivo antigen preparation for the serological detection of drug‐dependent antibodies in immune haemolytic anaemias (1984) (41)
Modified polyethylenimines as non viral gene delivery systems for aerosol therapy: effects of nebulization on cellular uptake and transfection efficiency. (2004) (41)
Metered dose inhaler delivery of treprostinil for the treatment of pulmonary hypertension. (2009) (40)
Glycogen Synthase Kinase 3beta Contributes to Proliferation of Arterial Smooth Muscle Cells in Pulmonary Hypertension (2011) (40)
Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs (2007) (40)
The glutathione redox cycle as a defense system against hydrogen-peroxide-induced prostanoid formation and vasoconstriction in rabbit lungs. (1986) (40)
Changes in pulmonary surfactant function and composition in bleomycin-induced pneumonitis and fibrosis. (2004) (40)
Doppler‐Derived Renal Venous Stasis Index in the Prognosis of Right Heart Failure (2019) (40)
Heme oxygenase-2 and large-conductance Ca2+-activated K+ channels: lung vascular effects of hypoxia. (2009) (40)
Downregulation of hypoxic vasoconstriction by chronic hypoxia in rabbits: effects of nitric oxide. (2003) (39)
Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis (2015) (39)
Deregulation of the lysyl hydroxylase matrix cross-linking system in experimental and clinical bronchopulmonary dysplasia. (2014) (39)
Resident alveolar macrophages are master regulators of arrested alveolarization in experimental bronchopulmonary dysplasia (2018) (39)
Dry powder aerosolization of a recombinant surfactant protein-C–based surfactant for inhalative treatment of the acutely inflamed lung* (2010) (39)
The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice. (2009) (39)
Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis (2019) (39)
Effects of Multikinase inhibitors on pressure overload-induced right ventricular remodelling (2013) (39)
Lamin B1 loss promotes lung cancer development and metastasis by epigenetic derepression of RET (2019) (39)
Acute kidney injury and urinary biomarkers in hospitalized patients with coronavirus disease-2019 (2020) (39)
Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro--comparison to natural surfactant. (1991) (38)
Role of hypoxia-inducible factor-1alpha in hypoxia-induced apoptosis of primary alveolar epithelial type II cells. (2005) (38)
Advantage of buffered solutions or automated capnometry in air-filled balloons for use in gastric tonometry (1997) (38)
Cell Density Regulates Neutrophil IL-8 Synthesis: Role of IL-1 Receptor Antagonist and Soluble TNF Receptors (2001) (38)
Type II alveolar epithelial eicosanoid metabolism: predominance of cyclooxygenase pathways and transcellular lipoxygenase metabolism in co-culture with neutrophils. (1992) (38)
Ventilation-perfusion mismatch after lung ischemia-reperfusion. Protective effect of nitric oxide. (1999) (38)
Impact of HIF-1alpha and HIF-2alpha on proliferation and migration of human pulmonary artery fibroblasts in hypoxia. (2006) (38)
Role of endothelial cytoskeleton in high-permeability edema due to botulinum C2 toxin in perfused rabbit lungs. (1995) (37)
Persistent decrease of renal functional reserve in patients after cardiac surgery-associated acute kidney injury despite clinical recovery (2018) (37)
DNA transfer into human lung cells is improved with Tat-RGD peptide by caveoli-mediated endocytosis. (2006) (37)
Shedding of low-density lipoprotein receptor–related protein-1 in acute respiratory distress syndrome. (2011) (37)
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors (2005) (37)
Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs (2007) (36)
Analysis of tumor vessel supply in Lewis lung carcinoma in mice by fluorescent microsphere distribution and imaging with micro- and flat-panel computed tomography. (2005) (36)
Leukotriene and hydroxyeicosatetraenoic acid generation elicited by low doses of Escherichia coli hemolysin in rabbit lungs (1990) (36)
Comparison of different detection methods in quantitative microdensitometry. (2001) (36)
Human RELMβ is a mitogenic factor in lung cells and induced in hypoxia (2006) (36)
Evaluating the controlled release properties of inhaled nanoparticles using isolated, perfused, and ventilated lung models (2011) (36)
Targeting miR‐34a/Pdgfra interactions partially corrects alveologenesis in experimental bronchopulmonary dysplasia (2019) (36)
MiCEE is a ncRNA-protein complex that mediates epigenetic silencing and nucleolar organization (2018) (36)
Transcriptome profiling of primary murine monocytes, lung macrophages and lung dendritic cells reveals a distinct expression of genes involved in cell trafficking (2009) (36)
Histological Characterization of Mast Cell Chymase in Patients with Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease (2014) (36)
Compartment- and cell-specific expression of coagulation and fibrinolysis factors in the murine lung undergoing inhalational versus intravenous endotoxin application (2004) (36)
Inhaled Treprostinil for Treatment of Chronic Pulmonary Arterial Hypertension (2006) (36)
Redox signaling and reactive oxygen species in hypoxic pulmonary vasoconstriction (2010) (35)
Compartmentalized lung cytokine release in response to intravascular and alveolar endotoxin challenge. (1996) (35)
Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer model (2009) (35)
Simultaneous analysis of 4- and 5-series lipoxygenase and cytochrome P450 products from different biological sources by reversed-phase high-performance liquid chromatographic technique. (1998) (35)
Worldwide physician education and training in pulmonary hypertension: pulmonary vascular disease: the global perspective. (2010) (35)
Detection of reactive oxygen species in isolated, perfused lungs by electron spin resonance spectroscopy (2005) (35)
Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis (2018) (35)
The Inflammatory versus Constitutive Trafficking of Mononuclear Phagocytes into the Alveolar Space of Mice Is Associated with Drastic Changes in Their Gene Expression Profiles 1 (2005) (35)
Stabilization of Aerosolizable Nano-carriers by Freeze-Drying (2008) (35)
Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition (2008) (34)
Noninvasive detection of early pulmonary vascular dysfunction in scleroderma. (2009) (34)
Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensing (2010) (34)
Photoaging Mobile Apps in School-Based Tobacco Prevention: The Mirroring Approach (2016) (34)
Fatty acids differentially influence phosphatidylinositol 3-kinase signal transduction in endothelial cells: impact on adhesion and apoptosis. (2008) (34)
Identification of proteins in laser-microdissected small cell numbers by SELDI-TOF and Tandem MS (2004) (34)
Vascular distension and continued ventilation are protective in lung ischemia/reperfusion. (1998) (34)
Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice (2010) (34)
Increased LTB4 metabolites and PGD2 in BAL fluid after methacholine challenge in asthmatic subjects. (1993) (34)
HbA1c in pulmonary arterial hypertension: a marker of prognostic relevance? (2012) (34)
Endotoxin "priming" potentiates lung vascular abnormalities in response to Escherichia coli hemolysin: an example of synergism between endo- and exotoxin (1994) (33)
Understanding alveolarization to induce lung regeneration (2018) (33)
Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock (2006) (33)
Pressure overload leads to an increased accumulation and activity of mast cells in the right ventricle (2017) (33)
Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension. (2008) (33)
Lung dendritic cells elicited by Fms-like tyrosine 3-kinase ligand amplify the lung inflammatory response to lipopolysaccharide. (2007) (33)
Congenital erythropoietin over-expression causes “anti-pulmonary hypertensive” structural and functional changes in mice, both in normoxia and hypoxia (2005) (33)
Surfactant abnormalities after single lung transplantation in dogs: impact of bronchoscopic surfactant administration. (2004) (33)
Carbon ion radiotherapy of human lung cancer attenuates HIF‐1 signaling and acts with considerably enhanced therapeutic efficiency (2014) (33)
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (2004) (33)
Amplification of LTB4 generation in AM-PMN cocultures: transcellular 5-lipoxygenase metabolism. (1991) (33)
Induction of severe vascular leakage by low doses of Escherichia coli hemolysin in perfused rabbit lungs. (1992) (33)
[Pathophysiology of pulmonary hypertension]. (1994) (32)
Structural and functional prevention of hypoxia-induced pulmonary hypertension by individualized exercise training in mice. (2014) (32)
Classical IL-6 signaling: a promising therapeutic target for pulmonary arterial hypertension. (2018) (32)
Right heart failure in pulmonary hypertension: Diagnosis and new perspectives on vascular and direct right ventricular treatment (2019) (32)
Temporal and spatial regulation of bone morphogenetic protein signaling in late lung development (2007) (32)
Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018. (2018) (32)
New potential diagnostic biomarkers for pulmonary hypertension (2015) (32)
Immunomodulation by n-3- versus n-6-rich lipid emulsions in murine acute lung injury—Role of platelet-activating factor receptor (2007) (32)
Peroxisome proliferator-activated receptor-α reduces inflammation and vascular leakage in a murine model of acute lung injury (2008) (32)
Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding (2018) (32)
Granulomatous gastritis in Wegener's disease: differentiation from Crohn's disease supported by a positive test for antineutrophil antibodies. (1997) (32)
Caffeine administration modulates TGF-β signaling but does not attenuate blunted alveolarization in a hyperoxia-based mouse model of bronchopulmonary dysplasia (2017) (32)
Quality of life in clinically stable adult cystic fibrosis out-patients: associations with daytime sleepiness and sleep quality. (2012) (32)
The transforming growth factor-beta/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension. (2007) (32)
Hypoxia-induced pulmonary hypertension: different impact of iloprost, sildenafil, and nitric oxide. (2007) (32)
Nitric oxide (NO)-dependent but not NO-independent guanylate cyclase activation attenuates hypoxic vasoconstriction in rabbit lungs. (2000) (32)
Tumor–stromal interactions in lung cancer: novel candidate targets for therapeutic intervention (2012) (31)
Pro- and antifibrinolytic properties of human pulmonary microvascular versus artery endothelial cells: Impact of endotoxin and tumor necrosis factor-&agr; (2004) (31)
Treatment with low-dose tacrolimus inhibits bleeding complications in a patient with hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension (2018) (31)
Aerosolized PGE1, PGI2 and nitroprusside protect against vascular leakage in lung ischaemia-reperfusion. (2001) (31)
Arterial Hypertension In A Murine Model Of Sleep Apnea - Role Of NADPH Oxidases (2010) (31)
Amphiphilic, low molecular weight poly(ethylene imine) derivatives with enhanced stability for efficient pulmonary gene delivery (2011) (31)
Differential vasoconstrictor potencies of free fatty acids in the lung vasculature: 2-versus 3-series prostanoid generation. (1993) (31)
Immunomodulation by lipid emulsions in pulmonary inflammation: a randomized controlled trial (2015) (31)
Lung vascular injury after administration of viable hemolysin-forming Escherichia coli in isolated rabbit lungs. (1991) (31)
Severe VA/Q mismatch in perfused lungs evoked by sequential challenge with endotoxin and E. coli hemolysin. (1994) (31)
Recovery from circulatory shock in severe primary pulmonary hypertension (PPH) with aerosolization of iloprost (1998) (31)
Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations. (2013) (31)
Treprostinil inhibits the adhesion and differentiation of fibrocytes via the cyclic adenosine monophosphate-dependent and Ras-proximate protein-dependent inactivation of extracellular regulated kinase. (2011) (31)
Pulmonary medicine and (adult) critical care medicine in Europe (2002) (31)
Dynamic hyperinflation during exercise in patients with precapillary pulmonary hypertension. (2011) (30)
Paxillin regulates pulmonary arterial smooth muscle cell function in pulmonary hypertension. (2012) (30)
Evidence for the Fucoidan/P-Selectin Axis as a Therapeutic Target in Hypoxia-induced Pulmonary Hypertension. (2019) (30)
Local complement activation, thromboxane-mediated vasoconstriction, and vascular leakage in isolated lungs. Role of the terminal complement sequence. (1989) (30)
Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis (2019) (30)
Ligand-operated synthesis of 4-series and 5-series leukotrienes in human neutrophils: critical dependence on exogenous free fatty acid supply. (1992) (30)
Suppression of cytoskeletal rearrangement in activated human neutrophils by botulinum C2 toxin. Impact on cellular signal transduction. (1991) (30)
Endotoxin induced peritonitis elicits monocyte immigration into the lung: implications on alveolar space inflammatory responsiveness (2006) (30)
Right ventricular function correlates of right atrial strain in pulmonary hypertension: a combined cardiac magnetic resonance and conductance catheter study. (2019) (30)
Morphometric analysis of pulmonary intracapillary leukocyte pools in ex vivo-perfused rabbit lungs. (1994) (29)
Sex Differences in Right Ventricular-pulmonary Arterial Coupling in Pulmonary Arterial Hypertension. (2020) (29)
Photoaging smartphone app promoting poster campaign to reduce smoking prevalence in secondary schools: the Smokerface Randomized Trial: design and baseline characteristics (2016) (29)
Pharmacokinetics and metabolism of infused versus inhaled iloprost in isolated rabbit lungs. (2002) (29)
Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice. (2016) (29)
cAMP Phosphodiesterase Inhibitors Increases Nitric Oxide Production by Modulating Dimethylarginine Dimethylaminohydrolases (2011) (29)
Systematic comparison of the T7-IVT and SMART-based RNA preamplification techniques for DNA microarray experiments. (2006) (29)
The emerging role of epigenetics in pulmonary hypertension (2016) (29)
Bypassing mitochondrial complex III using alternative oxidase inhibits acute pulmonary oxygen sensing (2020) (28)
Exudate macrophages attenuate lung injury by the release of IL-1 receptor antagonist in gram-negative pneumonia (2011) (28)
SCRINSHOT enables spatial mapping of cell states in tissue sections with single-cell resolution (2020) (28)
Effect of sildenafil on hypoxia-induced changes in pulmonary circulation and right ventricular function (2007) (28)
Proteolytic cleavage of fibrinogen: amplification of its surfactant inhibitory capacity. (1993) (28)
Megalin mediates transepithelial albumin clearance from the alveolar space of intact rabbit lungs (2012) (28)
Following the Concentration of Polymeric Nanoparticles During Nebulization (2012) (27)
Increased S100A4 expression in the vasculature of human COPD lungs and murine model of smoke-induced emphysema (2015) (27)
Lung cGMP release subsequent to NO inhalation in pulmonary hypertension: responders versus nonresponders (2002) (27)
Regulation of macroautophagy in amiodarone‐induced pulmonary fibrosis (2015) (27)
Analysis of 2- and 3-series prostanoids by post-HPLC ELISA. (1993) (27)
c-ANCA-induced neutrophil-mediated lung injury: a model of acute Wegener's granulomatosis (2009) (27)
Hypercapnia Impairs ENaC Cell Surface Stability by Promoting Phosphorylation, Polyubiquitination and Endocytosis of β-ENaC in a Human Alveolar Epithelial Cell Line (2017) (26)
Anti‐proteinase 3 antibodies (c‐ANCA) prime CD14‐dependent leukocyte activation (2005) (26)
Multiparameter flow cytometric analysis of inflammatory cells contained in bronchoalveolar lavage fluid. (1994) (26)
Separation of human alveolar macrophages by flow cytometry. (1997) (26)
Nocturnal atrial fibrillation in a patient with obstructive sleep apnoea (2005) (26)
Biophysical inhibition of pulmonary surfactant function by polymeric nanoparticles: role of surfactant protein B and C. (2014) (26)
PPAR-α activation reduced LPS-induced inflammation in alveolar epithelial cells (2015) (26)
ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth (2014) (26)
Endotoxin priming of the cyclooxygenase-2-thromboxane axis in isolated rat lungs. (2000) (26)
Differential impact of ultrasonically nebulized versus tracheal-instilled surfactant on ventilation-perfusion (VA/Q) mismatch in a model of acute lung injury. (2000) (26)
Serum nitrite/nitrate levels in obstructive sleep apnea. (2001) (26)
NADPH Oxidase 4 is Not Involved in Hypoxia-Induced Pulmonary Hypertension (2016) (26)
Clinical use of lipids to control inflammatory disease. (1998) (26)
Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice (2015) (26)
Lipoteichoic acids from Staphylococcus aureus stimulate proliferation of human non-small-cell lung cancer cells in vitro (2017) (26)
Clot-embedded natural surfactant: kinetics of fibrinolysis and surface activity. (1994) (26)
Regulation and role of the ER stress transcription factor CHOP in alveolar epithelial type-II cells (2019) (26)
Inflammatory lipid mediator generation elicited by viable hemolysin- forming Escherichia coli in lung vasculature (1990) (26)
Alveolar epithelial barrier functions in ventilated perfused rabbit lungs. (2001) (26)
Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives (2016) (26)
Changes in biochemical and biophysical surfactant properties with cardiopulmonary bypass in children (2003) (26)
Lung CT Densitometry in Idiopathic Pulmonary Fibrosis for the Prediction of Natural Course, Severity, and Mortality (2019) (26)
Proteinaceous bacterial toxins and pathogenesis of sepsis syndrome and septic shock: the unknown connection (1994) (26)
Bronchoscopic surfactant administration preserves gas exchange and pulmonary compliance after single lung transplantation in dogs. (2004) (25)
Multilineage murine stem cells generate complex organoids to model distal lung development and disease (2020) (25)
Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF) (2019) (25)
Perturbations to lysyl oxidase expression broadly influence the transcriptome of lung fibroblasts. (2017) (25)
Aerosolized vasodilators in pulmonary hypertension. (2002) (25)
Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFRβ (2020) (25)
Pathogenesis of sepsis syndrome: possible relevance of pore-forming bacterial toxins. (1996) (25)
Cell Type-Specific mRNA Quantitation in Non-Neoplastic Tissues after Laser-Assisted Cell Picking (2001) (25)
On-line laser-photometric monitoring of aerosol deposition in ventilated rabbit lungs. (1996) (25)
Pulmonary microvascular injury induced by Pseudomonas aeruginosa cytotoxin in isolated rabbit lungs (1986) (25)
Amine-Modified Poly(Vinyl Alcohol)s as Non-viral Vectors for siRNA Delivery: Effects of the Degree of Amine Substitution on Physicochemical Properties and Knockdown Efficiency (2010) (25)
In situ localization of TNFalpha/beta, TACE and TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue. (2003) (25)
Non‐invasive lung cancer diagnosis by detection of GATA6 and NKX2‐1 isoforms in exhaled breath condensate (2016) (24)
Role of membrane lipids in the pulmonary vascular abnormalities caused by bacterial toxins. (1987) (24)
A simple echocardiographic estimate of right ventricular-arterial coupling to assess severity and outcome in pulmonary hypertension on chronic lung disease (2019) (24)
HIF-1alpha attenuates tumor growth in spite of augmented vascularization in an A549 adenocarcinoma mouse model. (2005) (24)
Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration (2005) (24)
Enhanced gene expression and reduced toxicity in mice using polyplexes of low-molecular-weight poly(ethylene imine) for pulmonary gene delivery (2009) (24)
The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension (2017) (24)
Direct eicosanoid profiling of the hypoxic lung by comprehensive analysis via capillary liquid chromatography with dual online photodiode-array and tandem mass-spectrometric detection (2008) (24)
Epidemiology of severe sepsis and septic shock in Germany: results from the German 'Prevalence' study (2005) (24)
Education Against Tobacco (EAT): a quasi-experimental prospective evaluation of a multinational medical-student-delivered smoking prevention programme for secondary schools in Germany (2015) (23)
Immunomodulation by fish-oil containing lipid emulsions in murine acute respiratory distress syndrome (2014) (23)
Synthesis of 4- and 5-series leukotrienes in the lung microvasculature challenged with Escherichia coli hemolysin: critical dependence on exogenous free fatty acid supply. (1997) (23)
Pulmonary Vasoconstrictor Response to Soluble Fibrin in Isolated Lungs: Possible Role of Thromboxane Generation (1988) (23)
Surfactant incorporation markedly alters mechanical properties of a fibrin clot. (1995) (23)
Evaluation of the prognostic value of electrocardiography parameters and heart rhythm in patients with pulmonary hypertension. (2016) (23)
Biosynthesis of constitutive nitric oxide synthase-derived nitric oxide attenuates coronary vasoconstriction and myocardial depression in a model of septic heart failure induced by Staphylococcus aureus &agr;-toxin (2001) (23)
Impact of short- and medium-chain fatty acids on mitochondrial function in severe inflammation. (2014) (23)
[Obstructive sleep apnea-related cardiovascular disease]. (2006) (23)
Staphylococcus Aureus Alpha Toxin Mediates Polymorphonuclear Leukocyte-Induced Vasocontraction and Endothelial Dysfunction (2002) (23)
Expression of mucosa-related integrin alphaEbeta7 on alveolar T cells in interstitial lung diseases. (1999) (23)
Role of Ca2+ and Mg2+ for endothelial permeability of water and albumin in vitro. (1989) (23)
Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplication. (2001) (23)
Subthreshold concentrations of anti‐proteinase 3 antibodies (c‐ANCA) specifically prime human neutrophils for fMLP‐induced leukotriene synthesis and chemotaxis (2001) (22)
Oligopeptidase B from Trypanosoma evansi A PARASITE PEPTIDASE THAT INACTIVATES ATRIAL NATRIURETIC FACTOR IN THE BLOODSTREAM OF INFECTED HOSTS* (2005) (22)
Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis (2010) (22)
Riociguat for treatment of pulmonary hypertension in COPD: a translational study (2019) (22)
Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI) : Gemeinsam stark (2006) (22)
Effects of a cytotoxic protein from Pseudomonas aeruginosa on phagocytic and pinocytic cells: In vitro and In vivo studies (1983) (22)
In situ localization and regulation of thromboxane A(2) synthase in normal and LPS-primed lungs. (2000) (22)
Pneumologie (1999) (22)
Pulmonary absorption of aerosolized fluorescent markers in the isolated rabbit lung. (2008) (22)
The Multi-Modal Effect of the Anti-fibrotic Drug Pirfenidone on NSCLC (2020) (22)
On the correlation of output rate and aerodynamic characteristics in vibrating-mesh-based aqueous aerosol delivery. (2014) (22)
Controlling the droplet size of formulations nebulized by vibrating-membrane technology. (2014) (22)
Surfactant abnormalities and adult respiratory failure (2007) (22)
Comparative gene expression profiling of post-natal and post-pneumonectomy lung growth (2009) (22)
Severe microcirculatory abnormalities elicited by E. coli hemolysin in the rabbit ileum mucosa. (1999) (22)
Zardaverine and aerosolised iloprost in a model of acute respiratoryfailure (2003) (22)
E-cadherin controls bronchiolar progenitor cells and onset of preneoplastic lesions in mice. (2012) (21)
Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment (2020) (21)
Mechanisms of Cardiac Depression Caused by Lipoteichoic Acids From Staphylococcus aureus in Isolated Rat Hearts (2005) (21)
Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration. (2006) (21)
Ventilation-perfusion relationships in isolated blood-free perfused rabbit lungs. (1992) (21)
Photoaging Mobile Apps: A Novel Opportunity for Smoking Cessation? (2015) (21)
The prognostic impact of thyroid function in pulmonary hypertension. (2016) (21)
Influence of aprotinin and gabexate mesilate on arachidonic acid release by the Ca-ionophore A 23187 in the lung. (1983) (21)
Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome (2006) (21)
Moraxella catarrhalis--infected alveolar epithelium induced monocyte recruitment and oxidative burst. (2005) (21)
Leukotriene-mediated coronary vasoconstriction and loss of myocardial contractility evoked by low doses of Escherichia coli hemolysin in perfused rat hearts* (2003) (21)
Nitric Oxide Synthase 2 Induction Promotes Right Ventricular Fibrosis (2019) (21)
A Medical Student-Delivered Smoking Prevention Program, Education Against Tobacco, for Secondary Schools in Germany: Randomized Controlled Trial (2017) (21)
Education Against Tobacco (EAT): a quasi-experimental prospective evaluation of a programme for preventing smoking in secondary schools delivered by medical students: a study protocol (2014) (20)
Apical, But Not Basolateral, Endotoxin Preincubation Protects Alveolar Epithelial Cells Against Hydrogen Peroxide-Induced Loss of Barrier Function: The Role of Nitric Oxide Synthesis1 (2002) (20)
Riociguat for pulmonary hypertension. (2010) (20)
Effects of hypercapnia and NO synthase inhibition in sustained hypoxic pulmonary vasoconstriction (2012) (20)
Linkage analysis in a large family with primary pulmonary hypertension: genetic heterogeneity and a second primary pulmonary hypertension locus on 2q31-32. (2002) (20)
Endogenous nitric oxide synthesis and vascular leakage in ischemic-reperfused rabbit lungs. (2001) (20)
Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment (2014) (20)
MAP1LC3B overexpression protects against Hermansky-Pudlak syndrome type-1-induced defective autophagy in vitro. (2016) (20)
Biomarkers of tissue remodeling predict survival in patients with pulmonary hypertension. (2016) (20)
Exploring the Ability of Electronic Nose Technology to Recognize Interstitial Lung Diseases (ILD) by Non-Invasive Breath Screening of Exhaled Volatile Compounds (VOC): A Pilot Study from the European IPF Registry (eurIPFreg) and Biobank (2019) (20)
Nitric oxide biosynthesis in an exotoxin-induced septic lung model: role of cNOS and impact on pulmonary hemodynamics. (1998) (20)
Staphylococcal alpha-toxin induced ventilation-perfusion mismatch in isolated blood-free perfused rabbit lungs. (1993) (20)
Impact of S-Adenosylmethionine Decarboxylase 1 on Pulmonary Vascular Remodeling (2014) (20)
Mechanics and mechanisms of pulmonary hypertension—Conference summary and translational perspectives (2013) (20)
Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formation. (2001) (20)
miR‐574‐5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES‐1 induction (2019) (20)
Characteristics and outcomes of a cohort hospitalized for pandemic and seasonal influenza in Germany based on nationwide inpatient data (2017) (20)
Novel soluble guanylyl cyclase stimulator BAY 41-2272 attenuates ischemia-reperfusion-induced lung injury. (2009) (20)
The PDE inhibitor zaprinast enhances NO-mediated protection against vascular leakage in reperfused lungs. (2000) (19)
Serum alpha-tocopherol levels after high-dose enteral vitamin E administration in patients with acute respiratory failure (2004) (19)
Cofilin, a hypoxia‐regulated protein in murine lungs identified by 2DE: Role of the cytoskeletal protein cofilin in pulmonary hypertension (2013) (19)
PAF-induced synthesis of tetraenoic and pentaenoic leukotrienes in the isolated rabbit lung. (2000) (19)
Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension (2011) (19)
Effects of arachidonic acid metabolism on hypoxic vasoconstriction in rabbit lungs. (1998) (19)
Therapeutic and pathological roles of fibroblast growth factors in pulmonary diseases (2017) (19)
Ex vivo analysis of the contribution of FGF10+ cells to airway smooth muscle cell formation during early lung development (2017) (19)
Human leukoagglutinating antibody evokes cooperative leukotriene synthesis in pulmonary microvasculature. Model of transfusion-related acute lung injury. (1991) (19)
Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension. (2017) (19)
Cationic lipids employed for antisense oligodeoxynucleotide transport may inhibit vascular cell adhesion molecule-1 expression in human endothelial cells: a word of caution. (1999) (19)
Endotoxin primes perfused rabbit lungs for enhanced vasoconstrictor response to staphylococcal alpha-toxin. (1993) (19)
Circulating adrenomedullin in obstructive sleep apnoea (2006) (19)
Increase in alveolar antioxidant levels in hyperoxic and anoxic ventilated rabbit lungs during ischemia. (2004) (19)
Mouse genetic background impacts susceptibility to hyperoxia‐driven perturbations to lung maturation (2019) (19)
Pulmonary Hemodynamic Response to Exercise in Chronic Thromboembolic Pulmonary Hypertension before and after Pulmonary Endarterectomy (2015) (19)
Short-Term Improvement in Pulmonary Hemodynamics is Strongly Predictive of Long-Term Survival in Patients with Pulmonary Arterial Hypertension (2013) (19)
Identification of a Repair-Supportive Mesenchymal Cell Population during Airway Epithelial Regeneration (2020) (19)
Differential influence of arachidonic vs. eicosapentaenoic acid on experimental pulmonary hypertension. (1995) (19)
Transglutaminase 2: a new player in bronchopulmonary dysplasia? (2014) (19)
Primary pulmonary hypertension is predominantly a hereditary disease. (2002) (19)
Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer (2017) (19)
Experience with the infratentorial supracerebellar approach in lesions of the quadrigeminal region, posterior third ventricle, culmen cerebelli, and cerebellar peduncle (2005) (18)
Endotoxin priming of thromboxane-related vasoconstrictor responses in perfused rabbit lungs. (1997) (18)
Attenuating endogenous Fgfr2b ligands during bleomycin-induced lung fibrosis does not compromise murine lung repair. (2015) (18)
E. coli hemolysin-induced lipid mediator metabolism in alveolar macrophages: impact of eicosapentaenoic acid. (2000) (18)
Boosting the aerodynamic properties of vibrating-mesh nebulized polymeric nanosuspensions. (2014) (18)
Impaired right ventricular lusitropy is associated with ventilatory inefficiency in pulmonary arterial hypertension (2019) (18)
Prolonged vasodilatory response to nanoencapsulated sildenafil in pulmonary hypertension. (2016) (18)
Animal models of pulmonary hypertension: role in translational research (2010) (18)
Resolvin E1 and its precursor 18R-HEPE restore mitochondrial function in inflammation. (2018) (18)
Comparison of pharmacokinetics and vasodilatory effect of nebulized and infused iloprost in experimental pulmonary hypertension: rapid tolerance development. (2006) (18)
The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension (2011) (18)
Targeting Jak-Stat Signaling in Experimental Pulmonary Hypertension. (2020) (18)
Bayesian Inference Associates Rare KDR Variants With Specific Phenotypes in Pulmonary Arterial Hypertension (2019) (18)
[Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis]. (2000) (17)
Generation of mediators by limited proteolysis during blood coagulation and fibrinolysis--its pathogenetic role in the adult respiratory distress syndrome (ARDS). (1986) (17)
Evidence for a role of protein kinase C in hypoxic pulmonary vasoconstriction. (1999) (17)
Mast cell chymase: an indispensable instrument in the pathological symphony of idiopathic pulmonary fibrosis? (2013) (17)
Macrophage-derived IL-6 trans-signalling as a novel target in the pathogenesis of bronchopulmonary dysplasia (2021) (17)
Effects of dimethylarginine dimethylaminohydrolase-1 overexpression on the response of the pulmonary vasculature to hypoxia. (2013) (17)
Targeting transglutaminase 2 partially restores extracellular matrix structure but not alveolar architecture in experimental bronchopulmonary dysplasia (2018) (17)
Air travel can be safe and well tolerated in patients with clinically stable pulmonary hypertension (2011) (17)
The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats (2011) (17)
Isoform-specific characterization of class I histone deacetylases and their therapeutic modulation in pulmonary hypertension (2020) (17)
Sildenafil versus Nitric Oxide for Acute Vasodilator Testing in Pulmonary Arterial Hypertension (2015) (17)
Heart Rate Variability is Related to Disease Severity in Children and Young Adults with Pulmonary Hypertension (2015) (17)
Health-related quality of life associates with change in FEV1 in COPD: results from the COSYCONET cohort (2020) (17)
An integrated approach for the systematic identification and characterization of heart-enriched genes with unknown functions (2009) (16)
Hypoxic pulmonary vasoconstriction--triggered by an increase in reactive oxygen species? (2006) (16)
Influence of the thromboxane antagonist BM 13.177 on the arachidonic acid-induced increase in pulmonary vascular resistance and permeability in rabbit lungs. (1985) (16)
Neurotrophic tyrosine kinase receptor B/neurotrophin 4 signaling axis is perturbed in clinical and experimental pulmonary fibrosis. (2011) (16)
Effect of 3 hours of passive smoke exposure in the evening on inflammatory markers in bronchoalveolar and nasal lavage fluid in subjects with mild asthma (1997) (16)
A Medical Student–Delivered Smoking Prevention Program, Education Against Tobacco, for Secondary Schools in Brazil: Study Protocol for a Randomized Trial (2017) (16)
Central sleep apnoea and unilateral diaphragmatic paralysis associated with vertebral artery compression of the medulla oblongata (2003) (16)
Spatiotemporal expression of flk-1 in pulmonary epithelial cells during lung development. (2008) (16)
Genomic organization and regulation of a human 7-helix transmembrane receptor which is expressed in pulmonary epithelial cells and induced in hypoxia. (2002) (16)
[Obstructive sleep apnoea and metabolic syndrome]. (2008) (16)
Distinct pathways of lipopolysaccharide priming of human neutrophil respiratory burst: Role of lipid mediator synthesis and sensitivity to interleukin-10 (2002) (16)
INDUCTION OF LYMPHOCYTE APOPTOSIS IN A MURINE MODEL OF ACUTE LUNG INJURY-MODULATION BY LIPID EMULSIONS (2010) (16)
Procedural safety of a fully implantable intravenous prostanoid pump for pulmonary hypertension (2017) (15)
Direct and simultaneous profiling of epoxyeicosatrienoic acid enantiomers by capillary tandem column chiral-phase liquid chromatography with dual online photodiode array and tandem mass spectrometric detection (2008) (15)
Protection against pressure overload-induced right heart failure by uncoupling protein 2 silencing (2019) (15)
Ultrastructural changes of lung capillary endothelium in response to botulinum C2 toxin. (1997) (15)
Nintedanib in Severe Pulmonary Arterial Hypertension. (2018) (15)
Synergism between endotoxin priming and exotoxin challenge in provoking severe vascular leakage in rabbit lungs. (1997) (15)
Targeting lipopolysaccharides by the nontoxic polymyxin B nonapeptide sensitizes resistant Escherichia coli to the bactericidal effect of human neutrophils. (2000) (15)
The Prognostic Significance of Inspiratory Capacity in Pulmonary Arterial Hypertension (2014) (15)
Maintained right ventricular pressure overload induces ventricular–arterial decoupling in mice (2017) (15)
Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity. (1999) (15)
Electrophysiological Studies in Patients with Pulmonary Hypertension: A Retrospective Investigation (2014) (15)
Severe Emphysema in the SU5416/Hypoxia Rat Model of Pulmonary Hypertension. (2019) (15)
Erkrankungen der Atmungsorgane (1956) (15)
Ventricular tachycardias in patients with pulmonary hypertension: an underestimated prevalence? A prospective clinical study (2015) (15)
Smoking: Is it a risk factor for pulmonary vascular diseases? (2012) (14)
Interaction of Antibodies to Proteinase 3 (Classic Anti-Neutrophil Cytoplasmic Antibody) with Human Renal Tubular Epithelial Cells: Impact on Signaling Events and Inflammatory Mediator Generation1 (2002) (14)
Liver carboxylesterase cleaves surfactant protein (SP-) B and promotes surfactant subtype conversion. (2006) (14)
Recognition of breathprints of lung cancer and chronic obstructive pulmonary disease using the Aeonose® electronic nose (2020) (14)
Staphylococcus aureus &agr;-toxin and Escherichia coli hemolysin impair cardiac regional perfusion and contractile function by activating myocardial eicosanoid metabolism in isolated rat hearts (2009) (14)
Chemical crosslinking of urokinase to pulmonary surfactant protein B for targeting alveolar fibrin (2003) (14)
Synergism of alveolar endotoxin "priming" and intravascular exotoxin challenge in lung injury. (1996) (14)
FXYD1 negatively regulates Na+/K+-ATPase activity in lung alveolar epithelial cells (2016) (14)
Comparative influence of the Ca-ionophore A 23187, bradykinin, kallidin and eledoisin on the rabbit pulmonary vasculature with special reference to arachidonate metabolism. (1983) (14)
Impact of SARS-CoV-2 pandemic on pulmonary hypertension out-patient clinics in Germany: a multi-centre study (2020) (14)
TREATMENT OF ARDS WITH rSP-C SURFACTANT.: 24 (1999) (14)
A Face-Aging App for Smoking Cessation in a Waiting Room Setting: Pilot Study in an HIV Outpatient Clinic (2018) (14)
Acute Hemodynamic Effects of Nebulized Iloprost via the I-Neb Adaptive Aerosol Delivery System in Pulmonary Hypertension (2015) (14)
A novel mouse Cre‐driver line targeting Perilipin 2‐expressing cells in the neonatal lung (2017) (14)
Clinical Aspects of Acute Lung Insufficiency (ALI/TRALI) (2008) (14)
Gibt es eine gesicherte Immuntherapie bei der Sepsis? (1997) (14)
Influence of tocopherol, its chromane compound, phytyl chains and superoxide dismutase on increased vascular resistance and permeability due to arachidonate metabolism in isolated rabbit lung. (1982) (14)
Efficient gene delivery to primary alveolar epithelial cells by nucleofection. (2013) (14)
Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension (2017) (13)
N-3 vs. n-6 fatty acids differentially influence calcium signalling and adhesion of inflammatory activated monocytes: impact of lipid rafts (2016) (13)
Epithelial cell plasticity defines heterogeneity in lung cancer. (2019) (13)
Hemodynamic phenotyping based on exercise catheterization predicts outcome in patients with heart failure and reduced ejection fraction. (2017) (13)
Inhibition of cytoskeletal rearrangement by botulinum C2 toxin amplifies ligand-evoked lipid mediator generation in human neutrophils. (1991) (13)
Call it by the correct name - pulmonary hypertension not pulmonary arterial hypertension. (2020) (13)
Genome-wide transcriptional profiling of mononuclear phagocytes recruited to mouse lungs in response to alveolar challenge with the TLR2 agonist Pam3CSK4. (2009) (13)
Extracorporeal Carbon Dioxide Removal Using a Renal Replacement Therapy Platform to Enhance Lung-Protective Ventilation in Hypercapnic Patients With Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome (2020) (13)
Estimation of absolute number of alveolar epithelial type 2 cells in mouse lungs: a comparison between stereology and flow cytometry (2019) (13)
Sildenafil zur Therapie der schweren pulmonalen Hypertonie und des beginnenden Rechtsherzversagens (2002) (13)
Potential of the isolated lung technique for the examination of sildenafil absorption from lung-delivered poly(lactide-co-glycolide) microparticles. (2016) (13)
Prognostic Relevance of Nonsustained Ventricular Tachycardia in Patients with Pulmonary Hypertension (2016) (13)
Reversal of nocturnal periodic breathing in primary pulmonary hypertension after lung transplantation. (2004) (13)
Immunoglobulin deficiency as an indicator of disease severity in patients with COVID-19 (2020) (13)
NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD (2020) (12)
Staphylococcal alpha-toxin provokes neutrophil-dependent cardiac dysfunction: role of ICAM-1 and cys-leukotrienes. (2002) (12)
Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension (2020) (12)
In vitro mimicry of essential fatty acid deficiency in human endothelial cells by TNFalpha impact of omega-3 versus omega-6 fatty acids. (2002) (12)
Restored alveolar epithelial differentiation and reversed human lung fibrosis upon Notch inhibition (2019) (12)
Resolvin E1 Improves Mitochondrial Function in Human Alveolar Epithelial Cells during Severe Inflammation. (2019) (12)
Drug Interactions in Pulmonary Arterial Hypertension and Their Implications (2009) (12)
Quantitative proteome analysis of alveolar type-II cells reveals a connection of integrin receptor subunits beta 2/6 and WNT signaling. (2013) (12)
The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort (2019) (12)
Clinical and Functional Characteristics of Patients with Unclassifiable Interstitial Lung Disease (uILD): Long-Term Follow-Up Data from European IPF Registry (eurIPFreg) (2020) (12)
Release and oxygenation of arachidonic acid: nonspecific triggering and pathophysiological consequences in isolated rabbit lungs. (1983) (12)
Neutrophil passage through isolated perfused rabbit lungs. (1991) (12)
Association of right atrial conduit phase with right ventricular lusitropic function in pulmonary hypertension (2020) (12)
TRIUMPH 1: Long-Term Safety and Efficacy of Inhaled Treprostinil Sodium in Patients with Pulmonary Arterial Hypertension (PAH) – Two Year Follow-Up. (2009) (12)
Tropolysin, a new oligopeptidase from African trypanosomes. (2005) (11)
Obstructive sleep apnea due to HIV-associated lipodystrophy. (2003) (11)
Risk assessment in severe pulmonary hypertension due to interstitial lung disease. (2020) (11)
Nitro blue tetrazolium inhibits but does not mimic hypoxic vasoconstriction in isolated rabbit lungs. (1998) (11)
Antisense oligomers for selective suppression of MCP-1 synthesis in human pulmonary endothelial cells. (2000) (11)
Use of n-3 fatty acid-containing lipid emulsions in the Intensive Care Unit environment: the clinician's view (2002) (11)
Das Deutsche Zentrum für Lungenforschung – Translationale Forschung für Prävention, Diagnose und Therapie von Atemwegserkrankungen (2012) (11)
Hypercapnia Impairs Na,K-ATPase Function by Inducing Endoplasmic Reticulum Retention of the β-Subunit of the Enzyme in Alveolar Epithelial Cells (2020) (11)
Nebulization of the acidified sodium nitrite formulation attenuates acute hypoxic pulmonary vasoconstriction (2010) (11)
Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension (2021) (11)
CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension (2020) (11)
Amelioration of elastase‐induced lung emphysema and reversal of pulmonary hypertension by pharmacological iNOS inhibition in mice (2020) (11)
Differential role of actin in lung endothelial and epithelial barrier properties in perfused rabbit lungs. (1996) (11)
Use of very old donors for lung transplantation: a dual-centre retrospective analysis (2017) (11)
Prävalenz von Schlaganfall und transitorischer ischämischer Attacke (TIA) bei obstruktiver Schlaf-Apnoe: eine retrospektive Erhebung an 187 konsekutiven Patienten (2000) (11)
Non-invasive screening of lung nodules in mice comparing a novel volumetric computed tomography with a clinical multislice CT. (2007) (11)
Characterization of lung‐delivered in‐situ forming controlled release formulations (2015) (10)
Assessing the Effectiveness of Pirfenidone in Idiopathic Pulmonary Fibrosis: Long-Term, Real-World Data from European IPF Registry (eurIPFreg) (2020) (10)
Hybrid-Primed Lymphocytes and Hybrid Vaccination Prevent Tumor Growth of Lewis Lung Carcinoma in Mice (2006) (10)
Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge (2010) (10)
[Therapy of pulmonary arterial hypertension]. (2005) (10)
Intravascular anti-IgE challenge in perfused lungs: mediator release and vascular pressor response. (1991) (10)
[Sildenafil for treatment of severe pulmonary hypertension and commencing right-heart failure]. (2002) (10)
Prevention and therapy of the adult respiratory distress syndrome (2004) (10)
A Dermatologist's Ammunition in the War Against Smoking: A Photoaging App (2017) (10)
Induction of vascular injury by Pseudomonas aeruginosa cytotoxin in rabbit lungs is associated with the generation of different leukotrienes and hydroxyeicosatetraenoic acids. (1991) (10)
Apoprotein-based synthetic surfactants inhibit plasmic cleavage of fibrinogen in vitro. (1993) (10)
Selective inhibition of large-to-small surfactant aggregate conversion by serine protease inhibitors of the bis-benzamidine type. (2003) (10)
Simvastatin Inhibits Inflammatory Properties of Staphylococcus aureus (cid:1) -Toxin (2002) (10)
Blockade of leucocyte function‐associated antigen‐1 (LFA‐1) decreases lymphocyte trapping in the normal pulmonary vasculature: studies in the isolated buffer‐perfused rat lung (2000) (10)
Apparently monogenic inheritance of anencephaly and spina bifida in a kindred (2004) (10)
Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study (2016) (10)
Exhalative Breath Markers Do Not Offer for Diagnosis of Interstitial Lung Diseases: Data from the European IPF Registry (eurIPFreg) and Biobank (2019) (10)
Hämodynamische Definition der pulmonalen Hypertonie: Kommentar zu der vorgeschlagenen Änderung durch das 6th World Symposium on Pulmonary Hypertension (2019) (10)
Nebulization of active pharmaceutical ingredients with the eFlow(®) rapid: impact of formulation variables on aerodynamic characteristics. (2014) (10)
Amplification of Lipopolysaccharide-Induced Cytokine Synthesis in Non–Small Cell Lung Cancer/Neutrophil Cocultures (2009) (10)
Fish oil-containing lipid emulsions in patients with sepsis (2010) (9)
A novel non-invasive and echocardiography-derived method for quantification of right ventricular pressure-volume loops. (2021) (9)
Hybrid-primed lymphocytes and hybrid vaccination prevent tumor growth of lewis lung carcinoma in mice. (2006) (9)
Heart rate response during 6-minute walking testing predicts outcome in operable chronic thromboembolic pulmonary hypertension (2016) (9)
Stereological analysis of individual lung lobes during normal and aberrant mouse lung alveolarisation (2018) (9)
A highly sensitive gas chromatographic method does not detect exhalation of volatile hydrocarbons from isolated ventilated lungs under massive peroxidative stress. (1988) (9)
Measurement of exhaled hydrogen peroxide from rabbit lungs (2004) (9)
Elevated FiO2 increases SARS-CoV-2 co-receptor expression in respiratory tract epithelium (2020) (9)
Use of fish oil to prevent graft rejection (1998) (9)
Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET (2020) (9)
Susceptibility of microtubule‐associated protein 1 light chain 3β (MAP1LC3B/LC3B) knockout mice to lung injury and fibrosis (2019) (9)
Tamoxifen dosing for Cre-mediated recombination in experimental bronchopulmonary dysplasia (2017) (9)
Cytochrome P450 epoxygenase-derived 5,6-epoxyeicosatrienoic acid relaxes pulmonary arteries in normoxia but promotes sustained pulmonary vasoconstriction in hypoxia. (2020) (9)
Physiologie und Pathophysiologie der pulmonalen Zirkulation (1999) (9)
Restoration of Megalin‐Mediated Clearance of Alveolar Protein as a Novel Therapeutic Approach for Acute Lung Injury (2017) (9)
TGF-β inhibits alveolar protein transport by promoting shedding, regulated intramembrane proteolysis, and transcriptional downregulation of megalin. (2017) (9)
Evaluating Systolic and Diastolic Cardiac Function in Rodents Using Microscopic Computed Tomography (2018) (9)
Altered proteasome function in right ventricular hypertrophy. (2019) (9)
CCR 2-positive monocytes recruited to inflamed lungs downregulate local CCL 2 chemokine levels (2004) (9)
Free arachidonic versus eicosapentaenoic acid differentially influences the potency of bacterial exotoxins to provoke myocardial depression in isolated rat hearts (2006) (9)
Cyclooxygenase-2–Dependent and Thromboxane-Dependent Vascular and Bronchial Responses are Regulated via p38 Mitogen-Activated Protein Kinase in Control and Endotoxin-Primed Rat Lungs (2003) (9)
[Pulmonary hypertension due to chronic lung disease: Recommendations of the Cologne Consensus Conference 2016]. (2016) (8)
Measuring health-related quality of life with the Euroqol EQ-5D instrument in clinical trials of new treatments for pulmonary hypertension (2001) (8)
Gezielte Therapie der pulmonal arteriellen Hypertonie (PAH) (2014) (8)
A Face-Aging Smoking Prevention/Cessation Intervention for Nursery School Students in Germany: An Appearance-Focused Interventional Study (2018) (8)
Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome (2021) (8)
Right ventricular pressure-volume loop shape and systolic pressure change in pulmonary hypertension. (2021) (8)
Targeting CREB-binding protein overrides LPS induced radioresistance in non-small cell lung cancer cell lines (2018) (8)
[The German centre for lung research - translational research for the prevention, diagnosis and treatment of respiratory diseases]. (2012) (8)
Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension (2016) (8)
Clinical and Operative Determinants of Acute Kidney Injury after Cardiac Surgery (2020) (8)
Proteases as mediators of pulmonary vascular permeability. (1989) (8)
Quality of life in clinically stable adult cystic fibrosis out-patients: associations with daytime sleepiness and sleep quality (2012) (8)
Poor sleep quality is associated with exercise limitation in precapillary pulmonary hypertension (2015) (8)
Fibroblast Growth Factor—14 Acts as Tumor Suppressor in Lung Adenocarcinomas (2020) (8)
Alteration of pressure-volume characteristics due to different types of edema induction in isolated rabbit lungs. (1983) (8)
Genetic Delivery and Gene Therapy in Pulmonary Hypertension (2021) (8)
Transforming Growth Factor-- Dependent Growth Inhibition in Primary Vascular Smooth Muscle Cells Is p 38-Dependent (2005) (8)
Polymer nanoparticle-based controlled pulmonary drug delivery. (2014) (8)
Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertension (2017) (8)
Multibeat Right Ventricular-Arterial Coupling during a Positive Acute Vasoreactivity Test. (2019) (8)
Elimination of B-RAF in Oncogenic C-RAF-expressing Alveolar Epithelial Type II Cells Reduces MAPK Signal Intensity and Lung Tumor Growth* (2014) (8)
[Hemodynamic Definition of Pulmonary Hypertension: Commentary on the Proposed Change by the 6th World Symposium on Pulmonary Hypertension]. (2019) (7)
Effects of carbon monoxide-releasing molecules on pulmonary vasoreactivity in isolated perfused lungs. (2016) (7)
Shroom expression is attenuated in pulmonary arterial hypertension (2008) (7)
Chemical coupling of a monoclonal antisurfactant protein-B antibody to human urokinase for targeting surfactant-incorporating alveolar fibrin. (2002) (7)
Phagocytosis of viable Candida albicans by alveolar macrophages: flow cytometric quantification. (1994) (7)
Adenylate Kinase 4—A Key Regulator of Proliferation and Metabolic Shift in Human Pulmonary Arterial Smooth Muscle Cells via Akt and HIF-1α Signaling Pathways (2021) (7)
Schwere Sepsis – neue Therapieverfahren (2001) (7)
Activation of the pulmonary arachidonic acid system and its consequences for hemodynamics and fluid balance. (1987) (7)
Impact of the new definition for pulmonary hypertension in patients with lung disease: an analysis of the United Network for Organ Sharing database (2021) (7)
Effect of p53 activation on experimental right ventricular hypertrophy (2020) (7)
[Prevalence of stroke and transitory ischemic attacks in obstructive sleep apnea: a retrospective analyis so f 187 consecutive patients]. (2000) (7)
Combined human papillomavirus typing and TP53 mutation analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma (2018) (7)
Inhaled treprostinil [corrected] for treatment of chronic pulmonary arterial hypertension. (2006) (7)
PARENTERALE OMEGA-3-LIPIDBEHANDLUNG BEI INFLAMMATORISCHEN SYSTEMERKRRENKUNGEN (1993) (7)
Pulmonary Drug Delivery with Nanoparticles (2011) (7)
Subthreshold doses of nebulized prostacyclin and rolipram synergistaically protect against lung ischemia-reperfusion (2003) (7)
Diagnose und Therapie der Sepsis S-2-Leitlinien der Deutschen Sepsis-Gesellschaft e.V. (DSG) und der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin (DIVI) (2006) (7)
Innovative formulations for controlled drug delivery to the lungs and the technical and toxicological challenges to overcome(.). (2016) (7)
Correction: Macrophage-expressed IFN-β Contributes to Apoptotic Alveolar Epithelial Cell Injury in Severe Influenza Virus Pneumonia (2016) (7)
Micro-computed tomography imaging of composite nanoparticle distribution in the lung. (2012) (6)
Alterations in Doppler-derived renal venous stasis index during recompensation of right heart failure and fluid overload in a patient with pulmonary hypertension. (2019) (6)
[ARDS. Intensive therapy of acute lung failure]. (1995) (6)
The use of electronic nose technology for the detection of lung cancer: analysis of exhaled volatile compounds by Aeonose® (2018) (6)
[Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension]. (1998) (6)
Omega-oxidized leukotriene B4 detected in the broncho-alveolar lavage fluid of patients with non-cardiogenic pulmonary edema, but not in those with cardiogenic edema (2005) (6)
The prognostic relevance of oxygen uptake in inoperable chronic thromboembolic pulmonary hypertension (2017) (6)
In-situ complement activation, pulmonary hypertension and vascular leakage in rabbit lungs--the role of the terminal complement complex. (1989) (6)
Alterations in Alveolar Surfactant following Severe Multiple Trauma (1990) (6)
Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET (2022) (6)
A Protective Kidney-Lung Approach to Improve Outcomes in Mechanically Ventilated Patients (2016) (6)
Unmasking right ventricular-arterial uncoupling during fluid challenge in pulmonary hypertension. (2021) (6)
Septic lung. (1987) (6)
[Pulmonary hypertension due to left heart diseases]. (2018) (6)
Constitutive homo- and hetero-oligomerization of TβRII-B, an alternatively spliced variant of the mouse TGF-β type II receptor (2006) (6)
Influence of amine-modified poly(vinyl alcohol)s on vibrating-membrane nebulizer performance and lung toxicity. (2016) (6)
Relevance of Angiopoietin-2 and Soluble P-Selectin Levels in Patients with Pulmonary Arterial Hypertension Receiving Combination Therapy with Oral Treprostinil: A FREEDOM-C2 Biomarker Substudy (2016) (6)
Immunogenicity and reactogenicity of homologous mRNA-based and vector-based SARS-CoV-2 vaccine regimens in patients receiving maintenance dialysis (2022) (6)
Experimental Results in the Prevention of RDS with α-Tocopherol (1981) (6)
Fibronectin decreases pulmonary vascular permeability under baseline conditions and after administration of arachidonic acid in rabbit lungs. (1986) (6)
Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival (2022) (6)
Notch1 Induces Defective Epithelial Surfactant Processing and Pulmonary Fibrosis. (2022) (6)
Customized Vibrating-Membrane Nozzles for Enhanced Fluid Atomization (2015) (6)
Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of Versican (2021) (6)
The Lung Vasculature: A Driver or Passenger in Lung Branching Morphogenesis? (2021) (6)
Vaskuläre Folgeerkrankungen bei obstruktiver Schlafapnoe (2006) (6)
Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension (2020) (6)
Control Interventions Can Impact Alveolarization and the Transcriptome in Developing Mouse Lungs (2018) (6)
[Pulmonary fibrosis--a therapeutic dilemma?]. (2006) (6)
Inhaled trepostinil for treatment of chronic pulmonary arterial hypertension. Author's reply (2006) (6)
Myeloid-cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice (2021) (6)
Ambulant erworbene Pneumonie (2018) (6)
Surfactant and Adult Respiratory Distress Syndrome (1994) (5)
Cancer cell motility is affected through 3D cell culturing and SCF/c-Kit pathway but not by X-irradiation. (2016) (5)
[Pulmonary hypertension: pathophysiology, genetics and functional genomics]. (2005) (5)
Vasodilatative Prostanoide von der Infusion zum Aerosol: neue Perspektiven für das ARDS und die primäre pulmonale Hypertonie (1997) (5)
Effects of BPA on right ventricular mechanical dysfunction in patients with inoperable CTEPH – A cardiac magnetic resonance study (2021) (5)
The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension (2016) (5)
Differential influence of calcium channel-blockers on prostanoid generation and thromboxane-mediated vasoconstriction in rabbit lungs. (1987) (5)
Detection of Organic Hydroperoxides in Rabbit Lung Lavage Fluid, but not in Lung Tissue Homogenate, Using GSH Peroxidase and GSH Reductase (1984) (5)
Thromboxane-Mediated Pulmonary Vasoconstriction in Rabbits Induced by Acute Alveolar Hypoxia (1985) (5)
Dynamische Hyperinflation bei der pulmonal arteriellen Hypertonie: „Hyperinflator“ und „Non-Hyperinflator“ (2013) (5)
Exercise hemodynamics in heart failure patients with preserved and mid-range ejection fraction: key role of the right heart (2021) (5)
Effects of macitentan and tadalafil monotherapy or their combination on the right ventricle and plasma metabolites in pulmonary hypertensive rats (2020) (5)
[NO and alternative inhalational therapy approaches in pulmonary hypertension]. (1997) (5)
Inhalative Application Of Soluble Guanylyl Cyclase Stimulator BAY 41-8543 For Treatement Of Pulmonary Arterial Hypertension (2010) (5)
Escherichia coli hemolysin causes thromboxane-mediated hypertension and vascular leakage in rabbit lungs. (1989) (5)
Genetic Deletion of p66shc and/or Cyclophilin D Results in Decreased Pulmonary Vascular Tone. (2020) (5)
The effect of long-term doxycycline treatment in a mouse model of cigarette smoke-induced emphysema and pulmonary hypertension. (2021) (5)
Genetic Deficiency and Pharmacological Stabilization of Mast Cells Ameliorate Pressure Overload-Induced Maladaptive Right Ventricular Remodeling in Mice (2020) (5)
Metastasis-Associated Protein 2 Represses NF-κB to Reduce Lung Tumor Growth and Inflammation (2020) (5)
New metrics for translational research. (2014) (5)
Fibrinolysis-inhibitory capacity of clot-embedded surfactant is enhanced by SP-B and SP-C. (2003) (5)
Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study (2019) (5)
Obstructive sleep apnea in a patient with the Melkersson–Rosenthal syndrome (2010) (5)
Therapie des ARDS (1999) (5)
Evaluation of pulmonary hypertension by right heart catheterisation: does timing matter? (2020) (5)
Hypoxia in lung vascular biology and disease. (2006) (5)
[Pneumology -- from phthisiology to regenerative medicine]. (2005) (5)
In cancer cell lines inhibition of SCF/c-Kit pathway leads to radiosensitization only when SCF is strongly over-expressed (2017) (4)
Facial-Aging Mobile Apps for Smoking Prevention in Secondary Schools in Brazil: Appearance-Focused Interventional Study (2018) (4)
Reply to Bogaard et al.: Emphysema Is—at the Most—Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension (2019) (4)
Medizinische Therapie in Klinik und Praxis (2003) (4)
Behandlung der Pulmonal Arteriellen Hypertonie (2000) (4)
Inhaled NO and the guanylate cyclase stimulator Bay 41-2272 in oleic acid induced acute lung injury in rabbits (2005) (4)
Recombinant production of a hybrid plasminogen activator composed of surfactant protein B and low-molecular-weight urokinase (2008) (4)
[Inhalation combination therapy in chronic obstructive lung disease. TRISTAN-study]. (2004) (4)
Right ventricular dyssynchrony: from load-independent right ventricular function to wall stress in severe pulmonary arterial hypertension (2020) (4)
Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets? (2022) (4)
Effects of bacterial toxins and calcium-ionophores on endothelial permeability in vitro. (1989) (4)
A comparison of airway pressures for inflation fixation of developing mouse lungs for stereological analyses (2020) (4)
Differential LysoTracker Uptake Defines Two Populations of Distal Epithelial Cells in Idiopathic Pulmonary Fibrosis (2021) (4)
[Increase of pulmonary vascular resistance and permeability due to the metabolism of free arachidonic acid (author's transl)]. (1981) (4)
SPARCL1 as a biomarker of maladaptive right ventricular remodelling in pulmonary hypertension (2020) (4)
Cancer and pulmonary hypertension: Learning lessons and real-life interplay (2020) (4)
Effects Of The Soluble Guanylate Cyclase Stimulator Riociguat On Emphysema Development In Tobacco-Smoke Exposed Mice (2011) (4)
Decreased Thymic Output Contributes to Immune Defects in Septic Patients (2020) (4)
Impact of surface tension on the conversion rate of large to small surfactant aggregates. (2003) (4)
Increased frequency of the restless legs syndrome in adults with cystic fibrosis. (2019) (4)
Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression (2021) (4)
Indefinite cytomegalovirus prophylaxis with valganciclovir after lung transplantation (2019) (4)
Pulmonale Hypertonie und schlafbezogene Atmungsstörungen (2005) (4)
Bacterial Exotoxins and Sepsis (1994) (4)
NO und alternative inhalative Therapieansätze bei pulmonaler Hypertonie (1997) (4)
Epigenetic reactivation of transcriptional programs orchestrating fetal lung development in human pulmonary hypertension (2022) (4)
Maternal and perinatal obesity induce bronchial obstruction and pulmonary hypertension via IL-6-FoxO1-axis in later life (2022) (4)
Lungenfibrosen—ein therapeutisches Dilemma? (2006) (4)
LSC - 2017 - Reprogramming Of Tumor Associated Macrophages By Modulating Wnt/ß-catenin Signalling In Lung Cancer (2017) (4)
Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment (2022) (4)
Computer-assisted morphometry of the intracapillary leukocyte pool in the rabbit lung (1993) (4)
Transmission of microRNA antimiRs to mouse offspring via the maternal–placental–fetal unit (2018) (4)
[Pulmonary hypertension : What is new in therapy?]. (2016) (4)
Reproducible effects of intravenously administered fish oil in acute relapsing psoriasis (1996) (4)
Constitutive homo- and hetero-oligomerization of TbetaRII-B, an alternatively spliced variant of the mouse TGF-beta type II receptor. (2006) (4)
Role of JAK-STAT pathway in pulmonary fibrosis (2013) (3)
Proteinaceous bacterial toxins and pathogenesis of sepsis syndrome and septic shock: the unknown connection (2004) (3)
Mitochondrial Respiration in Peripheral Blood Mononuclear Cells Negatively Correlates with Disease Severity in Pulmonary Arterial Hypertension (2022) (3)
An essential function for autocrine hedgehog signaling in epithelial proliferation and differentiation in the trachea (2022) (3)
Transcriptome profiling reveals the complexity of pirfenidone effects in IPF (2019) (3)
Expression of B-RAF V600E in Type II Pneumocytes Causes Abnormalities in Alveolar Formation, Airspace Enlargement and Tumor Formation in Mice (2011) (3)
Long-term comprehensive cardiopulmonary phenotyping of COVID-19 (2022) (3)
[Pathophysiology of the microcirculation]. (1985) (3)
SCRINSHOT, a spatial method for single-cell resolution mapping of cell states in tissue sections (2020) (3)
Systematic aging of degradable nanosuspension ameliorates vibrating-mesh nebulizer performance (2015) (3)
Effects of bacterial exo- and endotoxins on endothelial arachidonate metabolism. (1989) (3)
Immune modulation by parenteral lipids: Platelet activating factor is not the only clue (2007) (3)
Prevention Of Cigarette Smoke-Induced Pulmonary Hypertension By The Soluble Guanylate Cyclase Stimulator Riociguat (2012) (3)
Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension (2021) (3)
Bacterial Exotoxins and Vascular Injury (1993) (3)
Response by Tello et al to Letter Regarding Article, "Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension". (2019) (3)
Non-Invasive Beatmung des akuten hypoxämischen Lungenversagens – State of the Art 2000 (2000) (3)
[Molecular basis for the pathogenicity of S. aureus alpha-toxins]. (1984) (3)
[Obstructive sleep apnea and cardiovascular diseases--hypothesis on the pathophysiological interlinks]. (2001) (3)
Alteration of Pulmonary Surfactant in Ards - Pathogenetic Role and Therapeutic Perspectives (1998) (3)
The transforming growth factor-β/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension (European Respiratory Journal (2007) 29, (1094-1104)) (2007) (3)
Immunomodulation by an Omega-6 Fatty Acid Reduced Mixed Lipid Emulsion in Murine Acute Respiratory Distress Syndrome (2020) (3)
Is PKM2 Phosphorylation Prerequisite for Oligomer Disassembly in Pulmonary Arterial Hypertension? (2019) (3)
Surfactant Inhibitory Plasma-Derived Proteins (1987) (3)
Inhaled Iloprost Improves Right Ventricular Load-Independent Contractility in Pulmonary Hypertension. (2022) (3)
[Treatment of pulmonary artery hypertension]. (2000) (3)
Impact of a Phosphorothioate Oligodeoxynucleotide MCP-1 on NF-κB, AP-1, SP1 and NF-κB, and AP-1 Subunit Composition in Human Pulmonary Endothelial Cells (2001) (3)
Damage to the Host by Channel-Forming Bacterial Toxins (1985) (3)
[Reverse remodeling -- paradigm shift in the treatment of pulmonary hypertension]. (2006) (3)
TGF‐β regulates Na,K‐ATPase activity by changing the regulatory subunit stoichiometry of the Na,K‐ATPase complex (2011) (3)
[Imatinib for pulmonary arterial hypertension]. (2014) (3)
Picturing of the Lung Tumor Cellular Composition by Multispectral Flow Cytometry (2022) (3)
Stimulation of Soluble Guanylate Cyclase by Riociguat prevents Tobacco smoke-induced Pulmonary Hypertension in mice (2012) (3)
Pathophysiologie der Lungenembolie (1984) (3)
Amplification of LPS and LTA induced cytokine synthesis in NSCLC/neutrophil cocultures (2008) (3)
Secreted Protein Acidic and Rich in Cysteine, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension. (2022) (3)
Evaluation of Regional Pulmonary Ventilation in Spontaneously Breathing Patients with Idiopathic Pulmonary Fibrosis (IPF) Employing Electrical Impedance Tomography (EIT): A Pilot Study from the European IPF Registry (eurIPFreg) (2021) (3)
Risk assessment in pulmonary hypertension based on routinely measured laboratory parameters (2021) (3)
TRIUMPH: LONG-TERM EFFICACY AND SAFETY OF INHALED TREPROSTINIL SODIUM IN PULMONARY ARTERIAL HYPERTENSION (PAH) (2008) (3)
Aberrant expression and activity of histone deacetylases (HDACs) in lungs of patients with sporadic Idiopathic Pulmonary Fibrosis (IPF) (2012) (3)
Mediatorblockade und Immunmodulation — Konzepte und Praxisreifes (2005) (3)
Inhalative application of soluble guanylyl cyclase stimulator BAY 41–8543 for treatement of pulmonary arterial hypertension (2010) (3)
[Inhalative strategies for improvement of pulmonary hemodynamics and gas exchange in sepsis and severe pulmonary hypertension]. (2000) (3)
Inhalative Kombinationstherapie bei chronisch obstruktiver Lungenerkrankung (2004) (3)
Interaction of Alveolar Surfactant with Plasma-Derived Proteins, Especially Fibrin Monomer, as Causative Principle of Surfactant Dysfunction (1984) (3)
Targeting ADORA1/PDE10A Signalosome Regulated cAMP Microenvironment as a Novel Therapeutic Approach for Treating Pulmonary Hypertension (2019) (3)
Interstitial Lung Disease: Seasonality of Hospitalizations and In-Hospital Mortality 2005–2015 (2021) (2)
Role and regulation of Jumonji C domain-containing histone demethylases 1A and 2B in pulmonary hypertension (2016) (2)
Effects of short-term infusion of lipid emulsions on pro-inflammatory cytokines and lymphocyte apoptosis in septic and non-septic rats (2011) (2)
Process Evaluation of a Medical Student–Delivered Smoking Prevention Program for Secondary Schools: Protocol for the Education Against Tobacco Cluster Randomized Trial (2019) (2)
Targeting peptidyl-prolyl isomerase 1 in experimental pulmonary arterial hypertension (2022) (2)
IRE1 Signaling As a Putative Therapeutic Target in Influenza Virus-induced Pneumonia. (2019) (2)
IRAG1 Deficient Mice Develop PKG1β Dependent Pulmonary Hypertension (2020) (2)
[ARDS (adult respiratory distress syndrome)]. (1996) (2)
Association of Clonal Hematopoiesis of Indeterminate Potential with Inflammatory Gene Expression in Patients with COPD (2022) (2)
Statuserhebung zur invasiven und nicht-invasiven Beatmung auf deutschen Intensivstationen (2003) (2)
Effects of apoptosis signal- regulating kinase 1 (ASK1) inhibition in experimental pressure overload-induced right ventricular dysfunction (2015) (2)
Commercially available transfection reagents and negative control siRNA are not inert. (2020) (2)
Cellular consequences of uncharacterized surfactant protein-A2 (SFTPA2)-gene mutations associated with familial IPF and lung cancer (2019) (2)
Antifibrotic Effects Of Riociguat In A Murine Model Of Chronic Right Ventricular Pressure Overload (2012) (2)
63. Knochenbruch und Nervenverletzung (1975) (2)
Ernährung und Immunonutrition bei Sepsis (2006) (2)
Implication of in vivo circulating fibrocytes ablation in experimental pulmonary hypertension murine model (2020) (2)
Effects of alpha-tocopherol, its carboxylic acid chromane compound and two novel antioxidant isoflavanones on prostaglandin H synthase activity and autodeactivation (1988) (2)
Neue Therapieoptionen in der Behandlung der pulmonalarteriellen Hypertonie (2005) (2)
Effects Of Riociguat On Pulmonary Vascular Remodeling In Severe Experimental Pulmonary Hypertension (2011) (2)
Interleukin-10 In Experimental Bronchopulmonary Dysplasia (2017) (2)
Fibrocytes boost tumor-supportive phenotypic switches in the lung cancer niche via the endothelin system (2022) (2)
c-ANCA induce neutrophil-mediated lung injury a model of acute Wegener ́s Granulomatosis Short title: Anti-PR3-antibodies mediate acute lung injury (2009) (2)
Tocopherol in hoher enteraler Dosierung als Prophylaxe und Therapie der Schocklunge (1979) (2)
Translational Research in Acute Lung Injury and Pulmonary Fibrosis MAP 1 LC 3 B overexpression protects against Hermansky-Pudlak syndrome type-1-induced defective autophagy in vitro (2016) (2)
Quantification of neo-angiogenesis by micro-computed tomography in xenograft mouse model of lung cancer (2008) (2)
Over expression of endothelin-1 (ET-1) in lung fibroblasts (LFb) from patients with pulmonary arterial hypertension (PAH), evidence for loss of inhibitory control (2016) (2)
[Is there a reliable immunotherapy in infection?]. (1997) (2)
The H2S-generating enzyme 3-mercaptopyruvate sulfurtransferase regulates pulmonary vascular smooth muscle cell migration and proliferation but does not impact normal or aberrant lung development. (2020) (2)
Relevance of Cor Pulmonale in COPD With and Without Pulmonary Hypertension: A Retrospective Cohort Study (2022) (2)
lung model (see comments) Reproduction of transfusion-related acute lung injury in an ex vivo (2011) (2)
Transcriptional Profiling of Insulin-like Growth Factor Signaling Components in Embryonic Lung Development and Idiopathic Pulmonary Fibrosis (2022) (2)
Alveolar Surfactant and ARDS (1998) (2)
Pharmacological Inhibition of Epidermal Growth Factor Signaling in Experimental Pulmonary Arterial Hypertension. (2009) (2)
Peritoneal ultrafiltration for refractory fluid overload and ascites due to pulmonary arterial hypertension. (2015) (2)
Prevention of Lung Fibrosis in a Rabbit Model of Bleomycin-Induced Lung Fibrosis Upon Aerosol Application of Heparin or Urokinase (2001) (2)
Function of NADPH oxidase 1 in pulmonary arterial smooth muscle cells from monocrotaline-induced pulmonary hypertension (2012) (2)
The role of FoxO transcription factors in normal and aberrant late lung development (2017) (2)
Osteopontin and galectin-3 as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertension. (2021) (2)
The Interleukin 13 Receptor System: A Novel Pathogenetic Mechanism in Pulmonary Arterial Hypertension (2007) (2)
Follow-Up (Measurement) of Corrected QT Interval in Adult Patients before and after Lung Transplantation (2017) (2)
Phosphodiesterase‐5 Inhibitors in Pulmonary Arterial Hypertension (2008) (2)
Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – A prospective, randomized, controlled trial (2016) (2)
A Highly Selective Endothelin-A Receptor Antagonist TBC3711 Reverses Monocrotaline Induced Pulmonary Hypertension (2010) (2)
Protocol for the generation of murine bronchiolospheres (2021) (2)
[Update pulmonary arterial hypertension : Definitions, diagnosis, therapy]. (2017) (2)
Mediatorblockade (Mediatorinhibitoren, -antagonisten, -antikörper) (1993) (2)
Das alveoläre Surfactantsystem, seine pathogenetische Bedeutung für das akute Lungenversagen (ARDS) und therapeutische Perspektiven (2000) (2)
[Therapy of pulmonary arterial hypertension]. (2009) (2)
Effects of BAY 41-8543 and sildenafil on right heart structure and function in pulmonary artery banded mice (2011) (2)
Exposomes to Exosomes: Exosomes as Tools to Study Epigenetic Adaptive Mechanisms in High-Altitude Humans (2021) (2)
A role for the accessory type III transforming growth factor β receptor (Tgfbr3) in lung alveolarisation (2016) (2)
Pulmonary Vascular Research Institute GoDeep: A meta‐registry merging deep phenotyping datafrom international PH reference centers (2022) (2)
Whole-genome sequencing of a sporadic primary immunodeficiency cohort (2020) (2)
[Panniculitis of the thigh and lung emphysema in a 54-year-old patient]. (2015) (2)
Regulation of macroautophagy in amiodarone induced pulmonary fibrosis (2014) (2)
Right ventricular–pulmonary arterial coupling and its relationship to exercise haemodynamics in a continuum of patients with pulmonary vascular disease due to chronic thromboembolism (2022) (2)
High-dose IgG for neutropenic patients with acquired immunodeficiency syndrome (AIDS) (1991) (2)
Update pulmonalarterielle Hypertonie (2017) (2)
Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer (2022) (2)
Inspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension (2017) (2)
Clinical Relevance of Right Atrial Functional Response to Treatment in Pulmonary Arterial Hypertension (2021) (2)
Role of microRNA-21 in right ventricular hypertrophy and fibrosis (2012) (2)
Noninvasive Surrogate Markers of Pulmonary Hypertension Are Associated with Poor Survival in Patients with Lung Cancer (2)
Renal markers for monitoring acute kidney injury transition to chronic kidney disease after COVID-19. (2021) (2)
Regulation and localization of the telomerase enzyme-complex and the shelterin-telosom-complex in sporadic idiopathic pulmonary fibrosis (IPF) (2013) (1)
Inflammation : Role of the CCL 2-CCR 2 Axis Neutrophil Emigration During Lung Monocytes Are Potent Facilitators of Alveolar (2003) (1)
Leukotrienes and ARDS (2005) (1)
Role of mast cells and chymase in pulmonary vascular remodeling (2011) (1)
Novel causative genes for heritable pulmonary arterial hypertension (2017) (1)
Inhibition of profibrotic signaling in fibroblasts from patients with idiopathic pulmonary fibrosis (IPF) by histone deacetylase-inhibitors (HDACi) or the IPF drug pirfenidone (2014) (1)
[Community-acquired pneumonia]. (2018) (1)
Comparison of the Antifibrotic Efficacy of the Pan-Histone Deacetylase-Inhibitor Panobinostat Versus the IPF-Drug Pirfenidone in Fibroblasts from Patients with Idiopathic Pulmonary Fibrosis (2018) (1)
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH (2021) (1)
The role of Sonic Hedgehog in postnatal mouse lung development (2011) (1)
Utilising biomarkers to predict right heart maladaptive phenotype: a step toward precision medicine (2021) (1)
Co-incubation of PMN and CaCo-2 cells modulates inflammatory potential. (2017) (1)
[Physiology and physiopathology of the pulmonary circulation]. (1999) (1)
Potential Role of Protease-Activated Receptor-2 in Pathogenesis of Pulmonary Hypertension. (2009) (1)
[Hospital-acquired pneumonia]. (2018) (1)
[The position of respiratory medicine in Germany: status quo and future outlook]. (2010) (1)
afety and Efficacy of Inhaled Treprostinil as Add-On herapy to Bosentan in Pulmonary Arterial Hypertension (2006) (1)
Impact of litter size on survival, growth and lung alveolarization of newborn mouse pups. (2020) (1)
[A microsurgical bypass operation for the prevention and therapy of cerebral ischemia. Indication and technic]. (2008) (1)
Alveolar Oxidative Stress in Patients with Sporadic Idiopathic Pulmonary Fibrosis Is Associated with Oxidant-Antioxidant Imbalance Despite Induction of the Antioxidant Transcription Factor Nrf2. (2009) (1)
[Emerging therapies for the treatment of pulmonary arterial hypertension]. (2005) (1)
In-depth risk stratification in pulmonary arterial hypertension (2020) (1)
Long-term screening for pulmonary hypertension after pulmonary embolism (2014) (1)
Sildenafil for lung fibrosis and pulmonary hypertension (2003) (1)
Increased Generation Of Reactive Oxygen Species In Pulmonary Arterial Smooth Muscle Cells In Monocrotaline-induced Pulmonary Arterial Hypertension In Rats (2010) (1)
Therapie der pulmonalarteriellen Hypertonie (2009) (1)
Genome-wide transcriptional profiling of mononuclear phagocytes recruited to mouse lungs in response to alveolar challenge with the TLR 2 agonist Pam 3 CSK (1)
Transgenic mice expressing a surfactant protein B–urokinase fusion protein in the distal respiratory epithelium are protected against acute lung injury and postinflammatory fibrosis (2007) (1)
Reprogramming of Tumor Associated Macrophages by Modulating Wnt beta-Catenin Signalling in Lung Cancer (2018) (1)
Die Rolle von Arachidonsäuremetaboliten in der Pathogenese des Asthma bronchiale (1990) (1)
The European IPF Registry: Addressing challenges and characteristics of patients with Idiopathic Pulmonary Fibrosis (2018) (1)
Regulation of NADPH Oxidases in a Mouse Model of Tobacco Smoke Induced COPD. (2009) (1)
Therapeutic efficacy of TBC 3711 in monocrotaline-induced pulmonary hypertension (2011) (1)
Functional phenotype and role of resident and recruited bone marrow derived exudate macrophages in influenza virus-induced lung injury and repair (2018) (1)
Reversal Of Experimental Pulmonary Hypertension By The Multi-kinase Inhibitor Sunitinib (2010) (1)
[Three cases of a fulminant course of idiopathic pulmonary fibrosis (Hamman-Rich syndrome)]. (1993) (1)
Carbon Monoxide Modulates the Activity of Sodium Channels in the Alveolar Epithelium: A Role for δENaC?. (2009) (1)
Schock und akute Kreislaufinsuffizienz (2005) (1)
A study of Platelet Activation by Bacterial Toxins (2007) (1)
The role of mitochondrial reactive oxygen species in the response of the pulmonary vasculature to hypoxia and right heart remodeling (2017) (1)
Hmga2is required for canonical WNT signaling during lung development (2014) (1)
Circulating hyaluronic acid signature in CAP and ARDS - the role of pneumolysin in hyaluronic acid shedding. (2022) (1)
Death Ligands Are Upregulated in Influenza Pneumonia and Contribute to Depletion of the Resident Alveolar Macrophage Pool (2019) (1)
Pulmonary Mast Cell Activation And Increased Chymase In Patients With Pulmonary Hypertension And Fibrosis (2011) (1)
Gene regulatory roles for lysyl oxidases in the context of BPD (2017) (1)
S40 Phenotypic characterisation of GDF2 mutation carriers in a large cohort of patients with pulmonary arterial hypertension (2018) (1)
[Consumptive coagulopathy and lung function]. (1982) (1)
GLI1+ cells are a source of repair-supportive mesenchymal cells (RSMCs) during airway epithelial regeneration (2022) (1)
Inflammatory Cell Dynamics Is Perturbed in the Oxygen-Injured Developing Mouse Lung: Implications for the Pathogenesis of Bronchopulmonary Dysplasia (2020) (1)
Alveolo-Vascular Alterations in a Mouse Model of Tobacco-Smoke Inhalation. (2009) (1)
Regulation and role of notch signaling in epithelial progenitor cell differentiation and proliferation in the normal and the fibrotic lung (2011) (1)
Publisher Correction: Whole-genome sequencing of a sporadic primary immunodeficiency cohort (2020) (1)
N-3 vs. n-6 fatty acids differentially influence calcium signalling and adhesion of inflammatory activated monocytes: impact of lipid rafts (2016) (1)
Role of Phosphodiesterases in Idiopathic Pulmonary Fibrosis (2006) (1)
Arachidonic acid/cytochrome p450-derived mediators decrease hypoxic pulmonary vasoconstriction in isolated, ventilated and perfused mouse lungs (2014) (1)
Improvement of right heart structure and function by BAY 41-8543 in pulmonary artery banded mice (2011) (1)
Surfactant protein B proforms as potential new biomarkers for idiopathic pulmonary fibrosis (2014) (1)
TRAF2 Is a Novel Ubiquitin E3 Ligase for the Na,K-ATPase β-Subunit That Drives Alveolar Epithelial Dysfunction in Hypercapnia (2021) (1)
Medikamentöse Therapie der pulmonalen Hypertonie (2005) (1)
Effect of endotoxin on COX-2 dependent proliferation of NSCLC cells: Role of CD14, TLRs, and EGFR signaling. (2009) (1)
Pulmonary hypertension in renal dialysis patients - A matter of water (2015) (1)
Optimising the delivery of antagomiRs to the neonatal mouse lung (2016) (1)
Long Term Open Label Treatment with Inhaled Treprostinil for Pulmonary Arterial Hypertension. (2009) (1)
HMGA2 mediated epigenetic regulation of Gata6 controls epithelial WNT signaling during lung development (2017) (1)
SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension (2022) (1)
Pre-transplant renal functional reserve and renal function after lung transplantation. (2020) (1)
Metformin induces lipogenic differentiation in myofibroblasts to reverse mouse and human lung fibrosis (2018) (1)
Die Therapie der idiopathischen pulmonalen Fibrose (2013) (1)
IL-1 Receptor Antagonist Exerts Anti-apoptotic And Barrier-protective Effects Towards Alveolar Epithelium In A Murine Model Of LPS-induced Acute Lung Injury (2010) (1)
Surfactant-Therapie für das akute Lungenversagen (ARDS) (2001) (1)
Interactions between neutrophils and NSCLC cells in vitro effects on neutrophil inflammatory mediator generation and tumour cell proliferation. (2009) (1)
Evaluation of Diagnostic Accuracy and Radiation Exposure of Dual-Energy Computed Tomography (DECT) in the Course of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Evaluation der diagnostischen Genauigkeit und der Strahlendosis der Dual-Energy-Computertomografie (DECT) bei chronisch thromboemb (2021) (1)
ARDS: Mögliche Rolle bakterieller Exotoxine (1992) (1)
Zunahme des Strömungswiderstandes und der Gefäßpermeabilität in der pulmonalen Strombahn als Folge des Metabolismus freier Arachidonsäure (1981) (1)
[Pulmonary hypertension and sleep-related breathing disorders]. (2005) (1)
Hypercapnia-induces IRE1α-driven Endoplasmic Reticulum-associated Degradation of the Na,K-ATPase β-subunit. (2021) (1)
1-10-2008 AMP-Activated Protein Kinase Regulates CO 2-Induced Alveolar Epithelial Dysfunction in Rats and Human Cells by Promoting Na , K-ATPase Endocytosis (2019) (1)
Formation of TIAR/TIA-1-containing stress granules depends on the kinetics of oxygen partial pressure decline and may suppress angiogenesis by HIF pathway (2008) (1)
Nosokomial erworbene Pneumonie (2018) (1)
Die Berlin-Definition (2012) (1)
Role of Notch Signaling in Pulmonary Hypertension (2012) (1)
709 ABNORMALITIES IN B CELL DIFFERENTIATION AND T CELL SUPPRESSION IN IMMUNODEFICIENCY WITH HYPER-IgM (1978) (1)
Non-invasive lung cancer diagnosis by detection of GATA6 and NKX2-1 isoforms in exhaled breath condensate (2017) (1)
fibrosis : a rationale for therapeutic intervention receptors in idiopathic pulmonary 2 A / B Increased expression of 5-hydroxytryptamine (1)
Medizinische Therapie 2005|2006 (2005) (1)
PINK1-mediated Mitophagy Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension. (2021) (1)
Selective inhibition of chemokine CCL2/MCP-1 reduces experimental pulmonary hypertension (2013) (1)
Lung ageing in C57/Bl6 and BALB/c mice is characterized by a defective surfactant metabolism, increased ER stress and inflammasome induction (2016) (1)
Erkrankungen der oberen Atemwege (2007) (1)
[How much insulin does the critical ill need?]. (2011) (1)
L-α-phosphatidic acid : Ca-Ionophore with stimulation of the arachidonic acid cascade in the pulmonary vascular bed (1984) (1)
Minoxidil Cannot Be Used To Target Lysyl Hydroxylases during Postnatal Mouse Lung Development: A Cautionary Note (2020) (1)
Staphylococcal α-toxin stimulates PGI2-production in pulmonary endothelial cells. Initiation by transmembrane Ca-flux, possibly through toxin pores (1984) (1)
Role of adenylate kinase 4 as a new metabolic regulator of pulmonary artery smooth muscle cells under hypoxia (2019) (1)
The role of miR-135b in normal and aberrant post-natal lung development (2017) (1)
The Role Of Histone Deacetylase 9 In Idiopathic Pulmonary Fibrosis (2017) (1)
CHAPTER 24 – Calmodulin and the Lung Arachidonic Acid System (1985) (1)
Abstract 18972: Inhibition of Ca2+/Calmodulin-Dependent Phosphodiesterase1A Restores Right Ventricular Dysfunction in Experimental Pulmonary Hypertension (2010) (1)
Increased pulmonary vascular remodeling in UCP2 deficiency (2012) (1)
[Severe sepsis--new therapeutic options]. (2001) (1)
Long-Term Hypercapnia Impairs ENaC Function In Alveolar Epithelial Monolayers: A Role For Ubiquitination? (2011) (1)
HIV-assoziierte pulmonale Hypertonie (2005) (1)
Identification of novel rare sequence variation underlying heritable pulmonary arterial hypertension (2018) (1)
Urokinase Inhibition Reduces Primary Tumor Growth And Metastasis Formation In A Murine Lung Carcinoma Model (2010) (1)
Intraindividual response to treatment with pirfenidone in two independent European IPF cohorts (2014) (1)
The role of pulmonary lipofibroblasts in alveolar septation (2011) (1)
Role of HGF in the healthy and injured lung (2015) (1)
Sildenafil bei pulmonaler Hypertonie. Kommentar (2003) (1)
Intensivmedizin in der Inneren Medizin (2006) (1)
Contribution of progenitor cells in experimental right heart hypertrophy induced by pulmonary artery ligation (2011) (1)
[Arachidonic acid metabolites as mediators of an increase in resistance and a barrier disorder in pulmonary microcirculation]. (1983) (1)
Dry powder nebulization of a recombinant surfactant protein C-based surfactant for treatment of acute respiratory distress syndrome (2007) (1)
Idiopathische Interstitielle Pneumonien: Pathomechanismen und Therapieoptionen (2005) (1)
SELEKTIVE BLOCKADE INFLAMMATORISCHER MEDIATOREN ALS THERAPIEKONZEPT IN DERSEPSIS (1993) (1)
Nicht invasive Beatmung des akuten hypoxämischen Lungenversagens (2001) (1)
Flt3L elicited lung dendritic cells are recruited via β2 integrin dependent pathways and amplify the lung inflammatory response to LPS (2006) (1)
Granulozyten-Endothel-Interaktion: Mechanismen der Abwehr und Autoaggression (1994) (1)
Impact of a phosphorothioate oligodeoxynucleotide MCP-1 on NF-kappaB, AP-1, SP1 and NF-kappaB, and AP-1 subunit composition in human pulmonary endothelial cells. (2001) (1)
Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: The role of phosphodiesterase 4. (2022) (1)
Registry of the University of Giessen Lung Center on New Cases of Pulmonary Hypertension Patients in the Years 1996 to 2005. (2009) (1)
Relative role of hepatocyte growth factor in mediating epithelial cell-protective effects in lung fibrosis – a role of Bcl-xL induction (2011) (1)
[Mechanism of cell damage by E. coli hemolysin]. (1988) (1)
Preserved right ventricular function in mitochondrial uncoupling protein 2 deficient mice in pressure overload induced right ventricular insufficiency (2015) (0)
Wnt Signaling Pathway in Right Ventricular Remodeling (2012) (0)
Effects Of The Multikinase Inhibitor Sunitinib On Right Ventricular Remodeling In An Experimental Model Of Right Heart Hypertrophy (2010) (0)
Hypoxic Regulation Of Pyruvate Kinase Isoforms M1 And M2 And Their Inhibition By SiRNA In A549 Cells (2010) (0)
Characterization Of Tcf21+Lung Cells During Neo-Alveolarization (2017) (0)
Mitochondrial autophagy in the development of amiodarone induced pulmonary fibrosis (2014) (0)
Decreased plasma levels of the brain-derived neurotrophic factor correlate with right heart congestion in pulmonary arterial hypertension (2023) (0)
[The role of arachidonic acid metabolites in the pathogenesis of bronchial asthma]. (1990) (0)
Effects of riociguat in severe experimental pulmonary hypertension (2011) (0)
Intermedin Enhances Alveolar Edema Clearance By Promoting Na,K-ATPase Exocytosis In A Protein Kinase A-Dependent But CAMP-Independent Manner (2012) (0)
Proangiogenic and wound healing molecular and histological fingerprint of chronic thromboembolic pulmonary hypertension (2017) (0)
P-43 – Mitochondria-targeted antioxidant MitoQ intercepts superoxide radical formation under acute hypoxia: Evaluation of the oxidative stress in murine pulmonary arterial smooth muscle cells by electron paramagnetic resonance spectroscopy (2016) (0)
Altered autophagy in Hermansky-Pudlak syndrome associated interstitial pneumonia (2011) (0)
Secreted Protein Acidic and Rich in Cysteine Regulates Vascular Cell Function in Pulmonary Hypertension (2022) (0)
Biological role of the proapoptotic transcription factor CHOP in Idiopathic Pulmonary Fibrosis (IPF) (2011) (0)
Long non-coding RNA ADPGK-AS1 controls anti-tumor immunity in macrophages through metabolic modulation (2020) (0)
Use of an emulsion, for the manufacture of a medicament for intravenous administration for the treatment of skin diseases (1992) (0)
Stimulation of pulmonary vascular arachidonic acid cascade by staphylococcal α-toxin: Inititiation by Ca-flux possibly through transmembrane toxin-channels (1984) (0)
Snail and Slug are Key Mediators of TGF-beta-induced Epithelial-to-Mesenchymal Transition in Lung Fibrosis (2007) (0)
Clinical and functional characteristics of patients with unclassifiable interstitial lung diseases (uILD) from eurIPFreg (2020) (0)
The role of pulmonary fibroblasts in alveolar septation (2012) (0)
Impact Of Mouse Strain On Arrested Alveolarization In Response To Hyperoxia Exposure As Neonates (2017) (0)
Treprostinil Mediated Activation of Peroxisome Proliferator-Activated Receptors in Pulmonary Hypertension. (2009) (0)
Use of minimally invasive surgery and therapies mitigating pulmonary arterial pressure and intraoperative blood loss may offer protection against cardiac surgery-associated acute kidney injury (2020) (0)
Pulmonary senescence in chronic obstructive pulmonary disease is primarily mediated by persistent DNA double strand breaks (2013) (0)
Eicosanoids and Acute Respiratory Failure — Pathophysiologic and Therapeutic Aspects (1992) (0)
Alveolar Remodeling in a Mouse Model of Chronic Tobacco Smoke Inhalation (2008) (0)
Hämodynamische Definition der pulmonalen Hypertonie: Kommentar zu der vorgeschlagenen Änderung durch das 6 th World Symposium on Pulmonary Hypertension Hemodynamic Definition of Pulmonary Hypertension: Commentary on the Proposed Change by the 6 th World Symposium on Pulmonary Hypertension (2019) (0)
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension (2019) (0)
Influenza-virus infection impacts on alveolar edema clearance: role of virus- and host factors in regulation of alveolar epithelial cell ENaC and Na,K-ATPase expression (2012) (0)
Abstract 2604: Involvement of circulating fibrocytes in the progression of adenocarcinomas by modulating EMT and tumor microenvironment. (2013) (0)
6 Phosphodiesterase-5 inhibitors in pulmonary arterial hypertension (2008) (0)
Dimethylarginine Dimethylaminohydrolase 2 in Idiopathic Pulmonary Fibrosis. (2009) (0)
TRAIL induction in lung macrophages is IFN-ß-dependent and results in alveolar epithelial apoptosis in IV pneumonia (2010) (0)
Role of Bcl-xL in hepatocyte growth factor-elicited epithelial protection in idiopathic pulmonary fibrosis (2014) (0)
Investigation of Nitric Oxide Synthase 2 in Different Pulmonary Cell Types and NOS2-Related Signaling Pathways in COPD (2020) (0)
ProfilesDrastic Changes in Their Gene Expression the Alveolar Space of Mice Is Associated with Trafficking of Mononuclear Phagocytes into The Inflammatory versus Constitutive (2005) (0)
Diagnostic accuracy of echocardiography in pulmonary hypertension due to interstitial lung disease (2018) (0)
Potential Role of NADPH Oxidase 1 Derived ROS in Vascular Remodeling in Monocrotaline-induced Pulmonary Arterial Hypertension of Rats (2010) (0)
Stem cell mediated lung repair after influenza-induced injury: role of the Fgf10/Fgfr2b axis (2016) (0)
Pulmonary Emphysema in Rats with Severe Pulmonary Hypertension Induced by SU5416 and Hypoxia (2019) (0)
Characterization of Matrix Metalloproteinase (MMP) expression and activity in the lungs of patients with Idiopathic Pulmonary Fibrosis (IPF) (2006) (0)
Assessing the effectiveness of pirfenidone in changing the natural course of idiopathic pulmonary fibrosis: the data from European IPF Registry (eurIPFreg) (2020) (0)
Siah2 in pulmonary hypertension and right ventricular hypertrophy (2013) (0)
Constitutive knockdown of Napsin A does not result in a fibrotic lung phenotype in mice (2012) (0)
Superoxide generation by NOX1 contributes to abnormal migration and proliferation of pulmonary arterial smooth muscle cells in rats (2011) (0)
Impact of tidal volume, GAP index and anti-fibrotic treatment on disease progression and mortality in IPF patients (2020) (0)
Vascular reverse remodeling in the mouse model of hypoxia-induced pulmonary hypertension – role of AMD-1 (2011) (0)
Influenza virus impairs fibroblast growth factor receptor 2b dependent epithelial regeneration from a distal airway epithelial progenitor pool (2014) (0)
Central Role Of C-Jun N-terminal Kinase In Hypercapnia-induced Alveolar Epithelial Dysfunction (2010) (0)
The Dual Neutral Endopeptidase/Endothelin Converting Enzyme Inhibitor SLV338 Inhibits Experimental Pulmonary Hypertension In Rats (2011) (0)
Cellular Homeostasis Mechanism (apoptosis/autophagy And Proliferation) In Calorie Restricted Lung Regeneration Murine Model (2010) (0)
Endogenous Fgfr2b ligands are dispensable for fibrosis formation and resolution in bleomycin-injured mice (2014) (0)
Stimulation of Prostacyclin Production in Cultured Pulmonary Artery Endothelial Cells by Pseudomonas Aeruginosa Cytotoxin: Membrane Attack and Calcium Influx (1985) (0)
Computer-assisted of the intracapillary leukocyte pool in the rabbit lung (1993) (0)
Abstract #4313: Evaluation of angiogenesis using micro-computed tomography in a xenograft mouse model of lung cancer (2009) (0)
PULMONARY PERSPECTIVE (2017) (0)
Mast cells in chronic pressure overload induced right ventricular hypertrophy (2012) (0)
Intravascular and Extravascular Coagulation and Fibrinolysis in the Diseased Lung (2008) (0)
Prevention Of Experimental Hypoxia-Induced Pulmonary Hypertension By Moderate Exercise Training In Mice (2011) (0)
Altered autophagy in the development of Hermansky-Pudlak syndrome associated Interstitial pneumonia (2012) (0)
Late Breaking Abstract - Role of interleukin-10 in normal and aberrant late lung development (2017) (0)
Erratum: Antihistone Properties of C1 Esterase Inhibitor Protect against Lung Injury (2022) (0)
Epidemiology of seasonal and pandemic influenza (H1N1) in German hospitals - Influence of comorbidity, ventilatory support and age on mortality (2014) (0)
Abstract 1839: Phosphodiesterase 4 regulates lung tumor growth through HIF regulation, proliferation, and angiogenesis (2012) (0)
Acute vasoreactivity testing with sildenafil vs nitric oxide in patients with PAH (2012) (0)
Circulating Fibrocytes In Pathogenesis And Therapy Of Pulmonary Hypertension - Role Of Receptor Tyrosine Kinases (2010) (0)
Mitochondrial Alterations Of Pulmonary Arterial Smooth Muscle Cells In Pulmonary Hypertension (2011) (0)
Morphometric analysis of pulmonary vascular remodeling in COPD (2009) (0)
[Chronic fibrosing lung diseases : Idiopathic pulmonary fibrosis from the perspective of its differential diagnosis]. (2019) (0)
Latest Publications in Cytometry Part A You Should Not Miss (2008) (0)
Correction to: Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice (2022) (0)
Wnt-Signaling Pathway In Experimental Right Heart Hypertrophy (2011) (0)
Invention relating to the prevention and treatment of diseases that are verusacht by thrombus or plunged (2003) (0)
Alveolar Space Independent of Leukocyte Trafficking into Pneumolysin-Induced Lung Injury Is (2004) (0)
Regulation of Macroautophagy in Idiopathic Pulmonary Fibrosis (2012) (0)
Liquid movements in ventilated and perfused isolated lungs of fetal sheep at 0.87, 0.90, and 0.95 of term. (1995) (0)
Wnt-inducible protein (WISP-1) is a key regulator of alveolar epithelial cell hyperplasia in pulmonary fibrosis (2006) (0)
Gamma-Glutamyltransferase in pulmonary hypertension: A reliable biomarker? (2020) (0)
endothelial cells: role of endothelial PAF generation -3 Fatty acids suppress monocyte adhesion to human ω (2016) (0)
WISP1: A novel regulator of idiopathic pulmonary fibrosis amenable to therapeutic intervention (2007) (0)
Abstract 1484: Functional and molecular characterization of macrophage-tumor cell communication (2012) (0)
MicroRNA-9 is a regulator of PDGFRβ expression in pulmonary arterial hypertension (2015) (0)
Macrophage TRAIL Expression Is IFN-ß-dependent And Mediates Alveolar Epithelial Apoptosis And Barrier Dysfunction In Influenza Virus Pneumonia (2010) (0)
Vascular Reverse Remodeling In Hypoxia-induced Pulmonary Arterial Hypertension (2010) (0)
Correction: Sommer et al. Decreased Thymic Output Contributes to Immune Defects in Septic Patients. J. Clin. Med. 2020, 9, 2695 (2022) (0)
Epigenetic regulation of alveolar ion transport (2011) (0)
S8.23 Oxygen dependency of mitochondrial respiratory chain function in hypoxic pulmonary vasoconstriction (2008) (0)
Reliability of echo systolic pulmonary arterial pressure to detect new definition of pulmonary hypertension (2020) (0)
Regulation of vascular endothelial growth factor expression in a mouse model of acute respiratory distress syndrome (ARDS) (2013) (0)
Abstract 944: Chemokine receptor signaling as a new tool to improve lung cancer diagnostics and therapy (2017) (0)
The role of Forkhead Box O 3a (FoxO3a) Transcription Factors in the Pathogenesis of Pulmonary Fibrosis (2012) (0)
Contribution of HMSE-1 to surfactant conversion under acute inflammatory conditions (2007) (0)
Role of NADPH Oxidase Derived ROS Production in Regulation of Kv Channels. (2009) (0)
The role of NFκB/IKK2 pathway in the pathogenesis of lung cancer (2012) (0)
Role of impaired lysosomal trafficking in pulmonary fibrosis (2006) (0)
[HIV-associated pulmonary hypertension ]. (2005) (0)
Macrophage and Cancer Cell Crosstalk Regulated MicroRNA 147b Plays a Crucial Role in Lung Cancer Progression (2018) (0)
Reversal of experimental hypoxia-induced pulmonary hypertension by moderate exercise training in mice (2011) (0)
Generation of vascular progenitor cells from ES cells and iPS cells for medical applications (2014) (0)
New Therapeutic Strategies for the Treatment of Experimental Pulmonary Hypertension : Role of the Epidermal Growth Factor (1997) (0)
S12.46 Hypoxic pulmonary vasoconstriction is modulated in ucp2 knock-out mice during acute and sustained hypoxia (2008) (0)
Regulation of ENaC Activity in the Alveolar Epithelium by TGF-β. (2009) (0)
Molecular Mechanisms Of Classical Transient Receptor Potential 1 (trpc1) Dysregulation In Chronic Hypoxia-Induced Pulmonary Vascular Remodeling (2016) (0)
The impact of caffeine on TGF-β signaling and brochopulmonary dysplasia (2017) (0)
Relevance of persistent foramen ovale in PAH patients on pulmonary vasoactive treatment (2012) (0)
Wnt signaling in right ventricular remodeling (2013) (0)
The role of cytochrome c oxidase subunit 4 isoform 2 (Cox4i2) in chronic hypoxia induced pulmonary hypertension (2016) (0)
formulation attenuates acute hypoxic pulmonary vasoconstriction (2010) (0)
LTI-201: Evaluation of the hemodynamics and safety of inhaled LIQ861 (treprostinil) in pulmonary arterial hypertension (WHO Group 1) patients (2020) (0)
The Max Planck Institute for Heart and Lung Research Curiosity-Driven Basic Research to Fight Cardio-Pulmonary Diseases. (2017) (0)
[Nutrition in intensive care]. (2011) (0)
COVID-19: spot urine rather than bronchoalveolar lavage fluid analysis? (2021) (0)
Functional and molecular characterization of macrophage-tumor cell communication (2012) (0)
Phosphodiesterase inhibitors as promising therapies for cigarette smoke-induced emphysema and pulmonary hypertension (PH) in mice (2014) (0)
Leukotriene andHydroxyeicosatetraenoic AcidGeneration Elicited byLowDosesofEscherichia coli Hemolysin inRabbit Lungs (1990) (0)
Stereological Monitoring Of Post-Natal Lung Maturation In The Mouse (2017) (0)
Involvement of cytoskeletal protein paxillin in the pathogenesis of pulmonary hypertension (2011) (0)
Hypercapnia-induced calcium dysregulation in the endoplasmic reticulum impairs Na,K-ATPase maturation in precision-cut lung slices and alveolar epithelial cells (2020) (0)
Survival in patients with different groups of pulmonary hypertension (2012) (0)
Oral Sildenaﬁl as Long-Term Adjunct Therapy to Inhaled Iloprost in Severe Pulmonary Arterial Hypertension (2016) (0)
Regulation of pulmonary arterial smooth muscle cell function in pulmonary hypertension via Paxillin (2012) (0)
Adhesion Molecules Virus Infection: Impact of Chemokines and Transepithelial Migration upon Influenza Alveolar Epithelial Cells Direct Monocyte (2006) (0)
Identification Of Putative Regulators Of Alveolarization (2010) (0)
Ubiquitination-driven down-regulation of the cell adhesion molecule Na,K-ATPase β-subunit by hypercapnia in alveolar epithelial cells (2012) (0)
Improved outcome of FAT mice in a model of acute lung injury in spite of increased spleenic lymphocytes apoptosis (2012) (0)
[Medical treatment of pulmonary hypertension: what's new?]. (2015) (0)
Alveolar Macrophages and Monocytes in Human Candida albicans Evoked by Proinflammatory Cytokine Production Surfactant Protein A Down-Regulates (1999) (0)
Procedural safety of a fully implantable pump for delivery of intravenous prostanoids in severe pulmonary hypertension: A two-center observational study (2016) (0)
The effect of endotoxin on cell-proliferation and responsiveness to treatment in Non-small-cell-lung-cancer (2012) (0)
The Emerging Role of Gas6/Axl Axis in Pulmonary Arterial Hypertension (2019) (0)
Reversal of pulmonary vascular remodeling induced by hypoxia in mice by the soluble guanylate cyclase activator Bay 58–2667 (2005) (0)
Inhalt Band 35, Heft 2, April 2008 (2008) (0)
Muring Lung Lipofibroblast Lineage Tracing (2016) (0)
[Pulmonary hypertension]. (2002) (0)
Stereological analysis of single lung lobes in newborn mice exposed to hyperoxia (2017) (0)
Inhibition of p38 MAPK improves heart function in experimental pressure-overload induced right ventricular hypertrophy and failure (2014) (0)
Targeting of mitochondrial superoxide in chronic hypoxia-induced pulmonary hypertension (2019) (0)
Imaging Of Right Ventricular Hypertrophy In Mice By Magnetic Resonance Imaging (2010) (0)
Influence of Early Growth Response 1 (Egr1) and Tenascin C (Tnc) on compensatory lung growth (2012) (0)
Late Breaking Abstract - The miR-34a/Pdgfra interaction can be targeted to correct defective alveolarization in experimental bronchopulmonary dysplasia (2017) (0)
Role of urokinase type plasminogen (uPA) in pulmonary vascular remodeling in a murine model of hypoxia induced pulmonary hypertension (2006) (0)
Contribution of the Edition Mediated by ADARs to the Progression of Lung Diseases (2020) (0)
Role of prostanoid receptor EP1 in the progression of non-small cell lung cancer (NSCLC) (2013) (0)
Protein Arginine Methyltransferasen (PRMT) in idiopathischer Lungenfibrose (2005) (0)
Interferon Regulatory Factor 9 Mediated Regulation of Lung Cancer Progression and Metastasis (2018) (0)
Use of an emulsion with polyunsaturated fatty acids are for intravenous administration for the treatment of skin diseases (1991) (0)
RELMb is a hypoxic induced mitogenic factor in human adenocarcinoma A549 celline. (2006) (0)
Histone Deacetylase 7 regulates master transcription factors and modulates mitochondrial function (2017) (0)
Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD (2020) (0)
Bacterial Toxins and Terminal Complement Complex: Significance for Lung Microvascular Injury (1991) (0)
Circulating Fibrocytes Depletion Results In Reduced Lung Tumor Growth And Metastasis By Modulating Macrophage Phenotype, Angiogenesis And Endothelin System (2017) (0)
articleEffects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice (2015) (0)
Lung CT densitometry in IPF for the prediction of disease severity and mortality (2019) (0)
Sex-specific Effect and Disconnect Between Plasma Levels of FXII and FXIIa-C1-esterase Inhibitor Complexes in Pneumonia (2020) (0)
Increased generation of reactive oxygen species in pulmonary arterial smooth muscle cells from monocrotaline-treated rats (2010) (0)
Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension (2022) (0)
Role of microRNA 17/92 cluster and microRNA 21 in the pathogenesis of pulmonary hypertension - Novel therapeutic targets (2013) (0)
Impact of timing on right heart catheterization measurements in pulmonary hypertension (2020) (0)
Short title: Anti-PR3-antibodies mediate acute lung injury (2009) (0)
SNAI transcription factors in epithelial-to-mesenchymal transition: Comparative analysis of experimental and idiopathic pulmonary fibrosis (2007) (0)
Synergistic Effect Of Imatinib And Sildenafil On Amelioration Of Pulmonary Hypertension—Role Of Src Kinase And Glycogen Synthase Kinase-3{beta} (2010) (0)
Uncoupling protein of Acanthamoeba castellanii mitochondria is activated by lipid peroxidation end product hydroxynonenal (2012) (0)
Regulation and localization of the Telomerase- and the Shelterin-telosom-complex in sporadic Idiopathic Pulmonary Fibrosis (2012) (0)
NO synthase isoforms are involved in the LPS-induced alteration of hypoxic vasoconstriction (2008) (0)
Vascular Cell-Specific Genome-Wide Profiling Of Epigenetic Landscape Reveals Gene Regulatory Signatures In Human Pulmonary Arterial Hypertension (2016) (0)
Right ventricular remodeling in response to pressure overload (2010) (0)
Liposomally Encapsulated Iloprost as Optimal Inhalation Therapy for Pulmonary Hypertension (2010) (0)
Controlled Sildenafil Dose Reduction in PAH Patients Previously Treated at 80 mg TID. (2009) (0)
Terguride attenuates myocardial remodelling and diastolic dysfunction in the pressure overloaded right heart (2011) (0)
Alveolar Macrophage TNF-± Induces Epithelial Expression Of GM-CSF And Mediates Alveolar Repair In Gram-negative Pneumonia In Mice (2010) (0)
Late lung development in mice, a careful assessing by cutting-edge stereology (2017) (0)
Sildenafil for lung fibrosis and pulmonary hypertension. Authors' reply (2003) (0)
Intermedin promotes pulmonary edema resolution by upregulating the Na,K-ATPase (2012) (0)
Dysfunctional autophagy in Hermansky-Pudlak syndrome associated lung fibrosis (2015) (0)
Differential rrole o of a actin iin llung e endothelial a and e epithelial b barrier properties iin p perfused rrabbit llungs (1996) (0)
iNOS Deletion in Alveolar Epithelium Cannot Reverse the Elastase-Induced Emphysema in Mice (2022) (0)
PDGF and Src tyrosine kinases in pulmonary arterial smooth muscle cells: Effects of dasatinib and nilotinib on pulmonary vascular remodeling (2011) (0)
Axl is a Novel Modulator of Bone Morphogenetic Protein Receptor 2 in pulmonary arterial hypertension (2021) (0)
Impact of different lipid emulsions on acute lung injury in a murine model (2005) (0)
Modulation of acute lung injury (ALI) by lipid emulsions - dependency of the chemerin 23 receptor (ChemR23)? (2012) (0)
LSC Abstract – Epigenome-wide mapping of histone modification landscape in human pulmonary arterial hypertension (2016) (0)
Effects Of Hypercapnia On NA,K-ATPASE Stability And Epithelial Cell Adhesion In Human Alveolar Epithelial Cells (2011) (0)
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2 (2021) (0)
Transforming growth factor-β inhibits alveolar epithelial protein transport by glycogen synthase kinase 3-β-mediated downregulation of megalin (2012) (0)
Pulmonary arterial hypertension: current therapies (2003) (0)
Characterization of pulmonary TCF21 positive cells during neo-alveolarisation (2017) (0)
Inhibition of profibrotic signaling in fibroblasts from patients with idiopathic pulmonary fibrosis by histone deacetylase-inhibitors or pirfenidone (2014) (0)
Mechanisms and Impact of Chemokines Epithelial Barrier: Adhesion Molecule Monocyte Migration Through the Alveolar (1999) (0)
Establishing of a pure entothelial cell culture from differentiating murine embryonic stem cells (2012) (0)
Essential Role of Mitochondrial Cytochrome c Oxidase Subunit 4 Isoform 2 (Cox4i2) for Acute Pulmonary Oxygen Sensing (2022) (0)
Sex-specific differences in plasma levels of FXII, HK, and FXIIa-C1-esterase inhibitor complexes in community acquired pneumonia. (2021) (0)
NO pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension (2004) (0)
Gene Regulatory Roles For Lysyl Oxidases In Lung Fibroblasts (2017) (0)
Localization pattern of β-catenin in chronic lung disease (2011) (0)
Advances in the Treatment of Pulmonary Arterial Hypertension (2007) (0)
Sildenafil citrate therapy for pulmonary arterial hypertension (vol 353, pg 2148, 2005) (2006) (0)
Bacterial Exotoxins and Acute Lung Failure (1991) (0)
The role of transglutaminase 2 in normal and aberrant late lung development (2016) (0)
Synthesis and studies on the biophysical activity of human lung surfactant peptide SP-C and its N-terminal fragments. (1994) (0)
Regulation of TRPC6 in the Acute Phase of Hypoxic Pulmonary Vasoconstriction. (2009) (0)
Epoxyeicosatrienoic Acids (eets) And 20-Hydroxyeicosatetraenoic Acid (20-Hete) Reduce Hypoxic Pulmonary Vasoconstriction In Isolated Ventilated And Perfused Mouse Lungs (2016) (0)
[Vasotropic therapy and artificial respiration for pulmonary hypertension]. (1999) (0)
Role of class IIa histone deacetylases in the pathogenesis of pulmonary hypertension (2014) (0)
Mitochondrial alterations in T cells after invivo and invitro smoke exposure (2022) (0)
A Possible Role Of Serotonin For The Development Of Tobacco-Smoke Induced Lung Emphysema And Pulmonary Hypertension (2012) (0)
Role of Bcl-xL in hepatocyte growth factor elicited epithelial protection in idiopathic lung fibrosis (2013) (0)
Hemodynamic phenotyping based on exercise catheterization predicts outcome in heart failure patients with reduced ejection fractionExercise hemodynamic phenotyping predicts outcome in HFrEF (2017) (0)
Poster Discussions (2018) (0)
[Pneumological intensive care medicine]. (2012) (0)
Impact Of Control Interventions In Lung Alveolarization During Post-Natal Lung Development (2017) (0)
Obesity aggravates monocrotaline–induced pulmonary hypertension in female Zucker rats (2015) (0)
Inhibition of Circulating Fibrocyte Recruitment and Differentiation by Treprostinil in Pulmonary Vascular Remodelling. (2009) (0)
Mouthpiece for inhalation therapy device for use by oxygen-dependent patients (2000) (0)
Role of impaired lysosomal trafficking in a murine model of Hermansky-Pudlak-syndrome associated interstitial pneumonia (HPSIP) (2009) (0)
[Differential therapy of pulmonary fibrosis]. (2006) (0)
PEGASUS - the effects of commercial air travel on patients suffering from pulmonary hypertension - a prospective, multicenter, multinational study (2018) (0)
High CO2 levels impair ENaC cell surface expression by promoting phosphorylation and polyubiquitination of ENaC β-subunit in human alveolar epithelial cells (2018) (0)
Use of lipids in a murine model of ALI and lymphocyte apoptosis – Harmful or beneficial? (2011) (0)
Expression of CD74 Is Up-Regulated by Hypoxia in Murine Alveolar Macrophages. (2009) (0)
Synthesis: Role of IL-1 Receptor Antagonist Cell Density Regulates Neutrophil IL-8 (2001) (0)
Anti-fibrotic effects of pirfenidone on pulmonary arterial vascular smooth muscle cells (2016) (0)
Mitochondrial Respiration And Reactive Oxygen Species In Acute Pulmonary Oxygen Sensing Of Pulmonary Arterial Smooth Muscle Cells (2010) (0)
Inhibition of Profibrotic Signaling in Primary Fibroblasts from Patients with Idiopathic Pulmonary Fibrosis (IPF) by Sirtuin-1/-2-Inhibitor Sirtinol (2019) (0)
Surfactant alterations and lung fibrosis in a murine model of amiodarone-induced pulmonary fibrosis (2007) (0)
Risk assessment in severe pulmonary hypertension due to interstitial lung disease (2020) (0)
PAR-2 depletion protects against the development of pulmonary hypertension (2012) (0)
Role of Reactive Oxygen Species in Acute Pulmonary Oxygen Sensing (2010) (0)
Effects of Multikinase inhibitors on pressure overload-induced right ventricular remodelling (2013) (0)
Quantitative lung morphology in a regenerative lung model (2009) (0)
Predictive value of 6 MWD and derived indices 3 months after initial PAH therapy for the necessity of a combination therapy in patients with pulmonary arterial hypertension (2013) (0)
Brief Communication Impact of a Phosphorothioate Oligodeoxynucleotide MCP-1 on NF-kB, AP-1, SP1 and NF- kB, and AP-1 Subunit Composition in Human Pulmonary Endothelial Cells (2001) (0)
Late-breaking abstract: Influenza A virus infection reduces alveolar fluid clearance by activation of AMPK and subsequent reduction of Na,K-ATPase protein abundance (2014) (0)
sGC activators and stimulators attenuate ischemia/reperfusion injury of the lung (2009) (0)
Inhaled Prostanoids in the Therapy of Pulmonary Hypertension (2008) (0)
Identification Of Candidate Gpcrs In Pulmonary Arterial Hypertension: Role Of Purinoceptor 2 (p2y2) In Pulmonary Vascular Remodeling (2016) (0)
Abstract 12334: A Flavor of Metabolic Disease in Pulmonary Hypertension (2015) (0)
Neutrophi l Act ivat ion by Ant i-Prote inase 3 Ant ibod ies in Wegener ' s Granulomatos (2003) (0)
Antioxidant Therapy of ARDS — Pathophysiological Rationale and Clinical Results (1984) (0)
Evidence of defective surfactant biosynthesis in patients with Idiopathic Pulmonary Fibrosis (IPF) (2006) (0)
cAMP Phosphodiesterase Inhibitors Increases Nitric Oxide Production by Modulating Dimethylarginine Dimethylaminohydrolases. (2009) (0)
Biological role of the proapoptotic transcription factor C/EBP homologous protein (CHOP) in Idiopathic Pulmonary Fibrosis (IPF) (2012) (0)
Vascular Effects of Heme Oxygenase-2 and the BK-Channel in Acute, Sustained, and Chronic Alveolar Hypoxia. (2009) (0)
Pro-proliferative and inflammatory signaling converge on the FoxO1 transcription factor in pulmonary hypertension – a new therapeutic approach (2015) (0)
Echocardiographic assessment of right ventricular structure and function in hypoxic induced pulmonary hypertension – effects of Riociguat and Sildenafil (2012) (0)
Impact of influenza virus infection on alveolar epithelial cell Na,K-ATPase expression and localization (2013) (0)
Combined Inhibition Of 5-HT2a And 5-HT2b-receptor Ameliorates Myocardial Hypertrophy And Diastolic Dysfunction In The Pressure Overloaded Right Heart (2010) (0)
Corrigendum to "Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling" [International Journal of Cardiology 167 (2013) 2630-2637]. (2022) (0)
[Pathophysiologic principles of cor pulmonale]. (1990) (0)
Effects of electronic cigarette aerosol on isolated murine lung cells and bronchoalveolar lavage fluid (2018) (0)
[Nutrition and immunonutrition in septic patients]. (2006) (0)
Fucoidan, A Natural Polysaccharidic Ligand Of P-Selectin, Obstructs Hypoxia-Induced Pulmonary Arterial Hypertension And Acute Lung Vasoconstriction (2016) (0)
The e effect o of 1 1 p ppm n nitrogen d dioxide o on b bronchoalveolar llavage cells a and iinflammatory m mediators iin n normal a and asthmatic s subjects (1995) (0)
Effects Of Dimethylarginine Dimethylaminohydrolase 1 (DDAH-1) In Acute And Sustained Hypoxia Induced Pulmonary Vasoconstriction (2011) (0)
Akutes respiratorisches Distress- Syndrom (ARDS) (2005) (0)
Combination Therapy with Sildenafil and Sitaxentan for Pulmonary Arterial Hypertension. (2009) (0)
Abstract 4681: Characterization of pulmonary hypertension in lung cancer. (2013) (0)
Nuclear miRNA/exosome-mediated transcriptional silencing within the context of TGFB1 signaling and Idiopathic Pulmonary Fibrosis (2017) (0)
Differential Regulation of Mitochondrial Respiration and Cytochrome Redox State in Acute Pulmonary Oxygen Sensing. (2009) (0)
Regulation of autophagy in pulmonary fibrosis (2014) (0)
EARLIER: End tidal carbon dioxide for earlier detection of pulmonary hypertension (2018) (0)
Series: Matrix metalloproteinases in health and lung diseases (2012) (0)
Circulating fibrocytes in pulmonary vascular remodelling (2009) (0)
Non-invasive Surrogate Markers of PH are Associated with Poor Survival in Lung Cancer Patients. (2021) (0)
Spatiotemporal expression of the VEGF‐receptor 2 during lung development (2006) (0)
pulmonary circulation Chronic airway infection leads to angiogenesis in the (2015) (0)
air spaces of the lung Invited Review: Active fluid clearance from the distal (2015) (0)
Driving murine embryonic stem cells toward endothelial phenotype for cell-based therapy (2011) (0)
Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP) (2013) (0)
A smooth muscle-like niche facilitates lung epithelial regeneration (2019) (0)
Hypercapnia Drives Degradation of the Na,K-ATPase β-Subunit by Decreasing Endoplasmic Reticulum Calcium Levels (2020) (0)
Short-term Hypercapnia Differentially Regulates Na,K-ATPase And ENaC Function In Polarized H441 Cell Monolayers (2010) (0)
Deficient autophagy in Hermansky-Pudlak syndrome associated interstitial pneumonia (HPSIP) (2013) (0)
Abstract 19526: Pathological Vascular Remodeling in Pulmonary Hypertension: A Role for Perturbed Matrix Cross-Linking? (2010) (0)
Abstract 15100: Inhibition of P38 Mapk Improves Heart Function in Sustained Pressure-overload Induced Right Ventricular Hypertrophy and Failure (2014) (0)
Pulmonary drug sustained release formulation (2014) (0)
Rassf1a Regulates Ros-Hif Axis In Hypoxia Driven Pulmonary Hypertension (2016) (0)
Identification of alveolar fibroblast subset-specific miRNA expression profiles and their impact on cell development, differentiation and subsequently alveolar septation in postnatal lung development (2012) (0)
Data on immunogenicity and reactogenicity to COVID-19 vaccination among patients receiving maintenance dialysis (2022) (0)
Cover Image, Volume 54, Number 7, July 2019 (2019) (0)
LSC 2013 abstract - Pulmonary senescence in chronic obstructive pulmonary disease is primarily mediated by persistent DNA double strand breaks (2013) (0)
venulesvasoconstriction in pulmonary arterioles and (2015) (0)
Phosphodiesterase 10 A Upregulation Contributes to Pulmonary Arterial Hypertension (2010) (0)
[New supportive therapy measures in acute lung failure]. (1995) (0)
Abstract 10916: Blocking MicroRNA-17 by Intravenous Injection of Antagomirs Improves Pulmonary Hemodynamics and Right Heart Function in Experimental Pulmonary Hypertension (2010) (0)
PAR-2 depletion protects against development of pulmonary hypertension (2012) (0)
Activation of soluble guanylate cyclase reverses pulmonary vascular remodeling induced by hypoxia in mice (2005) (0)
Possibilities of Radiosensitization and Reduced Invasion After Targeting the SCF/c-Kit Pathway in Human Cancer Cells (2017) (0)
Impact of lipid rafts on modulation of intramonocyte calcium‐signalling and adhesion of monocytes to endothelial cells by n‐3 and n‐6 fatty acids (2006) (0)
[Targeted therapy of pulmonary arterial hypertension (PAH)]. (2014) (0)
ResearchNebulization of the acidified sodium nitrite formulation attenuates acute hypoxic pulmonary vasoconstriction (2010) (0)
Patients with ARDS show incomplete restoration of alveolar surface activity upon recombinant SPC-based surfactant treatment : putative role of neutral lipids (2007) (0)
Role of Hypoxia Inducible Factor (HIF) and NADPH oxidases in regulation of Kv channels in pulmonary artery smooth muscle cells (2008) (0)
' s response to reviews Title : Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury (2008) (0)
Stimulation of arachidonate metabolism by endotoxin and the terminal complement complex C5b-8. (1989) (0)
Mining The Idiopathic Pulmonary Fibrosis (IPF) Proteome: Identification And Characterization Of Possible Biomarkers For Disease Pathogenesis (2010) (0)
Embryonic Stem Cells As Source For Endothelial Cells For Cell-based Therapies (2010) (0)
Gene expression profiling of laser-microdissected compartments in hypoxia-induced pulmonary hypertension (2004) (0)
The Fhl-1 Interacting Protein Paxillin Is Involved In The Pathogenesis Of Pulmonary Hypertension (2011) (0)
Screening for biomarkers in pulmonary hypertension (2012) (0)
A possible role of serotonin for the development of tobacco smoke-induced lung emphysema and pulmonary hypertension (2014) (0)
Lineage differentiation of pulmonary alveolar fibroblasts (2012) (0)
Acute response of iloprost inhalation using the Breelib nebulizer in pulmonary arterial hypertension: the Breelib acute study (2018) (0)
Establishment Of A Murine 3d In Vitro Lung Organoid Model To Study Epithelial Generation And Regeneration (2017) (0)
[Disorder of alveolar surface tension in relation to the development of edema in isolated rabbit lungs]. (1983) (0)
Acvrl 1 / Smad 1 Axis in Lung Fibroblasts Signaling from the Tgfbr 1 / Smad 2 / 3 Axis to β to Shift Transforming Growth Factor-Glucocorticoids Recruit Tgfbr 3 and Smad 1 Signal Transduction : (2014) (0)
Inflammatory Mediator Generation Epithelial Cells : Impact on Signaling Events Antibody ) with Human Renal Tubular ( Classic Anti-Neutrophil Cytoplasmic Interaction of Antibodies to Proteinase 3 and Ulf (2002) (0)
PULMONALE HYPERTONIE : DIAGNOSE, THERAPIE UND PROGNOSE (1993) (0)
Estimation of Absolute Number of Alveolar Epithelial Type 2 Cells: A Comparison Between Flow Cytometry and Stereology (2018) (0)
Abstract 1396: The role of NFκB/IKK2 pathway in the pathogenesis of lung cancer (2012) (0)
Acute lung injury induced by the pyrrolizidine alkaloid monocrotaline in mice (2006) (0)
Refinement Of A Hyperoxia-Based Mouse Model Of Bronchopulmonary Dysplasia (2016) (0)
The role of the type III transforming growth factor‐β receptor Tgfbr3 in the regulation of pulmonary vascular development (2012) (0)
Free Papers (2011) (0)
Author Correction: Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2 (2021) (0)
Chronisch-fibrosierende Lungenerkrankungen (2019) (0)
Genetic determinants of risk and survival in pulmonary arterial hypertension (2018) (0)
The Cytoskeletal Protein – Cofilin Is Associated With Pulmonary Arterial Hypertension (2010) (0)
Alveolar Surfactant Function in Severely Injured Patients (1991) (0)
Medicines to treat fibrotic lung diseases (2007) (0)
SURFACTANT ABNORMALITIES IN ARDS AND SEVERE PNEUMONIA.: 26 (1999) (0)
Oxide Synthesis Loss of Barrier Function : The Role of Nitric Cells Against Hydrogen Peroxide-Induced Preincubation Protects Alveolar Epithelial Apical , But Not Basolateral , Endotoxin (2002) (0)
[Pulmonary tissue regeneration -- a hope for the future]. (2006) (0)
Eicosanoids and the Pulmonary Circulation (1987) (0)
Stereological Quantification of Lung Regression and Regeneration in the Murine Model of Calorie Restriction and Refeeding. (2009) (0)
Effect Of Hypercapnia With And Without Acidosis On Acute And Sustained Hypoxic Pulmonary Vasoconstriction (2010) (0)
[Idiopathic interstitial pneumonias: pathomechanisms and therapeutic options]. (2005) (0)
Subtle assessment of quality of life in PH patients on inhaled iloprost treatment (2012) (0)
Imbalanced expression of the type I TGF-beta receptors ALK-1 and ALK-5 in pulmonary fibrosis (2007) (0)
Cellular and molecular relevance of classical transient receptor potential 1 in chronic hypoxia-induced pulmonary vascular remodeling (2016) (0)
Histological Assessment Of Immune/inflammatory Cells In Idiopathic Pulmonary Arterial Hypertension (2010) (0)
Response to: Comment on “Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding” (2018) (0)
Inhibition Of Ca2+/calmodulin-Dependent Phosphodiesterase1A Attenuates Right Ventricular Remodeling And Dysfunction In Two Rat Models (2011) (0)
Impact of Control Sirna Interventions on Lung Fibroblast Viability, Proliferation, and Gene Expression (2020) (0)
Obstructive sleep apnoea secondary to superior vena cava thrombosis in a patient with activated protein C resistance (2002) (0)
Impact of the epithelial HIF 2 alpha system on lung development (2008) (0)
LSC 2011 Abstract: Role of mast cells and chymase in idiopathic pulmonary fibrosis (2011) (0)
Aerosolized Recombinant Human Lysozyme in Mouse-Models of Pneumonia. (2009) (0)
Differentielle Genexpression nach kurzzeitiger Hypoxie (2007) (0)
Regulation of autophagy in amiodarone induced pulmonary fibrosis (2013) (0)
Hypercapnia impairs protein translation by activating integrated stress response (2018) (0)
The sPAP/VO2 ratio during cardiopulmonary exercise testing as predictor of manifest pulmonary hypertension (2012) (0)
Assessing the impact of parenteral caffeine administration on experimental bronchopulmonary dysplasia (2016) (0)
Riociguat for pulmonary hypertension – experience from a referral center (2016) (0)
The Influence Of Lipid Emulsions And The Chemerin 23 Receptor (ChemR23) In A Murine Model Of Acute Lung Injury (ALI) (2012) (0)
Doppler-Based Renal Venous Stasis Index as a New Prognostic Marker in Right Heart Failure (2018) (0)
Combination of nonspeciﬁc PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension (2001) (0)
A Role For The Accessory Type Iii Transforming Growth Factor-beta Receptor In Post-Natal Lung Alveolarization (2016) (0)
VE-Cadherin as a Specific Promoter for Genetic Labelling and Selection of Pure Embryonic Stem Cell-Derived Endothelial Cells for Therapeutic Purposes (2012) (0)
Role of autophagy in the development of amiodarone induced pulmonary fibrosis (2011) (0)
Randomized, controlled, prospective multicenter study: Training improves peak oxygen consumption and hemodynamics in patients with chronic severe pulmonary hypertension (2014) (0)
ADM Binds to Endothelial Cells and Induces Formation of cAMP but Does Not Change cGMP or [ Ca (2002) (0)
Effect of pH and CO2 on hypoxic pulmonary vasoconstriction and capillary permeability – impact of NO (2008) (0)
Lung aging in C57/Bl6 and BALB/c mice is characterized by defects in surfactant metabolism, increased ER stress-signalling and inflammasome formation (2015) (0)
Seeger Mechanisms of alveolar protein clearance in isolated rabbit lungs : Role of clathrin-and caveolae-mediated endocytosis of albumin by the alveolar epithelium INAUGURAL (2007) (0)
Hypoxia-inducible-factor 2 alpha mediates cisplatin resistance in the lung adenocarcinoma cell line A549 (2007) (0)
Lung aging in C57/Bl6 mice is characterized by defects in surfactant metabolism, decreased ERAD function, and increased expression of markers for endoplasmic reticulum (ER) stress and inflammasome formation (2014) (0)
Increased susceptibility to gammaherpesvirus-induced lung fibrosis of transgenic mice with conditional overexpression of the ER-stress-factor Chop in alveolar epithelium (2019) (0)
Reply to Zheng et al. (2021) (0)
105 Mitochondrial alterations in pulmonary arterial smooth muscle cells in pulmonary arterial hypertension (2010) (0)
Pharmacological inhibition of carbonic anhydrases 9 and 12 attenuates monocrotaline-induced pulmonary hypertension in rats (2019) (0)
Inhibition of profibrotic signaling in fibroblasts from patients with IPF by the pan-histone deacetylase-inhibitor LBH589 or the IPF drug pirfenidone (2015) (0)
Particules colloidales biodegradables notamment destinees a des applications pulmonaires (2003) (0)
Correction to: Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis (2022) (0)
Evaluation of angiopoietin-2 and thrombomodulin as biomarkers for pulmonary hypertension (2013) (0)
In Vitro Cytotoxicity And Molecular Effects Of Electronic Cigarette Vapor Extract On Primary Isolated Mouse Lung Cells (2016) (0)
Microrna-34a Blockade Partially Restores Normal Septal Thickness In An Experimental Animal Model Of Bronchopulmonary Dysplasia (2016) (0)
Long chain triglyceride (LCT)‐based lipid emulsions increase and olive oil(OO)‐based lipid emulsions decrease leukocyte invasion and mortality in a model of acute lung injury (2006) (0)
The role of the accessory type III transforming growth factor-β receptors in the regulation of pulmonary vascular development (2012) (0)
Correction: Metastasis-Associated Protein 2 Represses NF-κB to Reduce Lung Tumor Growth and Inflammation. (2022) (0)
Experimental shock (2011) (0)
N-Lysine Methyltransferase SMYD2-Mediated Methylation Enhances HIF-1α Stability and Pro-Angiogenic Signaling (2019) (0)
Functional Role Of Lung Recruited Bone Marrow Derived Exudate M2-Polarized Macrophages In Influenza Virus-Induced Lung Injury And Repair (2017) (0)
The Role Of Forkhead Box O (foxo) Transcription Factors In Normal And Aberrant Late Lung Development (2017) (0)
A mouse model of sleep apnea - Role of endothelial and inducible NO synthases (2017) (0)
Sequenzspezifische Suppression Hypoxie-induzierbarer Transkriptionsfaktoren (HIFs) durch RNA interference in vitro und in vivo (2005) (0)
In vitro and in vivo tracing of fluorescently tagged cell types in lung (2012) (0)
Role Of Alveolar Epithelial Stress In A Murine Model Of Hermansky-Pudlak Syndrome Associated Interstitial Pneumonia (2010) (0)
Effects of multi-kinase inhibitors on pulmonary vascular and right ventricular remodelling (2011) (0)
Abstract 17755: Effects of Multikinase Inhibitors on Right Ventricular Remodeling (2010) (0)
Model of Transfusion-Related Acute Lung Injury (2005) (0)
Cyclooxygenase-2 Contractility of Isolated Rat Hearts : Evidence for a Role of Sphingosine and Synthesis Depresses α Endotoxin-Induced Myocardial Tumor Necrosis Factor (2000) (0)
Alveolar Epithelial Cells Shape Dendritic Cell Antiviral Responses By Expression Of GM-CSF In Severe Influenza Virus Pneumonia (2011) (0)
Effects of carbon monoxide releasing molecules (CO-RMs) on pulmonary vasoreactivity 1 in isolated perfused lungs (2015) (0)
Free Papers (2016) (0)
A Role For Microrna-29c In Arrested Alveolarization Associated With Experimental Bronchopulmonary Dysplasia (2016) (0)
Additional file 1: Figure S1. of Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study (2016) (0)
Experimental hypoxia-induced pulmonary hypertension is prevented by moderate exercise training in mice (2011) (0)
The Impact of Oxygen Injury in the Immediate Post-Natal Period on Lung Structure and Breathing Mechanics in Adult Mice (2020) (0)
[The antioxidative chromane structure of alpha-tocopherol protects against the consequences of arachidonic acid release in the pulmonary vascular bed (author's transl)]. (1981) (0)
Deficient Autophagy in Hermansky-Pudlak Syndrome associated lung fibrosis (2014) (0)
Refinement of the hyperoxia-based experimental mouse model of bronchopulmonary dysplasia (2016) (0)
Correction: Improvement of right heart structure and function by BAY41-8543 in pulmonary artery banded mice (2011) (0)
Role Of Notch Signaling In Pulmonary Arterial Hypertension (2011) (0)
Abstract 1594: Contribution of Stromal Lymphocytes to Lung Cancer Metastasis: Role in Epithelial Mesenchymal Transition (2016) (0)
LSC Abstract – Histone deacetylase 7 mediated metabolic remodeling: A new crosslink between pulmonary hypertension and cancer (2016) (0)
Shift in transcriptional landscape of human right ventricle in chronic thromboembolic pulmonary arterial hypertension (2020) (0)
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension (2019) (0)
Role Of Mast Cells In Experimental Pulmonary Hypertension (2010) (0)
Phosphodiesterase 4 Regulates Lung Tumor Growth Through HIF Regulation, Proliferation, And Angiogenesis (2012) (0)
Recruitment Maneuvers Impair Alveolar Epithelial Function by Inhibiting Na,K-ATPase Function in Rabbit Lungs. (2009) (0)
Identification and characterization of Bronchioalveolar stem cells (2012) (0)
Regulation of the pulmonary vascular tone by p66shc and cyclophilin D (2017) (0)
Lungenparenchymerkrankungen (2008) (0)
Exhalative markers FeNO, PGE2 and 8-isoprostane as diagnostic and prognostic biomarkers in interstitial lung diseases (2019) (0)
Research Workshop Pulmonary Hypertension (2010) (0)
[Abstracts of a research workshop pulmonary hypertension]. (2010) (0)
[The significance of inflammatory mediators for the development and therapy of acute lung failure]. (1988) (0)
The cup's i-ialffull- working with limitations to achieve appropriate Healthcare Technology Management (2004) (0)
[Prevention of acute lung failure (ARDS)]. (1993) (0)
Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET (2020) (0)
Inflammatory and fibrotic lung diseases (PP-085) (2010) (0)
[The development of internal medicine. Observations within the context of all medicine and future prospects]. (2007) (0)
Diagnosing diffuse parenchymal lung disease (DPLD) by non-invasive breath screening of exhaled volatile compounds using an electronic nose: a pilot study (2018) (0)
Lungengefäßerkrankungen (2008) (0)
Clinical characteristics of familial Idiopathic Pulmonary Fibrosis (f-IPF) at the University of Giessen Marburg Lung Center (2018) (0)
[ARDS: possible role of bacterial exotoxin]. (1992) (0)
Shunt volume dynamics in stroke patients with patent foramen ovale. (2013) (0)
[Disseminated osteolytic lesions in a 28-year-old refugee]. (2018) (0)
foramen ovale Shunt volume dynamics in stroke patients with patent (2015) (0)
[Therapy of mild, but symptomatic pulmonary hypertension]. (2009) (0)
Diagnosing Interstitial Lung Diseases Using Exhalative Breath Markers (2019) (0)
Susceptibility of LC3B knockout mice to lung injury and fibrosis (2018) (0)
Microsurgical management of gliomas (1984) (0)
Multimomentstudien am System Rechner-Operateur (1977) (0)
[A survey by the board of experts demands intensification of pneumology!]. (2001) (0)
[Respiratory insufficiency]. (1995) (0)
[Blood coagulation and the lung]. (1983) (0)
Susceptibility of LC3B knockout mice to lung injury and fibrosis (2019) (0)
[Pneumology. From the diagnosis of pulmonary functions to molecular medicine]. (1999) (0)
LEBENSBEDROHLICHE INFEKTIONEN DURCH BETA -HAMOLYSIERENDE STREPTOKOKKEN DERGRUPPE A (1996) (0)
Funktionelle Analyse von Fibroblasten in der Bleomycin-induzierten Lungenfibrose (2006) (0)
Allgemeine therapeutische Maßnahmen (2005) (0)
Untersuchung der rechtsventrikulären Hypertrophie durch Magnetresonanztomografie in Mäusen (2011) (0)
Charakterisierung der therapeutischen Effizienz von Histondeacetylase (HDAC)-Inhibitoren hinsichtlich der Modulierung von pro-koagulatorischen und fibrinolytischen Signalwegen in Lungenfibroblasten von Patienten mit idiopathischer pulmonaler Fibrose (IPF) (2018) (0)
Differenzielle Therapie bei Lungenfibrosen (2006) (0)
Medikamentöse Therapie der pulmonalen Hypertonie (2015) (0)
Einfluss des Urokinaseinhibitors CJ-463 auf Primärtumorwachstum und Metastasierung in einem murinen Lewis Lungen Karzinom Modell (2010) (0)
Modulation der hypoxischen pulmonalen Vasokonstriktion in mitochondrialen Uncoupling Protein 2 -defizienten Mäuselungen (2008) (0)
Einfluss von Urokinaseinhibitoren auf Tumorwachstum und Metastasierung an einem Lungenkarzinom-Modell (2007) (0)
Embryonale Stammzellen als Quelle von Endothel- und glatten Muskelzellen für zellbasierte Therapie von Pulmotension (2009) (0)
Die inflammatorische Response Influenza A Virus-infizierter mononukleärer Phagozyten und Alveolarepithelzellen (2005) (0)
Kohlenmonoxid (CO) beeinträchtig die pulmonale Wasser-Resorption durch Hemmung der Aktivität epithelialer Na+ Kanäle (2009) (0)
Wirkung des sGC-Stimulators Riociguat auf das pulmonalvaskuläre und rechtsventrikuläre Remodeling bei schwerer pulmonal-arterieller Hypertonie (2013) (0)
Untersuchungen zur Regulation des Lungenwachstums auf molekularer Ebene (2006) (0)
Untersuchung endothelialer Progenitorzellen bei pulmonaler Hypertonie (2004) (0)
Das anhaltende Dilemma der Therapie des ARDS – zur Perspektive der Flüssigkeitsbeatmung (1997) (0)
Etablierung einer Technik zur Quantifizierung von Superoxid an isoliert perfundierten Mauslungen mittels Elektronenspinresonanz-Spektroskopie (2005) (0)
Ein Mausmodell der obstruktiven Schlaf-Apnoe (2006) (0)
Entitäten der PH bei neu diagnostizierten Patienten – Bericht aus einem pneumologisch orientiertem PH-Zentrum (2013) (0)
Inhibierung mitochondrialer Funktionen in Monocrotalin-induzierter pulmonaler Hypertonie und ihre Reversibilität durch Dichloroacetat (2009) (0)
Serum-Matrix-Metalloproteinasen bei adulten Mukoviszidose-Patienten (2009) (0)
Erhöhte Expression und funktionelle Bedeutung des Interleukin 13 Systems in Idiopathischer Lungenfibrose (IPF) (2006) (0)
Vitamin C verbessert die endothel-abhängige Vasodilatation bei obstruktiver Schlaf-Apnoe (2004) (0)
Obstruktive Schlaf-Apnoe nach OP und Radiochemotherapie eines Zungengrundcarcinoms (2006) (0)
Gründungsaufruf: Deutsche sepsis-gesellschaft e.V. (DSG) (2001) (0)
Erythropoietin-Überexpression in der Maus: antipulmonalhypertensiver Schutz in Normoxie und Hypoxie (2005) (0)
Proliferation verschiedener Zellkompartimente während postnataler und post-Pneumektomie Alveolarisierung in der Maus (2009) (0)
Die essentielle Bedeutung des „Classical Transient Receptor Potential 6“ (TRPC6)-Ionenkanals für die hypoxische pulmonale Vasokonstriktion (2007) (0)
Einfluss von Apocynin auf die arterielle Hypertonie im Mausmodell der obstruktiven Schlaf-Apnoe (2008) (0)
Pulmonale epitheliale Expression des VEGF-Rezeptors 2 während der Lungenentwicklung der Maus (2005) (0)
Effekte der pulmonalen Ballonangioplastie (BPA) auf rechtsventrikuläre Funktion, Strain-Parameter und pulmonale Hämodynamik bei Patienten mit inoperabler chronisch thrombembolischer pulmonaler Hypertonie (2019) (0)
Bestimmung hypoxieinduzierter Expressionprofile auf Transkriptom- und Proteomebene in der Lunge (2005) (0)
In vitro-Vergleich der antifibrotischen Effizienz des pan-HDAC-Inhibitors LBH589 mit dem IPF-Medikament Pirfenidon in Lungenfibroblasten von Patienten mit IPF (2018) (0)
Einfluss des Rho-Kinase-Hemmstoffs Azaindol-1 auf Hämodynamik und Gefäßremodeling bei experimenteller pulmonaler Hypertonie (2011) (0)
Proteomanalyse von Lungengewebe von Patienten mit Idiopathischer Pulmonaler Fibrose (IPF) im Vergleich zur Nicht-spezifischen Interstitiellen Pneumonie (NSIP) und zu Lungengewebe von Donoren (2008) (0)
Granulozytäre NADPH-Oxidase-Expression bei obstruktiver Schlaf-Apnoe (2011) (0)
Rolle von HIF-1 alpha bei der Proliferation, Apoptose und Vaskularisierung in einem A549 Tumormodell der Maus (2004) (0)
Abnormale Anhäufung von nicht-prozessierten Surfactant-Protein (SP)-B-Vorstufen und Induktion einer apoptotischen Endoplasmatischen Reticulum (ER)-Stressantwort in Lungen von Patienten mit Idiopathischer Pulmonaler Fibrose (IPF) und Nicht-spezifischer Interstitieller Pneumonie (NSIP) (2007) (0)
Ernährung und metabolische Kontrolle bei Sepsis (2009) (0)
n-3 Fettsäuren hemmen die PI3-Kinase Signaltransduktion in HUVEC (2005) (0)
LPS aktiviert die PGE2-Synthese in humanen Lungenadenokarzinomzellen – Rolle von CD14 und EGF-Rezeptor-Crosslinking (2008) (0)
Charakterisierung der Expression des Kolonie-stimulierenden Faktor-1 Rezeptors in pulmonalarteriellen glatten Muskelzellen (2018) (0)
AMD-1: Ein neuer Kandidat für die Behandlung der pulmonalen arteriellen Hypertonie? (2010) (0)
Suche nach weitgehend unbekannten, an der Alveolarisierung beteiligten Genen (2009) (0)
Hypoxie induziert schnelle und charakteristische Änderungen des Expressionsprofils (2006) (0)
Stadien-abhängige epitheliale Expression des VEGF-Rezeptors 2 während der Lungenentwicklung der Maus (2006) (0)
Multiorganinfektionen — komplexe klinisch-infektiologische Krankheiten (2005) (0)
Dynamische Hyperinflation bei Patienten mit pulmonaler Hypertonie (2009) (0)
Chromatin-Immunoprezipitation neuer Zielgene von Smad3 in Fibroblasten: Bedeutung für Lungenfibrose (2005) (0)
Prävalenz schlafbezogener Atmungsstörungen bei pulmonaler Hypertonie (2010) (0)
Steuerung des Classical transient receptor potential channel 6 (TRPC6) – Schlüsselstelle der hypoxischen Vasokonstriktion (HPV) (2008) (0)
Regenerative Medizin weckt Hoffnungen (2005) (0)
Protektiver Effekt der antioxidativ wirksamen Chromanstruktur des Tocopherols auf die Folgen stimulierter Arachidonsäure-Freisetzung in der pulmonalen Strombahn (1981) (0)
Systemarterielle Hypertonie in einem Mausmodell der obstruktiven Schlaf-Apnoe (2006) (0)
Rolle von HIF für die Therapie Resistenz gegenüber Cisplatin an Adenokarzinoma (A549) Zellen in Normoxie und Hypoxie (2006) (0)
Strukturelle, funktionale und molekulare Charakterisierung des rechtsventrikulären Remodellings in drei pathophysiologisch unterschiedlichen Modellen (2007) (0)
Defizienz des mitochondrialen Entkopplungsproteins „Uncoupling Protein 2“ als neues Modell der pulmonalen Hypertonie (2014) (0)
Der Hypoxie-induzierbare-Faktor 2α in der Chemotherapieresistenz von Adenokarzinomzellen der Lunge (2007) (0)
Bedeutung von RACK1 als neuer Interaktionspartner des BMPRII bei Pulmonaler Hypertonie (2006) (0)
Sauerstoffsensitivität mitochondrialer Funktionen von pulmonalarteriellen Gefäßmuskelzellen in akuter und chronischer Hypoxie (2008) (0)
Der PAF-Rezeptor vermittelt die antiinflammatorische Wirkung von n-3 Lipidinfusionen (2004) (0)
Pulmonale Manifestation bei hereditärer hämorrhagischer Teleangiektasie (2009) (0)
Akute klinische Verschlechterungen von Patienten mit Idiopathischer Pulmonaler Fibrose (IPF) und Assoziation mit respiratorischen Infektionen (2010) (0)
Endotoxin induziert die Proliferation und Strahlenresistenz in NSCLC-Zelllinien (2012) (0)
Kompartiment- und zellspezifische Expression von Gerinnungs- und Fibrinolysefaktoren in der Mauslunge nach inhalativer oder systemischer Endotoxinapplikation (2004) (0)
Akute und chronische respiratorische Insuffizienz (2005) (0)
Kombinationsmundstück für Inhalationstherapiegeräte sauerstoffabhängiger Patienten (1999) (0)
Langzeitergebnisse eines Screenings auf pulmonale Hypertonie nach Lungenembolie (2014) (0)
NOX4 Expression beeinflusst das vaskuläre Remodelling unter Hypoxie in primären humanen pulmonalarteriellen Fibroblasten (2007) (0)
Pulmonale Hypertonie bei terminaler Niereninsuffizienz – eine Frage des Wassers? (2016) (0)
Akuter hämodynamischer Effekt durch eine schnelle Iloprost Inhalation über den Breelib Vernebler bei der pulmonal arteriellen Hypertonie: Eine Subgruppen Analyse der Breelib-Akut Studie (2019) (0)
Inhalation von Endotoxin bei freiwilligen Probanden – Modulation der inflammatorischen Antwort durch n-3 Lipide (2005) (0)
Differenzialdiagnostik und Therapie der idiopathischen interstitiellen Pneumonien (2011) (0)
Untersuchungen zur Gefäßversorgung in einem Lewis-Lung-Tumor-Modell der Maus (2004) (0)
Akute hämodynamische Effekte von Iloprost vernebelt über das I-neb Adaptive Aerosol Delivery (AAD)-System bei pulmonaler Hypertonie (2015) (0)
Symposium D: Pathogenitätsfaktoren und Abwehrmechanismen bei Infektionskrankheiten (1984) (0)
Das fokale Adhäsionsprotein Paxillin involviert in die Pathogenese der pulmonalen Hypertonie (2010) (0)
Therapeutische Wirksamkeit einer inhalativen Verabreichung von rekombinantem humanen Lysozym in murinen Pneumonie-Modellen (2009) (0)
Prävention des Ischämie/Reperfusion-induzierten Lungenschadens durch nNOS Hemmung – mögliche Beteiligung von „mitochondrial permeability transition pores“? (2010) (0)
HbA1c bei pulmonalarterieller Hypertonie – ein Marker mit prognostischer Relevanz? (2010) (0)
Intermediärund Abbauprodukte der Gerinnung als Mediatoren pulmonaler Gefäßreaktionen (1985) (0)
Lungen- und Atemwegserkrankungen (2009) (0)
Quantitative Bestimmung von asymmetrischem Dimethylarginin (ADMA) in Organen des kardiovaskulären Systems (2006) (0)
Inspiratorische Kapazität als prognostischer Faktor bei pulmonal-arterieller Hypertonie (2014) (0)
Dysregulation des TGF-beta Systems in Idiopathischer Lungenfibrose (2005) (0)
Untersuchungen zur Dosisfindung und Pharmakokinetik von inhalativ verabreichtem Heparin bei gesunden Probanden (2004) (0)
Signalpfade und zelluläre Konsequenzen der Überexpression von ER-Stress Sensormolekülen in vitro und in vivo (2009) (0)
TGF-beta inhibiert die Rückresorption der Alveolarflüssigkeit: existiert ein Zusammenhang mit ARDS? (2006) (0)
Eröffnungsansprache des Vorsitzenden auf der 112. Tagung der DGIM, Innere Medizin im postgenomischen Zeitalter (2006) (0)
Endotoxin induziert die Proliferation von NSCLC-Zellen in vitro und in vivo – Rolle von TLR4, Cyclooxygenase-2 und EGFR (2010) (0)
Klinische, radiologische und histo-pathologische Kriterien zur differential-diagnostischen Abgrenzung der exogen-allergischen Alveolitis von der nicht-spezifischen interstitiellen Pneumonie (2006) (0)
Inhalative Strategien zur Verbesserung der pulmonalen Hämodynamik und des Gasaustausches bei Sepsis und schwerer pulmonaler Hypertonie (2000) (0)
Akkumulation von nicht-prozessiertem Surfactant-Protein B und Induktion einer apoptotischen ER-Stress-Antwort bei Idiopathischer Pulmonaler Fibrose (IPF) (2007) (0)
Antioxidatives Vitamin C verbessert die endotheliale Funktion bei obstruktiver Schlaf-Apnoe (2006) (0)
Bakterielle Endo- und Exotoxine aktivieren die Zytokinsynthese isolierter Bronchialkarzinomzellen – Amplifikation durch Neutrophile Granulozyten (2008) (0)
Hypoxie-induzierte Freisetzung reaktiver Sauerstoffspezies (ROS) in isoliert perfundierten und ventilierten Mauslungen (2006) (0)
29. Spezielle Aspekte aus der Sicht des Neurochirurgen (1982) (0)
Abstracts der 25. Jahrestagung der Deutschen Gesellschaft für Schlafforschung und Schlafmedizin e. V. (2017) (0)
Nanohale – Nicht-virale Vektoren für den pulmonalen Gentransfer (2008) (0)
Aktivierung des Peroxisom Proliferator-Aktivierten Rezeptors (PPAR)alpha reduziert die Inflammation in einem Mausmodell des akuten Lungenversagens (2006) (0)
Prognostische Bedeutung von Rechtsherzkatheter, Echokardiografie, Serum BNP und HRCT für Patienten mit idiopathischer pulmonaler Fibrose (IPF) und pulmonalarterieller Hypertonie (PH) (2010) (0)
Regenerative Medizin - Perspektiven der Inneren Medizin?! (2006) (0)
Mögliche Bedeutung eines veränderten Surfactant-Metabolismus für die Pathogenese der Idiopathischen Pulmonalen Fibrose (2006) (0)
Pegasus – Fliegen mit pulmonaler Hypertonie, eine prospektive, multizentrische Beobachtungsstudie (2019) (0)
SEPSIS UND DAS AKUTE LUNGENVERSAGEN : EINE MOGLICHE ROLLE BAKTERIELLER EXOTOXINE (1993) (0)
PEGASUS – Fliegen mit Pulmonaler Hypertonie, ein prospektive Beobachtungsstudie (2018) (0)
Surfactant Protein-B Proformen als mögliche neue Serumbiomarker bei Idiopathischer Pulmonaler Fibrose (2014) (0)
Nichtinvasive Detektion einer abnormalen pulmonalen Druckreaktion auf Stress bei Angehörigen von Patienten mit Idiopathischer pulmonal-arterieller Hypertonie (2007) (0)
Akute hämodynamische Effekte von 20 ug/ml Iloprost (Ventavis) vernebelt über das I-neb Adaptive Aerosol Delivery (AAD)-System: Eine Pilotstudie (2018) (0)
Expression des TGF-beta-Systems in Hypoxie-induzierter Pulmonaler Hypertonie (2005) (0)
Das TGF-beta/BMP-System in der postnatalen Lungenentwicklung: Einfluss von Hyperoxie-induzierter Lungenschädigung (2005) (0)
Subjektive Schlafqualität bei pulmonaler Hypertonie (2011) (0)
Entwicklung eines Modells zur Untersuchung der hypoxischen Vasokonstriktion an isolierten Mauslungen (2004) (0)
Tirofiban zur inhalativen verabreichung zur therapie von erkrankungen, die durch thrombusbildung verursacht werden (2004) (0)
Untersuchung uncharakterisierter SP-A2 Varianten hinsichtlich der Induktion von Endoplasmatischem Retikulum (ER)-Stress bei der idiopathischen pulmonalen Fibrose (IPF) (2018) (0)
Inhibierung von pro-fibrotischen Signalwegen in Fibroblasten von Patienten mit sporadischer Idiopathischer Pulmonaler Fibrose (IPF) durch Histondeacetylase-Inhibitoren (HDACi) (2014) (0)
3. Forschungswerkstatt Pulmonale Hypertonie (2011) (0)
siRNA Transfektion der Lunge und des Bronchialkarzinomes im Mausmodell (2006) (0)
Zirkulierendes Adrenomedullin ist bei obstruktiver Schlafapnoe erhöht (2004) (0)
Identifizierung und Charakterisierung von möglichen Biomarkern bei der Idiopathischen Pulmonalen Fibrose (IPF) mittels komparativer Proteomanalyse (2010) (0)
Intermediär- und Endprodukte der klassischen Kaskadensysteme und des Arachidonsäuresystems als potentielle Mediatoren beim akuten Lungenversagen (ARDS) (1986) (0)
Multiorganinfektionen — komplexe klinisch infektiologische Krankheiten (2007) (0)
Ernährung in derIntensivmedizin (2011) (0)
Mediatorblockade in der Sepsis: Inhibitoren, Antagonisten und Antikörper (2000) (0)
Analysen zur Gefäßversorgung von LLC-Lungentumoren in C57BL/6N-Mäusen (2005) (0)
Pneumonie und Abszess (2002) (0)
Obstruktive Schlaf-Apnoe als Trigger von paroxysmalem Vorhofflimmern – eine Fallvorstellung (2005) (0)
Der planare Zellpolaritätsweg in der pulmonalen Hypertonie (2007) (0)
Generierung von Superoxidradikalen pulmonaler und systemische arterieller glatter Muskelzellen und Fibroblasten unter Hypoxie (2009) (0)
Der Einfluss von NADPH Oxidasen auf die LPS-induzierte Amplifikation der hypoxischen pulmonalen Vasokonstriktion (2008) (0)
Hypoxie-induzierte Proliferation pulmonalarterieller Fibroblasten: Synergismus von HIF-1 alpha und einem autokrinen Angiotensin-System (2005) (0)
Die Bedeutung der oralen Glukosetoleranztestung in der Diagnostik der pulmonalarteriellen Hypertonie (2012) (0)
Schwere pulmonale Hypertonie - Vasodilative Therapie in der Lungenstrombahn (2000) (0)
Nicht-invasive Evaluation der pulmonalen Zirkulation bei Angehörigen von Patienten mit idiopathischer pulmonalarterieller Hypertonie (2013) (0)
Diagnostische Möglichkeiten der positiven Ventrikulographie (1975) (0)
Vasotrope Therapie und Beatmung bei pulmonaler Hypertonie (1999) (0)
Komorbidität und Beatmungstherapie bestimmen die Mortalität von COPD-Patienten in deutschen Krankenhäusern – eine Analyse der ICD-Statistik (2014) (0)
Die Rolle von AMD-1 in vaskulären Umbauprozessen bei pulmonaler Hypertonie (2013) (0)
Inhibition von HIF-2α durch RNA Interferenz supprimiert die Tumorprogression am subkutanen Adenokarzinom (A549) Modell durch Beeinflussung von Proliferation, Apoptose (2007) (0)
Die Succinat Dehydrogenase Untereinheit D in hypoxie-induzierter pulmonaler Hypertonie (2009) (0)
Pathopyshiologische Grundlagen des Cor pulmonale (1990) (0)
Pulmonaler Hochdruck (2002) (0)
PGE1 UND PGI2 IN DER THERAPIE DER PULMONALEN HYPERTONIE : UBERSICHT UND PERSPEKTIVEN (1993) (0)
Isolation und Charakterisierung pulmonaler Lipofibroblasten (2009) (0)
Hemmung der Freisetzung von mitochondrialen reaktiven Sauerstoffspezies inhibiert die hypoxische pulmonale Vasokonstriktion (2011) (0)
Regulation von Hämoxygenase 2 und MaxiKα in Lungen von hypoxiebehandelten Mäusen (2008) (0)
Kompensatorisches Lungenwachstum nach Pneumonektomie bei der Maus wird partiell durch die Neubildung von Alveolen erzielt (2006) (0)
Effekte von BAY 41– 8543 in einem Tiermodell der Rechtsherzhypertrophie (2011) (0)
Der planare Zellpolaritätsweg in der idiopathisch pulmonal-arteriellen Hypertonie (2007) (0)
Rolle des Hepatozytenwachstumsfaktor (HGF) in der gesunden und geschädigten Lunge (2018) (0)
Der spinale Dermoidsinus (2005) (0)
Studie zur molekularen Regulation des Lungenwachstums (2007) (0)
Etablierung einer neuen spektrophotometrischen Technik zur in vivo Beobachtung sauerstoffsensitiver Cytochrome in der isoliert perfundierten Lunge (2006) (0)
DAG-abhängige Regulierung des TRPC6-Ionenkanals bei akuter hypoxischer pulmonaler Vasokonstriktion (2010) (0)
Die Inhibition von Napsin A induziert die Akkumulation von proSP-B und führt zur Auslösung von Endoplasmatischem Reticulum (ER)-Stress mit konsekutiver Lungenfibrose im Mausmodell (2008) (0)
Hypoxie induzierte Apoptose in Alveolarepithelzellen über die Hochregulation von HIF-1α (2004) (0)
Low density lipoprotein receptor-related protein-1 (LRP-1) – pathogenetische und prognostische Signifikanz beim akuten Lungenversagen (ARDS) (2011) (0)
Alveoläre Surfactant-Funktion und Gerinnung (1985) (0)
Pulmonale Zirkulationsveränderungen bei Hypoxie und Höhenaufenthalt und der Einfluss von Sildenafil – Eine Doppler-Echokardiographische Untersuchung (2005) (0)
Lebensqualität bei Mukoviszidose: Assoziationen mit Tagesschläfrigkeit und Schlafqualität (2011) (0)
Liposomal verkapseltes Iloprost zur optimierten inhalativen Therapie der pulmonalen Hypertonie (2010) (0)
Rolle der Phosphodiesterasen in der Hyperoxie-induzierten chronischen Lungenreifungsstörung der Maus (2006) (0)
Nanohale – Herstellung und Charakterisierung bioabbaubarer Nanopartikel und ihre Anwendung an der isolierten Kaninchenlunge (2008) (0)
Pulmonalvaskuläre mitochondriale Funktion in Hypoxie (2011) (0)
Vasodilatative Prostanoide und pulmonale Strombahn (1993) (0)
Abstracts der 30. Jahrestagung der Deutschen Gesellschaft für Schlafforschung und Schlafmedizin e. V. (2022) (0)
Inspiratorische Kapazität unter Belastung im Follow-up bei stabilen Patienten mit pulmonal arterieller Hypertonie (2013) (0)
Molekulare Mechanismen der Lungenalterung: Korrelation zu Pathogenitätsmechanismen bei der Idiopathischen Pulmonalen Fibrose (IPF) und bei der chronisch obstruktiven Lungenerkrankung (COPD) (2017) (0)
Hypoxische pulmonale Vasokonstriktion – Sauerstoffsensitivität mitochondrialer Funktionen in akuter und chronischer Hypoxie (2007) (0)
Inspiratorische Kapazität bei operabler chronisch thromboembolischer pulmonaler Hypertonie vor pulmonaler Endarteriektomie: eine prospektive Beobachtungsstudie (2016) (0)
Nanohale – Aerosolapplikation und Übertrittskinetiken von Fluoreszenzfarbstoffen am Modell der isolierten Kaninchenlunge (2008) (0)
Inhalation von Endotoxin bei freiwilligen Probanden – Ergebnisse einer Pilotstudie (2004) (0)
Epidemiologie der saisonalen und pandemischen Influenza (H1N1/2009) in deutschen Krankenhäusern – Einfluss von Komorbidität, Beatmung und Alter auf die Mortalität (2014) (0)
Persistenter alveolärer oxidativer Stress in Patienten mit sporadischer Idiopathischer Pulmonaler Fibrose (IPF) trotz Induktion des antioxidativen Transkriptionsfaktors NRF2 und NRF2-abhängiger Zielgene (2009) (0)
T2-Mapping bei Patienten mit inoperabler chronisch thromboembolischer pulmonaler Hypertonie (CTEPH) vor und 6 Monate nach pulmonaler Ballonangioplastie (BPA) (2020) (0)
Aktuelle Therapie der pulmonal-arteriellen Hypertonie (2010) (0)
Strukturelle und funktionelle Verbesserungen des Rechtsherzversagens durch den sGC Stimulator Riociguat in einem pulmonal-arteriellen Stenose Modell der Maus (2014) (0)
Beschleunigte Fibroseentwicklung bei Smad7 Knockout Mäusen nach inhalativer Bleomycin Exposition (2007) (0)
Zirkulierende Fibrozyten in der Pathogenese und Therapie von pulmonaler Hypertonie – die Rolle von Rezeptortyrosinkinasen (2011) (0)
Lungenembolie und Lungeninfarkt (2005) (0)
Lungenödem und akutes respiratorisches Distress-Syndrom (ARDS) (2002) (0)
ER Stress-induzierte Apoptose findet bei sporadischer Idiopathischer Pulmonaler Fibrose (IPF) exklusiv in alveolären Typ II Zellen (AECII) statt (2009) (0)
Lysozymspiegel und –aktivität sind erniedrigt in den Lungen von Patienten mit Idiopathischer Pulmonaler Fibrose (IPF) und tragen möglicherweise zur erhöhten Empfänglichkeit dieser Patientengruppe für das Auftreten pulmonaler Infektionen bei (2007) (0)
Rolle von Rezeptorkinase-Inhibitoren bei der Rekrutierung und Differenzierung zirkulierender Fibrozyten (2009) (0)
Aberrante Expression und Aktivität von Histon-Deacetylasen (HDAC) in Idiopathic Pulmonary Fibrosis (IPF) (2014) (0)
Suppression des Transkriptionsfaktors HIF-1a durch RNA interference: Effekte auf Zielgene und Zellproliferation in A549 Zellen (2004) (0)
Zeitverlauf hypoxieinduzierter Expressionsregulation in Lungenhomogenat, mikrodisseziierten Lungengefäßen und Alveolarzellen (2004) (0)
CD36, S100A4 und FKBP1– Hypoxie-induzierte Gene bei pulmonaler Hypertonie im Maus-Modell (2006) (0)
Intraselläres Epidermoid mit außergewöhnlichem Gesichtsfeldbefund (1960) (0)
Echokardiographische Beurteilung des rechten Atriums bei der pulmonalen Hypertonie: Relevanz der Reservoir Funktion (2020) (0)
Proteomanalyse von Lungengewebe von Patienten mit Idiopathischer Pulmonaler Fibrose (IPF) (2007) (0)
Relevanz eines persistierenden Foramen ovale bei Patienten mit PAH und vasoaktiver Therapie (2014) (0)
Simvastatin inhibits Staphylococcus aureus alpha toxin mediated polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction (2005) (0)
Study of marine actinobacteria diversity from X region de Los Lagos and evaluation of genes PKS/ NRPS as markers of biological activity (2017) (0)
Sonde de mesure (1995) (0)
Omega-3 Fatty Acid Expression Attenuates Chronic Hypoxia-Induced and Smoke-Induced Pulmonary Hypertension (2022) (0)
Susceptibility of Microtuble-Associated Protein 1 Light Chain 3 Beta Knockout Mice to Lung Injury and Fibrosis (2019) (0)
Imaging the right atrium in pulmonary hypertension: A systematic review and meta-analysis. (2022) (0)
Right atrial pressure to pulmonary artery wedge pressure ratio in chronic thromboembolic pulmonary hypertension (2022) (0)
Right ventricular function and lung perfusion in adaptive versus maladaptive experimental pulmonary hypertension (2021) (0)
Value of Right and Left Ventricular T1 and T2 Blood Pool Mapping in Patients with Chronic Thromboembolic Hypertension before and after Balloon Pulmonary Angioplasty (2023) (0)
Effects of preoperative high-oral protein loading on short- and long-term renal outcomes following cardiac surgery: a cohort study (2022) (0)
Evidence for Multiple Origins of De Novo Formed Vascular Smooth Muscle Cells in Pulmonary Hypertension: Challenging the Dominant Model of Pre-Existing Smooth Muscle Expansion (2021) (0)
TRPA1 Dependent Signaling in Cardiac Dysfunction and Pulmonary Hypertension (2022) (0)
NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD (2020) (0)
Loss of the classical transient receptor potential 3 partially protects from hypoxia-induced pulmonary hypertension in mouse (2020) (0)
Targeting Wnt-ß-Catenin-FOSL Signaling Ameliorates Right Ventricular Remodeling. (2023) (0)
GDF-15 and soluble ST2 as biomarkers of right ventricular dysfunction in pulmonary hypertension. (2023) (0)
Whole-genome sequencing of patients with rare diseases in a national health system (2020) (0)
Murine precision cut lung slices as a novel 3D-model for studying endocytic pathways in the lung (2021) (0)
GLUT1 Expression and Right Ventricular Adaptation to Pressure Overload in Experimental Pulmonary Hypertension (2023) (0)
Protocol Process Evaluation of a Medical Student – Delivered Smoking Prevention Program for Secondary Schools : Protocol for the Education Against Tobacco Cluster Randomized Trial (2019) (0)
Retraction: Nitric Oxide Synthase 2 Induction Promotes Right Ventricular Fibrosis (2022) (0)
Clathrin-Mediated Albumin Clearance in Alveolar Epithelial Cells of Murine Precision-Cut Lung Slices (2023) (0)
The physiological function of the purinergic receptor P2Y2 in pulmonary arterial endothelial cells and its role in pulmonary hypertension (2020) (0)
Impaired FGF10 Signaling Is Involved in the Development of Pulmonary Parenchymal and Vascular Remodeling (2022) (0)
Cell-specific Noxo1 Deletion in a Mouse Model of Cigarette Smoke-induced Emphysema and Pulmonary Hypertension (2023) (0)
Fibroblast growth factor 23 as a biomarker of right ventricular dysfunction in pulmonary hypertension. (2023) (0)
The Role of Mitochondrial Cytochrome Coxidase Subunit 4 Isoform 2 (Cox4i2) in Acute Pulmonary Oxygen Sensing (2022) (0)
Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD (2020) (0)
Nicotine promotes e-cigarette vapour-induced lung inflammation and structural alterations. (2023) (0)
CEACAM6 Impedes the HO-1-Mediated Defence Against Nitrosative/Oxidative Stress in COPD (2022) (0)
Evaluation of Diagnostic Accuracy and Radiation Exposure of Dual-Energy Computed Tomography (DECT) in the Course of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Evaluation der diagnostischen Genauigkeit und der Strahlendosis der Dual-Energy-Computertomografie (DECT) bei chronisch (2021) (0)
Reply to: The acute effects of prostacyclin on right ventricular contractility and pulmonary artery coupling. (2023) (0)
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension (2018) (0)
avorable Effects of Inhaled reprostinil in Severe Pulmonary Hypertension (2006) (0)
MAP Kinase Mediated Cross-Talk Between Macrophages and Pulmonary Artery Smooth Muscle Cells Is Essential for Tobacco Smoke-Induced Pulmonary Vascular Remodeling (2022) (0)
Reply to: Pulmonary Hypertension: A Predictor of Lung Cancer Prognosis? (2021) (0)
Hypercapnia Impairs Endoplasmic Reticulum Function and Decreases Plasma Membrane Abundance of the Na,K-ATPase in Alveolar Epithelial Cells and Precision-Cut Lung Slices (2022) (0)
Effects of Short- and Long-Term Exposure to E-Cigarette Vapour (0)
The fate of resident alveolar macrophages upon influenza virus infection is the result of a complex crosstalk among different innate immunity cell populations (2018) (0)
Regulation and role of the ER stress transcription factor CHOP in alveolar epithelial type-II cells (2019) (0)
Establishment of an In Vitro Model to Study Mesenchymal Cells During Postnatal Lung Development (2020) (0)
Cellular Consequences of Uncharacterized Surfactant Protein-A2 (SFTPA2)-Gene Mutations Associated with Familial Idiopathic Pulmonary Fibrosis (IPF) and Lung Cancer (2019) (0)
Acid Aspiration Leads to Depletion of Resident Alveolar Macrophages and Impairs Their Bactericidal Activity (2019) (0)
Development and Characterization of Reporter Mice for Canonical Transforming Growth Factor (TGF)-β Signaling (2019) (0)
Microenvironmental Th9- and Th17- Lymphocytes Induce Epithelial Mesenchymal Transition and Metastatic Spreading in Lung Cancer (2019) (0)
MiR-154 controls alveologenesis in lung development via TGF-β signaling (2018) (0)
Emerging Role of Adenylate Kinase 4 as a Metabolic Player Regulating Cellular Hypoxic Responses in Pulmonary Cells (2019) (0)
Viral Pneumonia Elicits a Lung Epithelial Repair Program in Transdifferentiating Alveolar Macrophages Characterized by Placenta-Expressed Transcript 1 (Plet1) Expression: Therapeutic Implications (2023) (0)
Analysis of Effectiveness of Pirfenidone in Subgroups of Idiopathic Pulmonary Fibrosis Based on Real World Data from European IPF Registry (2019) (0)
Mendelian randomization analysis of red cell distribution width in pulmonary arterial hypertension (2019) (0)
Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFR b (2020) (0)
Tamoxifen dosing for Cre-mediated recombination in experimental bronchopulmonary dysplasia (2016) (0)
No Impact of Tidal Volume on Disease Progression and Mortality in IPF Patients Recruited into the European IPF Registry (EURIPFREG) (2020) (0)
Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer (2017) (0)
Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis (2019) (0)
Histone deacetylase‐dependent control of lung alveolar fluid clearance (2013) (0)
Acid Aspiration Leads to Metabolic and Mitochondrial Dysfunction and Impaired Bactericidal Properties in Alveolar Macrophages (2020) (0)
Assessment of Regional Pulmonary Ventilation in Spontaneously Breathing Patients with Idiopathic Pulmonary Fibrosis (IPF) Employing Electrical Impedance Tomography (EIT): A Pilot Study from the European IPF Registry (eurIPFreg) and Biobank (2020) (0)
Glucocorticoids promote TGF‐beta signaling in lung fibroblasts by upregulating ligand and receptor expression, and uncoupling negative‐feedback inhibition (2011) (0)
Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis (2019) (0)
Increased Susceptibility to Gammaherpesvirus-Induced Lung Fibrosis of Transgenic Mice with Conditional Overexpression of the Pro-Apoptotic ER-Stress-Factor Chop in Alveolar Epithelium (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Werner Seeger?

Werner Seeger is affiliated with the following schools: